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SUMMARY/RESUMEN 
SUMMARY 
The currently growing interest in studying the human microbiota 
highlights its important contribution to health. Microorganisms perform 
functions critical to host physiology, including metabolism, nutrient 
absorption and immune and protective functions. Diet plays an important 
role in the oral microbiota, being at the same time the most significant 
external factor affecting the intestinal microbiota. Some food ingredients, 
such as polyphenols, probiotic bacteria and prebiotics have been 
demonstrated interesting features for approaching microbial modulation 
studies. 
Polyphenols are plant-derived compounds that show an extensive 
variety of chemical structures, based on which they exert different 
antimicrobial activities. Likewise, the intestinal microbiota can transform 
these food compounds into different metabolites. The capability of some 
bacteria to metabolize polyphenols could provide them with an additional 
advantage inside the complex intestinal ecosystem and could give rise to 
more bioactive metabolites with potential beneficial effects on human 
health. In this respect, Lactobacillus plantarum IFPL935 could exert a 
probiotic effect based on its ability to initiate the metabolism of flaval-3-
ols. Other food ingredients, such as prebiotics, selectively promote the 
composition and/or activity of the intestinal microbiota with beneficial 
effects on the human body. Currently, there is increasing interest in the 
search of new prebiotic ingredients able to modulate the microbiota of 
distal colon regions, usually dominated by proteolytic metabolism. 
The objective of this PhD Thesis has been to evaluate the impact of 
different food ingredients such as polyphenols, potential probiotics such 
as L. plantarum IFPL935 and slow fermentation prebiotics such as 
lactulose-derived oligosaccharides (OsLu), on the oral and intestinal 
microbiota. 
 The comparative study of the impact of different dietary 
polyphenols on the human intestinal microbiota was performed by batch 
incubations of colonic microbiota with cranberry, grape seed and red wine 
polyphenolic extracts. The three phenolic extracts showed antimicrobial 
activity against the microbiota, being Bacteroides, Prevotella and Blautia 
coccoides-Eubacterium rectale the most affected groups among those 
quantified by real time PCR. Grape seed polyphenols showed the highest 
antimicrobial effect among the three tested extracts. 
The modulatory effect of L. plantarum IFPL935 on the human 
intestinal microbiota was studied together with the red wine phenolic 
extract. There were performed batch incubations during 48 h and a long-
term experiment during two weeks, using the dynamic simulator of the 
human microbiota ecosystem, SHIME. By means of quantitative PCR, we 
observed in the batch incubations with red wine polyphenols a lower 
inhibition of Bacteroides and Bifidobacterium groups in presence of L. 
plantarum IFPL935 compared to the incubations without the strain. The 
analysis of fermentative metabolism also showed a higher production of 
butyric acid associated to the presence of L. plantarum IFPL935. 
The feeding of the SHIME during two weeks with red wine 
polyphenols exerted an initial antimicrobial effect over the colonic 
microbiota, being again Bacteroides and B. coccoides/E. rectale the most 
affected groups. It could be observed a gradual recovery of counts for all 
microbial groups through the first days of feeding with the red wine 
extract. However, the fermentative and proteolytic activities did not 
recover the initial levels until the second week of feeding with 
polyphenols. In this context, L. plantarum IFPL935 showed a protective 
role against the antimicrobial effect on the butyrate-producing groups, 
Ruminococcus, B. coccoides/E. rectale and Clostridium leptum. Likewise, 
L. plantarum IFPL935 had a positive impact on the butyric acid production 
in distal colon regions. 
 Concerning polyphenols metabolism, in presence of the complex 
human colonic microbiota, L. plantarum IFPL935 was able to initiate the 
metabolism of flavan-3-ols, detected by the significant increase of 
intermediate compounds such as diphenylpropan-2-ol, (5-(3′-
hydroxyphenyl)-γ-valerolactone and 4-hydroxy-5-(3’-hydroxyphenyl)-
valeric acid, and favoured the formation of end metabolites such as 
phenylpropionic acids. 
With the aim of evaluating the effect of moderate red wine intake on 
the composition of the oral and intestinal microbiota, it was performed a 
human intervention study during four weeks. Both, quantitative PCR and 
PCR-DGGE analysis of the salivary microbiota and metagenomic 
analysis of the faecal samples from the volunteers, did not show 
significant changes on the composition of the microbiota from both 
environments. The most predominant genera detected in saliva were 
Streptococcus (8 log bacteria/mL) and Lactobacillus and Prevotella (7 log 
bacteria/mL). In faeces, they were detected 2324 phylotypes, of which 30 
were found over the 0.5% of mean relative frequency, representing an 
84.6% of the total taxonomical assignments and bellowing to Firmicutes, 
Actinobacteria, Bacteroidetes and Proteobacteria phyla. Shannon index 
calculation showed an increase in microbial diversity of faecal samples 
after wine intake. However, the large inter-individual variability observed 
in the profiles of the intestinal microbiota exerted a stronger influence for 
the grouping of samples by individuals than the possible influence of wine 
intake. 
In order to unravel the effect of slow fermentation prebiotics on the 
human microbiota differentiated by colonic regions, it has been developed 
a new dynamic automatic in vitro gastrointestinal simulator (SIMGI). The 
computer-controlled system allows simulating the physiologic process of 
digestion and fermentation inside the human gastrointestinal tract. In 
addition, in this work, it has been demonstrated the capability of the 
 SIMGI to stable reproduce the composition and fermentative activity of 
the ascending, transverse and descending colon regions of the human 
microbiota. Thus, this system allowed performing the evaluation of the 
prebiotic effect of OsLu on the region-specific colon human microbiota. 
The stabilization of the human faecal microbiota inoculated in the SIMGI 
and differentiated by colonic regions was reached by feeding the system 
with a high energy diet based on the high content of fructose and easily 
fermentable carbohydrates. The quantitative PCR results did not show 
significant shifts in the composition of the microbiota due to the feeding 
with OsLu, but it allowed maintaining the microbial fermentative 
functionality, represented by net butyric acid production in the ascending 
colon region. In addition, it was avoided a full transition to proteolytic 
metabolism profiles, which took place when changing to a diet in which 
easily fermentable carbohydrates were removed. 
  
 RESUMEN 
El creciente interés dedicado al estudio de la microbiota humana 
ha puesto de manifiesto su importante contribución en la salud. Los 
microorganismos desempeñan funciones críticas para la fisiología del 
hospedador, incluyendo el metabolismo, la absorción de nutrientes y 
funciones inmunológicas y protectoras. La dieta juega un papel 
significativo en la microbiota oral, siendo a la vez el factor externo más 
relevante que afecta a la microbiota intestinal. Algunos ingredientes 
alimentarios, como los polifenoles, las bacterias probióticas y los 
prebióticos, poseen características que los hacen interesantes para 
abordar estudios de modulación de la microbiota oral e intestinal.  
Los polifenoles son compuestos presentes en las plantas que 
poseen una amplia variedad de estructuras químicas y en función de las 
mismas muestran cierta variabilidad en su actividad antimicrobiana. Así 
mismo, la microbiota intestinal puede transformar estos compuestos de 
los alimentos en diferentes metabolitos. La capacidad de algunas 
bacterias para metabolizar polifenoles puede aportarles ventajas dentro 
del ecosistema intestinal, además de favorecer la formación de 
metabolitos bioactivos beneficiosos para el organismo. En este sentido, 
Lactobacillus plantarum IFPL935 podría ejercer un efecto probiótico ya 
que posee la capacidad de iniciar el metabolismo de flavan-3-oles. Otros 
ingredientes alimentarios, como los prebióticos, favorecen selectivamente 
la composición y/o actividad de la microbiota intestinal que ejerce 
beneficios en la salud. En la actualidad se tiende a la búsqueda de 
nuevos prebióticos que puedan modular la microbiota de zonas distales 
del colon que suelen estar dominadas por un metabolismo proteolítico. 
El objetivo de la Tesis Doctoral ha sido evaluar el impacto de 
diferentes ingredientes alimentarios como polifenoles, potenciales 
probióticos como L. plantarum IFPL935 y prebióticos de fermentación 
 lenta como oligosacáridos de lactulosa (OsLu) sobre la microbiota oral e 
intestinal humana. 
La comparación del impacto de diferentes polifenoles de la dieta en 
la microbiota intestinal se realizó mediante incubaciones en condiciones 
estáticas de microbiota colónica con extractos de polifenoles de 
arándano rojo, pepita de uva y vino tinto. Los tres extractos fenólicos 
mostraron actividad antimicrobiana frente a la microbiota, siendo 
Bacteroides, Prevotella y Blautia coccoides-Eubacterium rectale los 
grupos bacterianos más afectados de los cuantificados por PCR a tiempo 
real. El extracto de pepita de uva mostró la mayor actividad 
antimicrobiana de los tres extractos estudiados. 
El efecto modulador de la cepa L. plantarum IFPL935 sobre la 
microbiota intestinal se estudió junto con el extracto de polifenoles de 
vino tinto. Se realizaron incubaciones tanto en condiciones estáticas 
durante 48 h, como durante dos semanas en el simulador dinámico del 
ecosistema microbiano intestinal humano SHIME. Mediante 
cuantificación por PCR a tiempo real, en las incubaciones estáticas con 
polifenoles de vino tinto se pudo observar una menor inhibición de los 
grupos bacterianos Bacteroides y Bifidobacterium en presencia de L. 
plantarum IFPL935. El análisis del metabolismo fermentativo también 
mostró una mayor producción de ácido butírico asociada a la presencia 
de L. plantarum IFPL935. 
La alimentación del SHIME durante dos semanas con el extracto 
de polifenoles de vino tinto ejerció un efecto antimicrobiano inicial sobre 
la microbiota colónica, observándose de nuevo la mayor inhibición frente 
a Bacteroides y B. coccoides/E. rectale. Se pudo observar una 
recuperación progresiva de los recuentos de todos los grupos 
microbianos durante los primeros días de administración del extracto de 
vino tino. Sin embargo, las actividades fermentativa y proteolítica no 
recuperaron los niveles iniciales hasta la segunda semana de suministro 
 de polifenoles. En este contexto, L. plantarum IFPL935 mostró un papel 
protector del efecto antimicrobiano sobre los grupos productores de ácido 
butírico Ruminococcus, B. coccoides/E. rectale y Clostridium leptum. 
Asimismo, L. plantarum IFPL935 ejerció un impacto positivo sobre la 
formación de ácido butírico en regiones colónicas distales. 
En relación al metabolismo de polifenoles, L. plantarum IFPL935 
en presencia de microbiota intestinal inició el metabolismo de flavan-3-
oles, detectado por el aumento significativo de la concentración de 
compuestos intermediarios como dihidroxifenilpropan-2-ol, 5-(3′-
hidroxifenil)-γ-valerolactona y ácido 4-hidroxi-5-(3′-hidroxyfenil)valérico, y 
favoreció la formación de metabolitos finales como ácidos 
fenilpropiónicos. 
Con objeto de evaluar el efecto del consumo moderado de vino 
tinto sobre la microbiota oral e intestinal, se llevó a cabo un estudio de 
intervención en humanos durante un periodo de cuatro semanas. Tanto 
el análisis por PCR cuantitativa y PCR-DGGE de la microbiota de la 
saliva de los voluntarios como el análisis metagenómico de sus muestras 
fecales, mostraron que no hubo cambios significativos en la composición 
de las poblaciones bacterianas. Los generos mayoritarios detectados en 
saliva fueron Streptococcus (8 log bacterias/mL) y Lactobacillus y 
Prevotella (7 log bacterias/mL). En heces, se detectaron más de 2324 
filotipos, de los cuales 30 tenían frecuencias relativas medias por encima 
del 0,5%, representaban el 84,6% del total de las asignaciones 
taxonómicas y pertenecían a los filos Firmicutes, Actinobacteria, 
Bacteroidetes y Proteobacteria. El cálculo del índice de Shannon mostró 
un aumento de la biodiversidad en las muestras de heces de los 
voluntarios tras el consumo de vino. Sin embargo, la alta variabilidad 
interindividual observada en los perfiles de la microbiota intestinal tuvo 
mayor efecto en el agrupamiento por individuos que el que pudiera 
ejercer el consumo de vino. 
 Para evaluar el efecto de ingredientes alimentarios, particularmente 
de prebióticos de fermentación lenta, sobre la microbiota humana 
diferenciada en regiones colónicas, se ha llevado a cabo el desarrollo de 
un nuevo modelo dinámico automatizado de simulación gastrointestinal in 
vitro (SIMGI). El sistema está controlado por ordenador y permite simular 
los procesos fisiológicos de digestión y fermentación que tienen lugar en 
el tracto gastrointestinal humano. Además, en este estudio se ha 
demostrado la capacidad del SIMGI para reproducir de manera estable la 
composición y la actividad fermentativa de la microbiota representativa 
de las regiones del colon ascendente, transverso y descendente. El 
simulador permitió, por tanto, llevar a cabo la evaluación del efecto 
prebiótico de los OsLu en la microbiota humana de distintas regiones del 
colon. La estabilización de la microbiota fecal humana inoculada en el 
SIMGI y diferenciada por regiones colónicas se alcanzó alimentando el 
sistema con una dieta con alto contenido energético, rica en fructosa y 
carbohidratos fácilmente fermentables. Los resultados de cuantificación 
microbiana por PCR a tiempo real no mostraron variaciones significativas 
en la composición de la microbiota debidas a la alimentación con OsLu, 
pero permitió mantener la funcionalidad fermentativa de la microbiota, 
reflejada en la producción neta de ácido butírico en la región ascendente 
del colon. Además, se evitó la transición completa a perfiles metabólicos 
proteolíticos que tuvieron lugar en el cambio a una alimentación en la que 
se eliminaron los carbohidratos fácilmente fermentables. 
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I.1 THE HUMAN MICROBIOTA 
Humans harbour densely resident microbial communities including 
bacteria, fungi, parasites and viruses refereed as microbiota and the 
genes they encode are known as microbiome (Hooper et al., 2010; 
Clemente et al., 2012). These human microbial populations contain more 
than 100 times the number of genes and 10 times the number of cells 
compared with the host (Qin et al., 2010; Huttenhower et al., 2012). 
Different sites in humans are colonized by microbial communities 
during neonatal and childhood development and throughout the lifetime of 
individuals. Each human habitat harbours a characteristic microbiota 
represented by a set of abundant taxa that is stable between individuals 
and over time (Reid et al., 2011). (Figure I.1). The oral cavity is densely 
populated with 108-1011 bacteria/g in dental plaque, somewhat higher 
than vagina with 108-109 bacteria/mL (Costello et al., 2009; Lamont et al., 
2011; Zhou et al., 2013). The skin is generally low densely populated, but 
regions such as the axillae and the perineum support much more 
microbes in number but less diversity (Grice and Segre, 2011; Callewaert 
et al., 2013). The upper regions of the respiratory tract also harbour high 
density of bacteria which markedly decrease to reach the bronchi and 
alveoli (Charlson et al., 2011). Within the gastrointestinal tract, the 
population densities and communities also vary depending on the site: 
the stomach, duodenum, and ileum have low population densities, 
whereas the jejunum, caecum, and colon are densely populated, 1011-
1012 bacteria/g (Huttenhower et al., 2012). Overall, the oral cavity and 
colon show by far the highest density of bacterial populations in the whole 
body. (Figure I.1) 
Many of these microorganisms such as those inhabiting the skin, 
oro-gastrointestinal or vaginal tract have co-evolved with humans along 
millions of years and show a mutualistic relationship with them. In most 
cases, healthy humans get used to their microbiota and either friendly 
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tolerates it and/or get profit on it. Microorganisms perform functions 
critical to host physiology, including metabolism, nutrient absorption and 
immune and protective functions (Walsh et al., 2014), while in turn, the 
host supplies niches and nutrients to the microbiota. 
  
  
Figure I.1. Distribution of the indigenous microbiota of the human body.  
Oral cavity
- Dental plaque 1011 bacteria/g
- Saliva 108 109 bacteria/ml
• very densely populated
• complex microbiota
• many species not yet identif ied
Skin
• sparsely populated  but axillae
and perineum densely 
populated
Urinary tract
• usually sterile except for
distal region of  urethra
Vagina
-Vaginal discharge 109 bacteria /ml
• densely populated
• microbiota dominated by lactobacilli
Upper respiratory tract
(anterior nares, nasopharynx, oropharynx)
• complex microbiota
• composition depends on anatomical site
Lung
• normally sterile
Gastrointestinal tract
Stomach <103 bacteria/g
Small intestine 105-107 bacteria/g
Colon 1011-1012 bacteria/g
•very densely populated
• contains most of  indigenous microbiota
• very complex microbiota
• many species not yet identif ied
Internal tissues
• normally sterile
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I.1.1 Acquisition and development of oral and intestinal 
microbiota 
In classic studies about acquisition of the intestinal microbiota 
(Tissier, 1900), it was stated that the body is sterile before birth. 
Nevertheless, there is evidence of bacteria presence in placenta, 
umbilical cord, amniotic fluid and meconium in healthy neonates (Jiménez 
et al., 2008; Moles et al., 2013; Stout et al., 2013; Aagaard et al., 2014). It 
has been hypothesized a process for transporting bacteria from the 
mother oral cavity to the placenta during pregnancy carried out by the 
blood (Zaura et al., 2014), based on the fact that human oral microbiota 
was found to be most akin to the placenta microbial profiles than the 
vaginal and faecal microbiota (Aagaard et al., 2014). These early 
microbial exposure of the foetus to maternal oral microbiota in placenta 
could represent a mechanism of “training” for the foetal immune system 
(Aagaard et al., 2014; Zaura et al., 2014). 
During and following birth, neonates become colonized by a vast 
array of microorganisms from the mother´s birth canal or skin, or from 
other environmental sources (Zaura et al., 2014). Vertical transmission 
from the mother to child during birth affects the diversity of the oral 
microbiota. Vaginally delivery mode has showed to positively affect the 
microbial diversity of children at 3 months of age (Holgerson et al., 2011). 
In addition, Li and colleagues have reported that oral microbiota of infants 
born with caesarean section acquired Streptococcus mutans almost one 
year earlier than vaginally born infants (Li et al., 2005); this species has 
been identified as a significant contributor to tooth decay. On the other 
hand, in the oral cavity the first persistent colonizers dominating nearly all 
oral mucosal sites are other species of Streptococcus (S. oralis, S. mitis, 
S. peroris and S. salivarius) (Zaura et al., 2014). Breast feeding also 
affects infant microbiota. It has been shown that Lactobacillus colonized 
the oral cavity of breastfed infants significantly more frequently than 
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formula fed infants, being L. gasseri the most prevalent species, which 
has showed probiotic properties that could influence the composition of 
the oral microbiota in infants (Vestman et al., 2013). The range of 
microorganisms that can be isolated from the oral cavity increases 
following the emergence of teeth and along the life. Horizontal 
transmission of microbiota among people from the same environment 
also affects oral microbiota diversity (Zaura et al., 2014). Local alterations 
in the environment, due to microbial activity (oxygen consumption, pH 
changes, etc.) and the provision of new sites for colonization and 
nutrients (bacterial cells themselves), promote the establishment of the 
adult-like microbial community. The oral cavity has two main types of 
surfaces for microbial colonization: non-shedding (teeth) and shedding 
(mucus). Studies of the oral cavity have shown that these different 
structures are colonized by distinct microbial communities (Marsh and 
Percival, 2006). Once established, the health microbiome should be 
sustained. In adults, factors such as correct hygiene permit a correct 
balance between host and microorganisms that helps to maintain oral 
health (Jenkinson and Lamount, 2005; Marsh and Percival, 2006). Under 
these conditions, dental plaque (in which microorganisms form a dynamic 
and complex ecosystem called biofilm) can have a protective role; 
however, it could also have a role as a reservoir of bacteria involved in 
caries and periodontitis (Jenkinson and Lamount, 2005; Marsh and 
Percival, 2006). The term supragingival plaque refers to those biofilms 
that are formed on the tooth surface above the level of the gingival 
margin. It could contain as much as 1011 bacteria/g of plaque, especially 
in patients with periodontitis (Marsh and Devine, 2011). In comparison to 
teeth and tongue, saliva presents a lower microbial load, containing 
approximately 108 bacteria /mL. 
The same as oral microbiota, the gastrointestinal microbiota is 
structured mainly by the mode of birth delivery. Infants born vaginally 
have communities resembling their own mother’s vaginal microbiota, 
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dominated by Lactobacillus, Prevotella or Sneathia (Reid et al., 2009; 
Reid et al. 2011). In contrast, those delivered by caesarean section 
harbour a microbiota characteristic of the skin communities of the mother, 
and are dominated by Staphylococcus, Corynebacterium and 
Propionibacterium (Reid et al., 2011). Since the intestine of the newborn 
contains oxygen, this initial colonization is slowly progressing towards 
dominance of facultative anaerobes, such as members of the 
Enterobacteriaceae family. Later, when gut turns out completely 
anaerobic, strict anaerobic bacteria dominate the microbial community, 
such as Bifidobacterium, Clostridium and Bacteroides. Furthermore, the 
composition of the intestinal microbiota can greatly differ between infants 
that are fed with either breast milk or formula. Human-breast milk 
contains its own microbial consortium (Hunt et al., 2011), along with non-
digestible oligosaccharides (human milk oligosaccharides, HMOs), 
maternal antibodies (IgA) and antimicrobial factors. In this regard, 
Bifidobacterium dominate the gut of breast-fed infants while formula fed 
infants show higher proportions of Bacteroides and Clostridium (Fallani et 
al., 2010; Bezirtzoglou et al., 2011). Furthermore, due to the bacterial 
DNA similarities found between human milk, maternal faecal samples, 
infant faeces and maternal peripheral blood mononuclear cells, it has 
been suggested that intestinal bacteria could migrate via the blood and 
lymph circulation to the mammary gland, for the formation of the breast 
milk microbiome. This represents a similar transport mechanism of that of 
the maternal oral microbiota to placenta (Jeurinketal et al., 2013). 
The introduction of solid food represents another important shift in 
the gut microbiota. It has been reported two distinct phases in gut 
colonization after birth separated by the introduction of solid foods (Vallés 
et al., 2014). Nutrients that become available to the infant gut microbiota 
strongly increase with solid foods, including numerous complex 
carbohydrates found in cereals, fruits, vegetables and tubers, providing 
new substrates that contribute to the increase in diversity. This is shown 
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in the rise of Bacteroides observed in 7-months infants (Vallés et al, 
2014). Furthermore, some new genera start to be detected, this is the 
case of Ruminococcus, which thrives on oligosaccharides (Cervera-Tison 
et al., 2012) and Akkermansia, a mucin degrader genus linked to the 
presence of new sources of protein (Derrien et al., 2010). 
Bifidobacterium, Veillonella and Escherichia decrease at one year old 
age, and short chain fatty acids (SCFAs) producers, such as Blautia, 
Butyrivibrio, Faecalibacterium, Eubacterium, Roseburia and Clostridium 
leptum, rise in abundance at this time. It has been suggested that the 
main core of the gut community is established at the age of one year; 
however, recent cross sectional studies have suggested that an adult-like 
gut community is not reached before three years of age (Yatsunenko et 
al., 2012). Until this age the microbiota of children shows larger inter-
individual variability and lower diversity than in adults (Lozupone et al., 
2012). It has been observed that changes in the microbiota in early life, 
due among other factors to antibiotic use, affect the microbial composition 
and susceptibility to immunological diseases into adulthood, although the 
biological mechanisms are not well understood (Kozyrskyj et al., 2011). 
Despite the highly unstable early stage of microbial colonization, 
the establishment of the adult intestinal ecosystem seems to follow a 
conventional program in healthy conditions (El Aidy et al., 2013). Due to 
the physiological and microbial changes in the intestinal environment, it 
leads to the final colonization of a robust and stable microbiota dominated 
by Firmicutes, Bacteroidetes and Actinobacteria, able to develop the 
mutualistic relation with the host, needed to maintain the intestinal 
homeostasis (Bäckhed et al., 2005; Yatsunenko et al., 2012). However, 
during pregnancy it has been shown an increase in Actinobacteria and 
Proteobacteria, but the gut microbiota returns to its original structure after 
delivery (Koren et al., 2012). Furthermore, elderly (>65 years old) are 
associated with an increase in the abundance of Bacteroidetes and a 
decrease in diversity and displays greater inter-individual variability than 
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that of younger adults (Claesson et al., 2011). The inter-individual 
variation in microbiota composition of elderly is associated to residence 
location, long-term stay in hospitals or rehabilitation clinics and antibiotics 
usage, among others (Claesson et al., 2011). 
I.1.2 Community composition and diversity of oral and intestinal 
microbiota 
I.1.2.1 Culture-independent techniques for studying the human 
microbiota 
Our understanding of the indigenous human microbiota and its 
composition, how it interacts with the host and how it maintains the 
balance in human health or causes disease, has been enhanced by 
advances in culture-independent techniques (Fraher et al., 2012). For 
many years, culture and biochemical typing have been very useful and 
even essentials to identify bacterial species. However, since the 1990s 
the development of culture‐independent techniques based on 16S rRNA 
gene sequences has revolutionized our knowledge and helped to 
evaluate the composition of the human microbiota (Rajilić-Stojanović et 
al., 2007; Ventura et al., 2009; Marchesi, 2011). These 
culture‐independent techniques have allowed demonstrating the microbial 
diversity of the human microbiota, providing qualitative and quantitative 
knowledge on bacterial species and changes in the microbiota in relation 
to health and disease (Fraher et al., 2012). Examples of these techniques 
are denaturing gradient gel electrophoresis (DGGE), quantitative 
polymerase chain reaction (qPCR), DNA microarrays, sequencing of 
cloned 16S rRNA gene amplicons and next-generation sequencing of the 
16S rRNA genes and microbial genomes (Table I.1). These next-
generation methods are typically applied to DNA amplicons directly or to 
the total genomic DNA. They are described as massively parallel 
sequencing as ‘massive’ numbers of DNA templates can be sequenced in 
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parallel; that is, at the same time and in the same reaction set-up, a very 
large amount of short sequences can be read and thus even bacteria that 
are in low abundance can be detected (Rogers and Venter 2005, Fraher 
et al., 2012). Commercially available technologies include 454 
Pyrosequencing®, Illumina®, SOLiD™ and Ion Torrent™ (Table I.1). The 
term metagenomics in microbiology refers to the study of the collective 
genomes of the microbiota from a site (named microbiome). Thus the 
metagenomic studies consist of sequencing all the DNA of a sample 
rather than a particular DNA fragment (Sekirov et al., 2010). Large 
metagenomic studies are that of The Human Microbiome Project, which 
has studied the structure, function and diversity of the healthy human 
microbiome from hundreds of samples and their correlations with diet and 
age (Huttenhower et al., 2012) and the Metagenomics of the Human 
Intestinal Tract (MetaHIT) project that has studied the metagenomic 
profile of hundreds of faecal samples from healthy adults, 
overweight/obese individuals and intestinal bowel disease patients (Qin et 
al., 2010; Arumugam et al., 2011). Due to the increasingly easy access of 
these culture-independent technologies, there is currently an increase of 
research groups performing broad spectrum studies of the human 
microbiota for different purposes, most of them related with health 
(Thomas et al., 2014). 
Metagenomic approaches have started to put forward the microbial 
functionalities embedded into the human microbiota (Lepage et al., 2013). 
The easy access to the oral cavity has allowed sampling and therefore 
obtaining much information of the microbiota from the different surfaces 
inside on it, such as buccal mucosa, subgingival and supragingival 
plaque, saliva, tongue, etc. (Wade, 2013; Zaura et al., 2014). However, 
most of the studies about composition, diversity and functions of the 
human gut microbiota have been conducted with faecal material (De 
Filippo et al., 2010; Wu et al., 2011; Huttenhower et al., 2012; Methé et 
al., 2012; Voreades et al., 2014), due to the easy and non-invasive 
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methods required to obtain these samples. It is generally accepted that 
faecal samples could represent luminal microbiota; however, mucosal 
associated microbiota, as well as the microbial communities present in 
the different colonic regions, are not represented, being only accessible 
by invasive methods so far (Watt et al., 2013). 
  
 Table I.1. Techniques for studying the human microbiota. 
 
Adapted from Fraher et al., 2012. 
Technique Description Advantages Disadvantages
Culture Selective media for isolation of bacteria. Semi-quantitative, cheap. Limited to certain bacterial groups, 
time consuming.
Quantitative - PCR Amplification and quantification of 16S rRNA. High sensitivity, quantitative, No identification of unknown species, 
The PCR product is labeled with a fluorochrome reporter. fast, phylogenetic identification PCR bias.
Fluorescence is directly proportional to the amount of product. and gene expression.
DGGE/TGGE Gel separation of 16S rRNA amplicons in bands using Semi-quantitative, bands can No phylogenetic identification, 
(denaturing gradient gel electrophoresis/ denaturant/temperature. Obtaining a molecular fingerprint. be excised and sequenced. PCR bias.
temperature gradient gel electrophoresis)  Each band represents one specie.
FISH Fluorescently labelled oligonucleotide probes hybridize Phylogenetic identification, Dependent on probe sequences,
(fluorescence in situ hybridization) complementary target 16S rRNA sequences. semi-quantitative, no PCR bias, unable to identify unknown species.
 When hybridization occurs, fluorescence can easily differentiate between 
can be enumerated using flow cytometry. live and dead cells.
DNA microarrays Fluorescently labelled oligonucleotide probes hybridize Phylogenetic identification, Cross hybridization, PCR bias, 
with complementary nucleotide sequences. semi-quantitative, fast, simultaneous species present in low levels 
 Fluorescence detected with a laser. identification of thousands of genes. can be difficult to detect.
Cloned 16S rRNA gene sequencing Cloning of full-length 16S rRNA amplicon, sanger Phylogenetic identification, PCR bias, laborious, expensive,
sequencing and capillary electrophoresis. quantitative.  cloning bias.
Direct sequencing of 16S rRNA amplicons Massive parallel sequencing of partial 16S rRNA Phylogenetic identification and 
amplicons for example, 454 Pyrosequencing® (Roche biodiversity analysis, PCR bias, expensive, laborious.
Diagnostics GMBH Ltd, Mannheim, Germany) (amplicon quantitative, fast, identification of
immobilized on beads, amplified by emulsion PCR, addition unknown bacteria, not need to insert
of luciferase results in a chemoluminescent signal)  gene fragments in a host.
Microbiome shotgun sequencing Massive parallel sequencing of the whole genome Phylogenetic identification, quantitative, Expensive, analysis of data is
(e.g. 454 pyrosequencing®, Illumina®, Ion Torrent™) whole-genome sequencing, allows computationally intense.
analysis of biodiversity and functionality. 
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I.1.2.2 Oral microbiota 
More than 200 microbial species from the oral cavity have been 
isolated using classical culture techniques, while culture-independent 
molecular methods primarily using 16S rRNA gene-based cloning studies 
have identified approximately 600 more phylotypes (Dewhirst et al., 
2010). Today, it is thought that the number may reach 10000 phylotypes 
as revealed by pyrosequencing analyses (Keijser et al., 2008; Zaura et 
al., 2009; Diaz, 2011). The bacterial community of the mouth is 
dominated by the phyla Firmicutes (Streptococcus, Veillonellaceae, 
Granulicatella), Proteobacteria (Neisseria, Haemophilus), Actinobacteria 
(Corynebacterium, Rothia, Actinomyces), Bacteroidetes (Prevotella, 
Capnocytophaga, Porphyromonas), Spirochaetes and Fusobacteria 
(Fusobacterium) (Lazarevic et al., 2009; Zaura et al., 2009; Lazarevic et 
al., 2010), which account for 96% of the species detected (Dewhirst et al., 
2010). The proportion of the microbiota that has been cultivated 
(approximately 40%) is higher for the oral cavity than for many other body 
sites. This reflects both the ease of access to samples for analysis and 
the great interest shown in the oral microbiota over time due to its role in 
two of the most common infections of humans, caries and periodontal 
diseases (Fitzgerald and Keyes, 1960; Bradshaw et al,. 2013). The main 
species on supragingival plaque belong to Streptococcus (mainly S. 
sanguis, S. oralis and S. mitis), Neisseria, Haemophilus and Actinomyces 
(Marsh and Devine, 2011). Recent studies of salivary microbiota in adults 
have revealed a characteristic microbial community with certain stability 
and a persistence of subject-specificity (Lazarevic et al., 2010; Stahringer 
et al., 2012; Romano-Keeler et al., 2014). Despite the variety of habitats 
and microbial communities in the oral cavity, there are species common 
to all sites that have been reported to belong to the genera 
Streptococcus, Abiotrophia, Gemella, Granulicatella and Veillonella 
(Dewhirst et al., 2010). 
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I.1.2.3 Intestinal microbiota 
The intestinal microbiota is a complex and dynamic community that 
contains a diverse range of microorganisms. The different regions of the 
intestinal tract vary widely in terms of transit time, pH, oxygen and nutrient 
availability, host secretions, mucosal surfaces and interactions with the 
immune system, all of which affect microbial composition. Metagenomic 
studies have shown that the majority of gut microbiota sequences belong 
to bacteria (Eckburg et al., 2005; Qin et al., 2010; Arumugam et al., 
2011). Currently, only a small minority of these bacteria -over 400 
species- has been successfully isolated and cultured (Eckburg et al., 
2005; Rajilić-Stojanović et al., 2007). More recently, culture-independent 
techniques have indicated that well over 1000 species are capable of 
colonizing the human gut (Huttenhower et al., 2012). Despite the high 
density of bacteria in the human gut and their complexity, diversity at the 
division level is low. Firmicutes, Bacteroidetes and Actinobacteria 
represent the dominant phyla, being 60-90% of the total population 
(Neish, 2009; Walker at el., 2011). The rest of the dominating bacterial 
phyla correspond to Proteobacteria, Verrucomicrobia and Fusobacteria 
(Eckburg et al., 2005; Tap et al., 2009; Arumugam et al., 2011). Within 
the Firmicutes phylum, 95% of the phylogenetic types are members of the 
Clostridia class, and much of them are related to butyrate‐producing 
bacteria, all of which fall within the clostridial clusters IV, XIVa, and XVI 
(Eckburg et al., 2005; Tap et al., 2009). Other bacteria commonly found in 
the human gut at genus level are Bacteroides, Faecalibacterium, 
Bifidobacterium, Roseburia, Alistipes and Lactobacillus that vary 
depending on age and individuals (Arumugam et al., 2011; Mueller et al., 
2006; Frank et al., 2007). Although there is a huge inter-individual 
variability in the intestinal microbiota composition, it has been suggested 
that the microbiota of most individuals can be categorized into one of 
three variants or ‘‘enterotypes’’ clusters, that are not nation or continent 
specific, dominated by Bacteroides, Prevotella and Ruminococcus, 
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respectively (Arumugam et al., 2011). These clusters may in fact be more 
appropriately characterized as a ratio of the abundance of Bacteroides 
and Prevotella, with the Ruminococcus enterotype folded into the 
Bacteroides group (Wu et al., 2011). These broad patterns were strongly 
associated with long-term diets, particularly protein and animal fat 
(Bacteroides) versus carbohydrates (Prevotella) (Wu et al., 2011); it 
remains to be seen how important they are in understanding overall 
microbial community functions. More recent studies, however, suggested 
rethinking about the term enterotypes, as most human gut microbiome 
data collected to date support continuous gradients of dominant taxa 
rather than discrete enterotypes; furthermore, an individual’s enterotype 
can be highly variable (Jeffery et al., 2012; Knights et al., 2014). 
I.1.3 Functions of the oral and intestinal microbiota: the impact 
on human health 
It is clear that the mutualistic relationship between the microbiota 
and the human host is essential in health maintenance (Wade, 2013; 
Zaura et al., 2014), but these interactions may vary according to the 
individual. Moreover, the genetic background, age, diet and health status 
of the host affect the activity and composition of the microbiota (Ottman et 
al., 2012). 
I.1.3.1 Oral microbiota 
The first function of the oral cavity during food ingestion is informing 
our brain of the palatability and acceptance of the food, as well as its 
processing by mechanical and hydrodynamic forces into suitable forms 
further digested in the gastrointestinal tract. In addition, the concerted 
action of different enzymes (amylase, ß-glucosidases, peptidases and 
esterases) from salivary glands, epithelial cells and/or bacteria, could 
initiate the digestion process of multiple diet components and permit 
growth of bacteria using saliva and mucus as a nutrient source. Further, 
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within the complexity of oral biofilms, the microbial species form 
communities with metabolic functions and inter- and intra-species 
interactions, and gain significant advantages such as protection against 
host defences and antimicrobial agents (Marsh and Devine, 2011; Wade, 
2012). Moreover, there is a host–microbiota cross talk during biofilm 
development that allows establishment of a healthy balance (De Ryck et 
al., 2014). 
The function of the oral microbiota leads to the interactions 
between beneficial or potentially pathogen oral bacteria, which have been 
divided into competition for nutrients, synergy, antagonism, neutralization 
of virulence factors and interference in signaling mechanisms (Kuramitsu 
et al., 2007). The maintenance of the functional stability and homeostasis 
along the life also depends on bidirectional interactions between the 
microbiota and the host (Zaura et al., 2014). Besides, it has been stated 
that the complex oral ecosystem, and not a unique bacteria, is 
responsible for the development of dental caries and other oral diseases 
(Jenkinson and Lamont, 2005; Siqueira and Rôças, 2009). 
Oral surfaces are continuously bathed in saliva, which contains a 
characteristic bacterial community, represents a nutrient source and 
keeps the pH close to neutrality. Thus, the saliva also plays an important 
role in the development and maintenance of the healthy microbial 
ecosystem (Stahringer et al., 2012; Romano-Keeler et al., 2014) and it is 
considered useful as a disease indicator (Mager et al., 2005; Lazarevic et 
al., 2010). Additionally, saliva contains lysozyme, peroxidase, amylase, 
secretory leukocyte, lactoferrin, transferrin and antimicrobial proteins 
(such as salivary immunoglobulins and salivary chaperokine) that are 
involved in both the innate and acquired immunity, and it represents an 
important tool for exclusion of transient pathogen microbes entering the 
mouth. Besides, saliva also plays an important role in the healing of 
several mucosal lesions, wounds and ulcers (Fábián et al., 2012). 
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The relevance of oral microbiota in the oral health and the 
knowledge about its impact on overall human health have been 
increasing in recent years (Wade, 2013; Arrieta et al., 2014). However, 
until now most of the studies addressing the oral microbiota had been 
focused on disease, when the symbiotic balance between the microbiota 
and the host is lost. This is reflected in the abundant information about 
the state of oral disease as opposed to the knowledge of the state of the 
healthy microbiota (Bartold and VanDyke, 2013; Bradshaw and Lynch, 
2013; Wade, 2013; Belibasakis, 2014). In vitro experiments using dental 
plaque microcosms indicate that differences in plaque species 
composition and functional activity are dependent of the individual host 
environmental characteristics (Filoche et al., 2007; 2008). When the 
host’s diet is rich in easily fermentable carbohydrates, such as sucrose, 
the pH can fall due to the production of acid by the microbiota, and it 
could allow colonization by acidophilic species that can result in dental 
caries (Marsh and Devine, 2011). Moreover, these microbiota responses, 
biomass yield and pH response to sucrose and starch are also different 
among individuals, which suggest that the increase in the prevalence of 
caries-associated pathogens is host specific (Marsh et al., 2011). 
I.1.3.2 Intestinal microbiota 
The human intestinal microbiota is currently being described as 
another organ due to the variety of functions that exert (Doré et al., 2013). 
It plays a role in metabolism, immunity, inflammation and cell proliferation, 
and is capable of communicating with distant organs of the host, including 
the brain. A balanced intestinal microbiota is crucial to health; thus, it is 
considered as a positive attribute, while imbalances or dysbiosis in the 
intestinal microbiota are associated with development of several diseases 
(Doré et al., 2013). 
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In order to summarize the importance of the intestinal microbiota 
and its activity in the human health, we may classify its functions in 
metabolic and trophic, protective and immunomodulatory functions 
(Guarner and Malagelada, 2003; Panda et al., 2014) (Figure I.3). 
The metabolic and trophic functions of the microbiota provide the 
host with metabolic capabilities lacking in human intestinal cells such as 
fermentation of non-digestible dietary components, methanogenesis, 
gluconeogenesis, fat storage regulation, processing of xenobiotics and 
biosynthesis of essential amino acids, vitamins and isoprenoids (Walter et 
al., 2006; Pandeya et al., 2012). Non-digestible carbohydrates present in 
the colon comprise unabsorbed monosaccharides (fructose, glucose), 
oligosaccharides and polysaccharides. The intestinal microbiota has the 
capability to degrade these carbohydrates as its energy source (Flint et 
al., 2012) (Figure I.2). The main products of this fermentative metabolism 
are SCFAs, but also it produces lactate, pyruvate, ethanol, succinate as 
well as the gases H2, CO2, CH4 and H2S. Among SCFAs, acetate, 
propionate and butyrate are the most abundant. These products are not 
only substrates for other colon bacteria but when absorbed in the colon 
they provide the host with around 10% of the energy requirement (Flint et 
al., 2012). The SCFAs production also affects the expression of host 
peptides and hormones, influencing appetite regulation (Sleeth et al., 
2010). Propionate has been shown to increase satiety and improve 
glucose homeostasis. The effects of propionate in the colon epithelium 
are less known, but due to its absorption and high concentrations in the 
blood circulation, it is thought to reduce lipogenesis, serum cholesterol 
levels and carcinogenesis in peripheral tissues (Hosseini et al., 2011). 
Several beneficial effects have been attributed to butyrate, such as anti-
inflammatory and anti-carcinogenic properties (Louis and Flint, 2009; 
Canani et al., 2010). Oral administration of butyrate to mice fed with a 
high-fat diet prevented development of insulin resistance and obesity, as 
reported by Gao and colleagues (2009). This effect was not due to a 
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reduced food intake, but to an increase in energy expenditure and 
induction of mitochondria function (Gao et al., 2009). Butyrate has also a 
trophic effect on the mucosa, it is an important energy source for the 
colonic epithelium and regulates cell growth, differentiation and renewal 
of epithelial cells (Cummings, 1995; Hamer et al., 2008; Vital et al., 2014). 
Due to the intestinal barrier features of the epithelial cells, this trophic 
function also contributes to the microbiota protective effects to the host 
(Figure I.3). Acetate, which is known as the major product of intestinal 
microbial fermentation, can be consumed by many intestinal bacteria 
giving rise to butyrate (Duncan et al., 2004). This cross-feeding 
interaction involves not only the butyrate-producing bacteria consuming 
acetate, but species that convert lactate to butyrate or propionate as well 
(Flint et al., 2012; Flint et al., 2015) (Figure I.2). The most abundant 
intestinal butyrate producing bacteria are Firmicutes from Clostridium 
clusters XIVa (such as Roseburia and Eubacterium rectale) and 
Clostridium clusters IV (such as Faecalibacterium prausnitzii) (Louis and 
Flint, 2009; Vallés et al., 2014; Voreades et al., 2014). Other starch 
degrading bacteria, such as Ruminococcus bromii (Clostridium cluster IV) 
or some Bifidobacterium species, can indirectly give rise to a high 
concentration of butyrate thanks to this bacterial cross-feeding (Leitch et 
al., 2007; Chassard et al., 2008; Russell et al., 2011). 
Increase in SCFAs concentration reduces pH inside the colon and 
facilitates absorption of other ions. They have been shown to improve the 
solubility of calcium and to enhance expression of calcium-binding 
proteins, with the associated bone benefit and the reduction of total 
cholesterol levels (Flint et al., 2012). The decrease in pH has also 
important consequences for the composition of the microbiota, for 
example, Bacteroides populations are reduced while butyrate-producing 
Firmicutes are favoured at mildly acidic pH (Duncan et al., 2009). 
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In addition, it has been shown that members of the intestinal 
microbiota such as some lactic acid bacteria (LAB) and Clostridium are 
able to synthesize vitamin K as well as most of the water-soluble B 
vitamins, such as biotin, cobalamin, folates, nicotinic acid, panthotenic 
acid, pyridoxine, riboflavin and thiamine (LeBlanc et al., 2013). 
The concentrations of urea, ammonia and free amino acids 
available in the ileum are low; nevertheless, large amount of ammonia is 
produced by colonic proteolytic bacteria from amino acids released from 
proteins and peptides. These amino acids cannot be absorbed to a 
significant extent by the colonic epithelium, but are precursors for the 
synthesis of organic acids by the microbial metabolism, that serve as 
energy substrates for the colonic mucosa and several peripheral tissues 
(Davila et al., 2013). However, some adverse effects of the gut microbiota 
metabolism are associated to an excessive proteolysis inside the colon. 
The production of detrimental metabolites, such as sulphide and 
ammonia in high concentration, or other toxic products, can affect the 
energy metabolism of colonic epithelial cells and have adverse 
consequences, including carcinogenesis, liver damage, intestinal 
infections and diarrhoea or constipation (Wallace et al., 2011). 
  
  
 
 
Figure I.2. Microbial carbohydrate metabolism: polysaccharides breakdown. 
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The protective function of the intestinal microbiota comprises the 
contribution of the barrier effect and growth inhibition of potential 
pathogens. In this regard, the microbiota is involved in the production of 
antimicrobial compounds, such as bacteriocins (Sekirov et al., 2010). 
Furthermore, it prevents colonization of potentially pathogenic 
microorganisms by competing for nutrients and epithelial sites and by 
coaggreation with pathogens (Figure I.3). 
Another important activity of the microbiota is that of modulating the 
immune response (Hooper and Macpherson, 2010; Jarchum and Pamer, 
2011; Mazmanian and Lee, 2014). From birth, reciprocal interactions 
between the microbiota and the mucosal immune response lead to the 
activation and maturation of the innate and adaptive immune system 
(Doré et al., 2013). Earliest comparison studies performed on germ-free 
and colonized mice have revealed a deep effect of microbial colonization 
on the formation of lymphoid tissues and development of epithelial 
functions (Hooper et al., 2012). It has been described that epithelial Toll-
like receptors are stimulated by intestinal microorganisms limiting the 
invasion and dissemination of several pathogen bacteria such as 
Salmonella enterica serovar Typhimurium (Vaishnava et al., 2008). 
Intestinal microbiota has also showed to serve as molecular adjuvant 
during parasitic infection with Toxoplasma gondii by activating cytokine 
production by dendritic cells (Benson et al., 2009). 
The constant challenge with bacterial antigens is crucial for the 
normal development and function of the gut associated lymphoid tissue 
(GALT) (Round and Mazmanian, 2009). This includes Peyer’s patches, 
IgA and CD4+ T cells. IgA specific for intestinal bacteria is produced with 
the aid of dendritic cells, which sample bacteria at the apical surfaces of 
epithelial cells, allowing monitoring bacteria that are associated with the 
mucosal surface (Hooper and Macpherson, 2010). Intestinal CD4+ T cells 
are essential mediators of immune homeostasis and inflammation (Shale 
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et al., 2013), being pivotal elements in the fact that the presence of 
commensal microorganisms in the intestine does not produce 
inflammatory responses, as occurs with the presence of pathogens 
(Hooper and Macpherson, 2010). When this balance is perturbed, 
inflammation results, as typified in humans by inflammatory bowel 
disease, ulcerative colitis and Crohn's disease (Maloy and Powrie, 2011). 
Moreover, it has been detected alterations of the intestinal microbial 
composition in patients with these inflammatory diseases (Sokol et al., 
2008). 
Some other immunological diseases such as allergies and atopic 
dermatitis have been associated to altered microbiota composition 
(Watanabe et al., 2003; Hanski et al., 2012). It has been hypothesized 
that the prevalence of these diseases in people of developed countries 
has a direct link with decreased contact with natural environmental 
biodiversity, which has also shown to affect the microbiota composition 
(Okada et al., 2010; Rook, 2012). Moreover, it has been described that 
diminished exposure to microbial biodiversity in early life leads to 
defective immunoregulation, exaggerated cytokine response to social 
stressors and susceptibility to depression (Rook et al., 2013). 
Furthermore, several studies have proposed that there is a pathway 
connecting the gastrointestinal tract to the brain via hormones and nervus 
vagus. It is suggested that the gastrointestinal microbiota reports to the 
brain, affecting mood, behaviour and the corresponding neurochemical 
changes (Tsurugizawa et al., 2009; Neufeld et al., 2011; Foster and 
Neufeld, 2013) (Figure I.3). Changes in the microbiota composition in 
mice have shown to influence behaviour and brain chemistry 
independently of the autonomic nervous system (Bercik et al., 2011). 
  
  
Figure I.3. Functions of the intestinal microbiota. 
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I.2 ORAL AND INTESTINAL MICROBIOTA MODULATION 
The type and number of organisms living in the community depend 
on the type and quantity of nutrients available and the physicochemical 
factors in a particular site. The nutritional and physicochemical conditions 
controlling microbial growth in an ecosystem obey two fundamental laws: 
Shelford’s law of tolerance and Liebig’s law of the minimum. 
I.2.1 Mechanical and physicochemical factors 
According to Shelford’s law of tolerance, that involves the non-
nutritional factors of an ecosystem, each organism, in order to grow, 
requires a complex set of physicochemical conditions that have to remain 
within its tolerance range. Furthermore, microorganisms have to survive 
any adverse elements, including the innate and acquired immune 
systems of the host, the production of antimicrobial compounds by the 
resident microbiota itself (Hooper and Macpherson, 2010; 
Lakshminarayanan et al., 2013) and the mechanical and hydrodynamic 
forces present in the site (Wilson, 2005). 
In the oral cavity, the temperature (35-36 °C), pH (6-7.5) and 
oxygen content range (65-10 mm Hg) allow the growth of an extensive 
range of aerobic and anaerobic microorganisms. Moreover, the 
mechanical forces generated during chewing and talking cause the 
detachment of microorganisms that travelled in the saliva (Wilson, 2005). 
After the exposure to the low pH in the stomach (from 1.5 to 5, 
during 1-4 hours), microorganisms are exposed to the effect of bile salts 
and pancreatic juices at the proximal part of the small intestine (pH 7 
during 2-6 hours). In contrast, the lower digestive tract, comprising the 
terminal ileum and the colon, is characterized by a longer retention time 
(48–70 hours), allowing dense microbial colonization (Wilson, 2005). At 
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this point, the microbial activity constantly shapes the colonic environment 
(Figure I.4). In addition, there is an oxygen gradient from the mucosal 
surface to the luminal part, where prevail anaerobic conditions. This fact 
allows that both aerobic and anaerobic microorganisms inhabit the human 
intestine (Van den Abbeele et al., 2011). 
 
Figure I.4. Microbiological and ecological features inside the colon. 
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I.2.2 Diet 
Liebig’s law of the minimum states that the nutrient present on the 
lower concentration in comparison with the requirements of an organism 
determines the biomass and yield of this organism. In the oral cavity the 
main source of nutrients for microbes is saliva, whose principal 
components are proteins and glycoproteins (such as mucins produced by 
epithelial cells), but also secreted products of the co-habitant microbes 
and constituents of dead microbes and epithelial cells which are 
continously being shed. Furthermore, oral microorganisms are able to 
obtain nutrients (mainly easily fermentable carbohydrates) from the host’s 
diet, which can impact on the composition of the oral communities 
(Wilson, 2005).  
On the other hand, the species composition of the intestinal 
microbiota has been shown to respond to dietary changes, determined by 
competition for substrates and by tolerance of intestinal conditions (Flint 
et al., 2015). There are a lot of nutrients available for the microbiota in the 
intestinal tract, such as host secretions, shed cells and bacterial products. 
However, the principal sources are derived from the host’s diet. As stated 
above, the main nutrients for microbes in the caecum and ascending 
colon are non-digestive carbohydrates, while in the transverse and 
descending colon dietary proteins become gradually more important 
(Wilson, 2005). Undigested fats are not used by colonic bacteria and thus 
are excreted in the faeces. Mucins produced by the host have an 
important role in intestinal health, as they form a protective layer on the 
intestinal epithelium (Derrien et al., 2004). Mucins also represent an 
energy source for intestinal bacteria (Chassard et al., 2008) including 
certain Clostridium cluster XIVa, Bacteroides vulgatus, several 
Bifidobacterium (B. adolescentis, B. breve and B. longum) and 
Akkermansia muciniphila (Derrien et al., 2004; Leitch et al., 2007). 
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In recent years several authors have described many examples of 
how changes in diet can affect the microbial populations than inhabit the 
human colon. Thus, De Filippo and colleagues have observed that, after 
introduction of solid food, African children, who follow high fibre content 
diet, had an enrichment of Bacteroidetes and depletion in Firmicutes 
when compared with European children, who follow a ‘western’ diet. 
Indeed they found in African children dominance of Prevotella and 
Xylanibacter, bacterial genera known to contain genes for complex plant 
polysaccharides (cellulose and xylan) hydrolysis, completely lacking in 
the European children (De Filippo et al., 2010). Similar observation was 
described by Wu an colleagues that associated Prevotella enterotype to 
people with high-fibre and high-carbohydrate diets, whereas a typical 
‘western’ diet, high in protein and fat, was associated with Bacteroides 
enterotype (Wu et al., 2011). Among the starch-utilizing bacteria, 
Roseburia and E. rectale (Clostridium cluster XIVa), have showed to 
diminish when consuming a diet low in carbohydrates content, which has 
also been associated to a decrease in faecal butyrate. Under these 
circumstances, F. prausnitzii (Clostridium cluster IV) became the main 
butyrate producer bacteria detected (Russell et al., 2011). Additionally, 
alterations of fibre and fat/protein content in the diets of a small cohort of 
children and adults caused changes in the microbial composition within a 
24-hours period (Wu et al., 2011). It has also been shown that short-term 
consumption of diets consisting entirely of animal or plant products 
altered the microbial community structure (David et al., 2014). However, 
long term monitoring of healthy unrelated adults showed recently that 
environmentally introduced changes of the intestinal microbiota including 
dietary regimes throughout adulhood, are primarily affecting the 
abundance but not the presence of specific microbial species 
(Rajilić‐Stojanović et al., 2013). Furthermore, long term microbial stability 
in adults has also been demonstrated with 37 US individuals sampled for 
up to five years (Faith et al., 2013). 
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In line with the microbial modulatory effect of diet and giving the 
importance of microbe-host interactions on health and disease, there are 
scientific, medical and commercial interests in improving microbiota 
modulation strategies beneficial to the host. There is growing evidence 
that functional ingredients such as probiotics, prebiotics and symbiotics 
exert health-promoting effects on the composition, interactions and 
activities of the intestinal microbiota (Preidis and Versalovic, 2009; Hardy 
et al., 2013; Kumar et al., 2015), therefore they serve as therapeutic 
adjuvants to counteract balance disruptions of the microbiota occurring in 
several diseases. 
In recent years, new dietary approaches to modulate the microbiota 
are being investigated. In this regard dietary polyphenols, present in tea, 
cranberry, grapes or red wine among other foods, have been identified as 
potential antimicrobial agents with bacteriostatic or bactericidal actions 
(Duda-Chodak, 2012). They have been proposed as anticariogenic 
components of mouthwashes or toothpastes (Navarrete and Rizzardinni, 
2011) and their intestinal microbiota modulatory properties are also 
starting to be studied (Etxcheberria et al., 2013). 
I.2.2.1 Probiotics  
The interest in the role that the human intestinal microbiota has in 
disease has continuously increased since the 1900s, when Metchnikoff 
proposed the concept that the intestinal microbiota can be modulated by 
the administration of bacteria. He established the hypothesis that 
replacing or diminishing putrefactive bacteria in the intestine with LAB 
could normalize bowel health and prolong life (Metchnikoff and Mitchell, 
1907). After many years, probiotics were defined as ‘‘live microorganisms 
that, when administered in adequate amounts, confer a health benefit on 
the host’’ (FAO/WHO, 2002). Recently, it has been suggested that 
probiotics do not need to be alive, because their cellular components, 
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such as cell wall peptidoglycans, could be sufficient to induce benefits 
(Collins, 2014). The International Scientific Association for Probiotics and 
Prebiotics (ISAPP) has recently elaborated consensus recommendations 
in order to take into account advances in science and applications and to 
unify criteria (Hill et al., 2014). They have also included in the concept of 
probiotics new commensals and consortia of defined strains from human 
samples with adequate evidence of safety and efficacy (Hill et al., 2014). 
Several important health-promoting characteristics can be observed 
in some microorganisms that are considered as probiotics, these are: (1) 
transient modulation of the gut microbial composition, (2) exclusion or 
inhibition of pathogens in the gut, (3) enhancement or maintenance of the 
epithelial barrier and (4) modulation of the immune system (Collado et al., 
2009; Lebeer et al., 2010). The majority of probiotic bacteria are 
bifidobacteria and LAB, mainly Lactobacillus, although Lactococcus, 
Streptococcus and Enterococcus species, certain yeast strains and some 
non-pathogenic strains of Escherichia coli, are also recognized as 
probiotics (Huycke and Gaskins, 2004; Dogi et al., 2008). Most evidence 
available about the impact of probiotic microorganisms on the microbiota 
composition and functions has been obtained by targeting Lactobacillus 
and Bifidobacterium (Savard et al., 2011), although the use of probiotics 
could also have an impact on other bacterial genera relevant to the 
intestinal health. Probiotics have confirmed their potential as therapeutic 
options for a variety of diseases with clinically documented health effects 
in human subjects (Strobel and Mowat, 2006), such as diarrhoea 
reduction in children (Deshpande et al., 2010; Kale‐Pradhan et al., 2010; 
Johnston et al., 2011) or prevention of allergic diseases, atopic eczema 
and rhinoconjunctivitis (Ouwehand et al., 2009; Bertelsen et al., 2014), 
among others. 
The beneficial properties of probiotic bacteria depend on the 
specific characteristics of a particular species and can vary even between 
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closely related bacterial strains. One example is the species Lactobacillus 
plantarum whose different strains can be found or isolated from healthy 
human colonic mucosa, human saliva, green olives, meat, chucrut or 
dairy products and exert different activities depending on the specific 
strain. It has been described an antagonistic effect against Helicobacter 
pylori caused by L. plantarum MLBPL1 (Rokka et al., 2006) and the 
reduction of enterocolitis in rats assisted by L. plantarum DSM 9843 (Mao 
et al., 1996). L. plantarum strain b240 showed a strong antagonistic effect 
against S. enterica serovar Typhimurium on intestinal epithelial cells, 
probably due to a high ability to induce IgA (Ishikawa et al., 2010). 
Goossens and colleagues observed an increase in the intestinal content 
of LAB and clostridia by the intake of L. plantarum 299v, in patients with 
previous history of polyps or a positive family history of colorectal cancer 
(Goossens et al., 2006). More recently, L. plantarum DK119, isolated 
from fermented Korean cabbage, has showed antiviral effects on 
influenza virus infection by modulating the host innate immunity of 
dendritic and macrophage cells and the cytokine production pattern in 
mice (Park et al., 2013). Additionally, other L. plantarum strains (Lp09 and 
Lp45) have been explored as probiotic agents for the management of 
hypercholesterolemia in rats, with promising results (Huang et al., 2013). 
Our research group has focused on the potential probiotic strain L. 
plantarum IFPL935, isolated from a raw goat’s milk cheese (Fontecha et 
al., 1990). In previous studies, it has been reported that L. plantarum 
IFPL935 was able to initiate the catabolic pathway of flavan-3-ols present 
in a grape seed extract (Tabasco et al., 2011). Adhesion to the intestinal 
mucosa is regarded as a prerequisite for colonization and is an important 
characteristic related to the ability of probiotic strains to confer a health 
benefit by stimulation of the host immune system and competition with 
pathogens. In this regard, L. plantarum IFP935 has shown the capacity of 
adhere to epithelial cell lines (Caco-2 and HT-29) (Bustos et al., 2012). 
Furthermore, in vitro studies have demonstrated that L. plantarum 
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IFPL935 inhibited significantly the adhesion to epithelial cells of the 
pathogenic strain Staphylococcus aureus CECT240 (García-Cayuela et 
al., 2014). 
I.2.2.2 Prebiotics 
A prebiotic was first defined by Gibson and Roberfroid in 1995 as a 
‘non-digestible food ingredient that beneficially affects the host by 
selectively stimulating the growth and/or activity of one or a limited 
number of bacteria in the colon, and thus improves host health’ (Gibson 
and Roberfroid, 1995). Later on time, the same authors updated this 
definition in order to extend the concept to the entire intestinal tract 
(Gibson et al., 2004). Then, in 2008, the ISAPP has defined ‘a dietary 
prebiotic’ as, ‘a selectively fermented ingredient that results in specific 
changes in the composition and/or activity of the gastrointestinal 
microbiota, thus conferring benefit(s) upon host health’. 
Several oligosaccharides and polysaccharides (including dietary 
fibre) have been claimed to have a prebiotic effect, but not all dietary 
carbohydrates are prebiotics. In order, for a food ingredient, to be 
considered as a prebiotic, it has to obey three criteria: (1) resistance to 
gastric acidity, hydrolysis by mammalian enzymes and gastrointestinal 
absorption, (2) fermentation by intestinal microbiota and (3) selective 
stimulation of the growth and/or activity of intestinal bacteria associated 
with health and wellbeing. 
The demonstration of the prebiotic effect of these food components 
has to be carried out in vitro and in vivo by the performance of nutritional 
feeding trials in the targeted species, as occurs with other functional 
foods (Diplock et al., 1999). The prebiotics commonly used in the food 
industry are short-chain oligosaccharides, which are easily fermented in 
the ascending colon, where the microbiota is known to have a 
saccharolytic metabolism (Macfarlane et al., 1992) (Figure I.2). As a 
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consequence, the distal colon is dominated by a proteolytic metabolism, 
leading to the formation of polyamines and ammonia, which are regarded 
as a risk factor for chronic colonic diseases (such as colon carcinoma) 
(Cassidy et al., 1994; Terpend et al., 2013) (Figure I.2). Consequently, 
there is a great interest in finding prebiotics that exert biological activity in 
the distal colon (Terpend et al., 2013). In order to do that, it is useful to 
combine short-chain with long-chain fructans (Van Loo, 2004). In this line, 
it has been described the enzymatic synthesis of oligosaccharides 
derived from lactulose (OsLu) aiming at the production of a new group of 
more slowly fermenting prebiotics (Cardelle-Cobas et al., 2008; Cardelle-
Cobas et al., 2012). 
The most tested examples of prebiotic compounds are inulin-type 
fructans (ITF) and galacto-oligosaccharides (GOS) (Gibson and 
Roberfroid, 2008). However, there are a variety of fermentable 
ingredients, such as fructo-oligosaccharides (FOS), gluco-
oligosaccharides, lactulose, isomalto-oligosaccharides, soy 
oligosaccharides, pectins, xylooligosaccharides (XOS) and various gums 
and mucopolysaccharides that have also demonstrated their prebiotic 
potential (Roberfroid et al., 2010). These components are naturally found 
in some fruits, vegetables and grains. There is evidence that dietary 
supplementation with FOS and inulin can promote specific groups of 
bacteria (Bouhnik et al., 2004; Ramirez-Farias et al., 2009). Today, the 
prebiotic effect is commonly monitored by using bifidobacteria or 
lactobacilli as markers, but may include other species in the future, if their 
positive health benefits can be confirmed (Roberfroid et al., 2010). 
Certain species of Ruminococcaceae and Lachnospiraceae are 
recognized to exert potentially beneficial health effects due to the 
production of butyrate. Some authors have reported different selective 
growth profiles of these bacteria on several prebiotic substrates, which 
included starch, inulin, FOS, GOS and XOS (Scott et al., 2014).  
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Infant formula/foods have been supplemented with bifidogenic 
prebiotics in order to mimic the naturally presence of HMOs from mother’s 
milk and prevent possible paediatric diseases (Bakker-Zierikzee et al., 
2006; Scholtens et al., 2008). Some preliminary studies have shown 
promising results of the use of prebiotics by inducing changes in intestinal 
microbiota composition of patients with inflammatory bowel disease (IBS) 
that improve their intestinal activity and well-being (Paineau et al., 2008). 
Several experimental studies with prebiotics have been focused on the 
prevention of colon cancer due to the role of the intestinal microbiota 
composition in the reduction of toxic substances inside the colon 
(Rowland et al., 2009). It has been also described the intake of certain 
foods with prebiotic properties as a good strategy to prevent obesity-
related disorders (Cani et al., 2009).  
Mixtures of both probiotics and prebiotics are referred to as 
symbiotics. The interest of these products is due to the selective effect 
that the prebiotic could promote on the probiotic component. This could 
enhance the viability of the probiotic bacteria during storage and during 
the passage through the gastrointestinal tract and promote growing of this 
specific probiotic bacteria (Marx et al., 2000; Schrezenmeir and De Vrese, 
2001; Champagne et al., 2005). Certain symbiotics have shown to be 
more effective than probiotics or prebiotics alone in colorectal cancer 
prevention (Liong et al., 2008), in improving the quality of life in patients 
suffering from ulcerative colitis (Fujimori et al., 2009) or in general 
modulation of the microbiota (Saulnier et al., 2008; Grimoud et al., 2010). 
I.2.2.3 Polyphenols 
Polyphenols are plant-derived compounds that show an extensive 
variety of chemical structures. They are classified as flavonoids and 
nonflavonoids. Polyphenols are one of the most diverse bioactive 
phytochemicals which can be found in a wide range of foods such as 
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onions, tea, cacao, strawberries, cranberries, grapes, wine, etc. There are 
evidences of a dual interaction of microbiota and these food components. 
Thus, polyphenols can modulate the microbiota, inhibiting the 
development of some bacterial groups, while the microbiota can 
transform these food compounds into different metabolites based on the 
different microbiota functionalities (Lee et al., 2006; Tzounis et al., 2008; 
Kemperman et al., 2013). These metabolites are often better absorbed 
than the parent food phenolics, and could have specific biological effects 
that extend those of their precursors (Selma et al., 2009). It has been 
estimated that 90–95% of dietary polyphenols are not absorbed in the 
small intestine and therefore accumulate in the colon (Tuohy et al., 2012). 
In this regard, through microbial transformations, polyphenols could be 
absorbed and reach the target tissues and organs in order to exert its 
biological effect. Therefore, potential positive effects of polyphenol-rich 
foods might be dependent on biotransformation into more bioavailable 
forms by intestinal bacteria, potentially modulating related health benefits. 
There is increasing evidence that health benefits associated to the 
moderate consumption of red wine could be due to its phenolic 
compounds. In vitro and animal model studies have shown protective 
effects of red wine polyphenols against atherosclerosis, such as inhibition 
of LDL oxidation in human plasma (Lourenço et al., 2008) and relaxations 
of coronary arteries in pigs (Ndiaye et al., 2003). Furthermore, wine 
polyphenols could exhibit colon cancer inhibition (Franke et al., 2002) and 
antibacterial effects (Cueva et al., 2010). The interest in the interactions 
between polyphenols and intestinal microbiota has increased in the last 
years (Selma et al., 2009; Pozo-Bayón et al., 2012; Espley et al., 2014). 
Wine and grape derivatives are attractive products for studying the impact 
on microbiota through polyphenols metabolism due to their high content 
and structural diversity (Forester and Waterhouse, 2009). Phenolic 
compounds of wine consist of a complex mixture of flavonoids, such as 
flavan-3-ols or flavanols and anthocyanins, but also of nonflavonoids such 
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as resveratrol, cinnamates and gallic acid. The non-glycosylated phenolic 
compounds can be directly absorbed in the small intestine. However, 
glycosylated polyphenols including anthocyanins, flavonols and 
resveratrol glycosides could be hydrolyzed by the action of ß-
glucosidases from bacteria and/or epithelial cells in the mouth (Walle et 
al., 2005) (Figure I.5). Further transformations take place in the colon 
involving the formation of simple phenols, phenolic and aromatic acids 
and lactones with different degrees of hydroxylation and side chain length 
that could be further absorbed and subsequently submitted to intestinal 
and hepatic metabolism by phase II enzymes (Aura, 2008; Selma et al., 
2009) (Figure I.5). 
Additionally, metabolic studies have shown changes in the 
metabolic profile of urine, plasma and faeces, following the ingestion of 
polyphenol rich foods and beverages, including grape or wine extracts 
intake (Grün et al., 2008; Jacobs et al., 2008; Bolca et al., 2013). For 
example, in the case of proanthocyanidins, it has been suggested that the 
microbial capacity to metabolize these compounds is affected by a 
predominant microbial inhibitory effect (Aura, 2012). 
Several in vitro studies have been conducted with the purpose of 
screen the selective action of different phenolic compounds at different 
concentrations. Tzounis and colleagues showed that the incubations of 
faecal microbiota with flavanol monomers (catechin and epicatechin) at 
different concentrations favour the growth of B. coccoides-E. rectale and 
Lactobacillus and Bifidobacterium (at a lower concentration). By contrast, 
at the highest concentration assayed, the growth of Clostridium 
histolyticum was decreased (Tzounis et al., 2008). By means of in vitro 
gastrointestinal simulation techniques and pyrosequencing analysis, it 
was observed that a red wine-grape extract favoured the growth of 
Klebsiella, Alistipes and Akkermansia, while Bifidobacterium, B. 
coccoides and Bacteroides showed a decrease (Kemperman et al., 
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2013). In a human intervention study comparing gin, red wine and 
dealcoholized red wine, a selective effect on microbial modulation was 
observed in faeces. Regarding red wine intake, the phyla Proteobacteria, 
Fusobacteria, Firmicutes and Bacteroidetes, and the genera 
Bifidobacterium and Prevotella experienced an increase; however, 
Clostridium and in particular C. histolyticum showed a decrease during 
the intervention with red wine. By contrast, these effects disappeared or 
were minimized after a deacolcoholized red wine intake (Queipo-Ortuño 
et al., 2012). The different findings on the selective antimicrobial effect of 
polyphenols and the small number of volunteers tested make necessary 
to undertake more investigations in this line and open a way in the 
development of new strategies for studying the potential intestinal 
microbial modulation by polyphenols. 
On the other hand, several in vitro and in vivo studies have shown 
that wine components also inhibit the adhesion of and/or exert activity 
against oral bacteria (Kongstad et al., 2008; Furiga et al., 2009). 
Comparisons of microbiota profiles from the supra- and subgingival 
plaques in adults with different drinking habits have shown that wine 
drinkers present lowest numbers of different microbial groups than water 
drinkers (Signoretto et al., 2010). As a potential accessory for the control 
of periodontal disease, wine catechins have shown to exert a strong 
antimicrobial effect against Porphyromonas gingivalis and Prevotella 
intermedia (Ho et al., 2001). Proanthocyanidins from red wine have been 
recognized as one of the most powerful components with anti-adhesion 
and anti-biofilm activity against S. mutans (Daglia et al., 2010). 
  
  
Figure I.5. General scheme of polyphenols metabolism. 
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I.3 IN VITRO MODELS TO STUDY THE HUMAN GUT 
MICROBIOTA 
The evaluation of intestinal microbial diversity by either cultivable or 
genomic methodologies has been mostly carried out with faecal samples. 
These samples are considered as representative of the distal large 
intestine; however, they do not provide knowledge about dynamic 
microbial process at the site of fermentation in the intestine. All the in vitro 
fermentative models have the common purpose of cultivate a complex 
intestinal microbiota under controlled environmental conditions for 
carrying out microbial modulation and metabolism studies. Thus, they are 
considered excellent tools to study the human gut microbiota, given the 
difficulty to access the main niches of colonization in the gastrointestinal 
tract. Moreover, they allow the screening of a large variety of 
experimental conditions such as dietary ingredients without ethical 
constraints. 
The simplest in vitro models to study the intestinal microbiota are 
static batch fermentations. These models are generally performed in 
small sealed bottles or reactors with either a range of pure or mixed 
cultures of strains or suspensions of faecal material containing microbial 
communities from human origin. They are used to describe microbial 
growth and their ability to metabolize different substrates. These systems 
have the inconvenient that changes in pH and the accumulation of 
microbial metabolites lead to the inhibition of microbial activity, so they 
could not represent the facts occurring in vivo. In spite of these 
methodological limitations, faecal batch incubations have demonstrated to 
be a useful tool to investigate metabolic profiles of SCFAs produced by 
intestinal microbiota from the fermentation of a large variety of dietary 
components such as inulin-type fructans and resistant starch complex 
carbohydrates (Pompei et al., 2008; Lesmes et al., 2008). They have 
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been valuable for a first assessment of intestinal polyphenols metabolism 
(Gross et al., 2010) or for comparison of different sources or doses of 
polyphenols (Possemiers et al., 2007; Bolca et al., 2009; De Weirdt et al., 
2010). The inoculation density, together with the substrate depletion rate, 
also defines microbial growth in these systems. Low cell densities allow 
typical S-shaped growth curve due to the presence of an initial abundant 
nutrient and the consumption of the substrates at the end of the 
incubation. Conversely, systems with high cell densities similar to those 
found in the colon result in limited growth (Payne et al., 2012). 
In contrast to short-duration experiments with batch models, long–
term experiments with dynamic, multi-compartment gastrointestinal 
simulators are used when gut microbial dynamics and activities need to 
be assessed. The clear advantage of these models is to allow real time 
measurement of the effects of foods or other chemical compounds in the 
gastrointestinal ecosystem (Kong and Singh, 2010; Wickham and Faulks, 
2012). Most of these dynamic models are based on the Reading model 
firstly described by Gibson and colleagues (1988), which involves a three-
stage continuous culture system simulating the ascending, transverse 
and distal colon. This system allowed setting of pH for the three vessels 
at 5.5, 6.2 and 6.8 respectively, which is a critical parameter for this 
microbial ecosystem. The nutritious medium commonly used consists of 
protein substrates (casein and peptone), complex carbohydrates (pectin, 
xylan, arabinogalactan and resistant starches) that are not digested by 
gastrointestinal enzymes, and a mixture of salts and vitamins (Gibson et 
al., 1988). The continuous replenishment of nutrients and the control of 
physiological temperature and anaerobic conditions are crucial in the 
adaptation and survival of the in vitro gut microbiota. This allows the 
establishment of steady-state conditions in terms of microbial composition 
and metabolic activity. Furthermore, the control of defined pH values, 
downstream nutrient limitations and retention times in the different in vitro 
compartments allows a region-specific differentiation of the microbial 
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communities and their activity (Van den Abbeele et al., 2010). Anaerobic 
conditions are usually reached through continuous flushing of CO2 or N2. 
Some examples of these dynamic fermentation models are the SHIME 
(Simulator of the Human Intestinal Microbial Ecosystem), consisting in 
three glass reactors that represent the ascending, transverse and 
descending colon and that possess two previous glass vessels 
representing the gastric and duodenal stages (Molly et al., 1993), and the 
TIM-2 (Minekus et al., 1999) composed by a continuous single-stage 
fermenter to simulate the proximal colon conditions. The TIM-2 is able to 
reproduce the peristaltic mixing of the luminal content and the absorption 
of water and fermentation products. The previously designed TIM-1 
(Minekus et al. 1995) can simulate the process occurring in the upper 
gastrointestinal tract (stomach and small intestine) and the effluent of the 
TIM-1 can be manually introduced in the TIM-2 in order to mimic the full 
transit through the gastrointestinal system (Hatanaka et al., 2012). 
Comparisons of results obtained from the TIM-2 and SHIME models have 
demonstrated the suitability of both models when studying the effects of 
diet on SCFAs production and its influence on specific bacteria (Van den 
Abbeele et al., 2013). Another example of fermentation model is the twin-
vessel single-stage chemostat model recently described by McDonald 
and colleagues (2014), which reproduces the human distal gut 
environment by maintaining neutral pH conditions and a constant culture 
volume. Moreover, recent developments of a single-stage model 
simulating the ileum microbiota have been reported (Venema and Van 
den Abbeele, 2013). 
The colonization, reproducibility and functional stability of human 
gut microbiota inside the models depend in part of the inoculum. They 
can be used diverse alternatives depending on the purpose of the study. 
Inoculation with liquid faecal suspension from one individual can be useful 
for biological repetition of a study in order to observe individual variability 
or stability (Van den Abbeele et al., 2010). Pooling stools from several 
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individuals can be used to inoculate a batch fermenter and produce a 
standardized inoculum to be frozen and reused in order to obtain sets of 
equivalent inocula (Rajilić‐Stojanović et al., 2010; Martinez et al., 2013). 
Cinquin and colleagues (2004) have developed an immobilization process 
for the entrapment of faecal microbiota in mixed xanthan-gellan gum gel 
beads with the purpose of establish biofilm-associated states of microbial 
populations in conjunction with a continuous wash-out of less competitive 
bacteria. This last system has recently been updated into the model 
PolyFermS, allowing maintenance of the microbial diversity over long time 
and performance of parallel experiments with exactly the same microbiota 
(Berner et al., 2013). Recent developments focusing in reproducibility of 
the experiments face the inoculation of the in vitro models with defined 
populations of pure strains from the human gut microbiota (Newton et al., 
2013).  
Since most of the models have been focused on simulating either 
the upper gastric-small intestine digestion or the colonic fermentation 
process, our research group has pursued the development of a new 
system which combines the gastrointestinal process from the stomach 
until the final part of the colon under a unique computer controller. This 
new system, named SIMGI, is composed by a gastric compartment that 
simulates peristaltic mixing movements, a reactor simulating the small 
intestine and three stage continuous fermenters that reproduce the colon 
region-specific microbiota and its metabolism. It possesses the 
particularity to allow joint or separated simulation of the gastric and 
colonic fermentative processes (Barroso et al., 2015). 
The ability of the in vitro gut models described above to simulate 
the in vivo conditions is limited by the lack of the intestinal epithelium and 
mucus. The evaluation of the host’s response is normally conducted by 
means of cell culture experiments. They are easy and quick ways to study 
cellular behaviour, cell signalling pathways and cell interactions. The most 
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frequent cell lines currently used are Caco-2 and HT29-MTX that are able 
to form a polarized monolayer of differentiated intestinal epithelial cells 
(Lesuffleur et al., 1991; Louvard et al., 1992; Sambuy et al., 2005). 
Furthermore, co-cultures of cell lines in combination with immune cells 
have been characterized in an attempt to mimic the human intestinal 
mucosal environment (Christoffersen et al., 2012). 
Additional tools for modelling the physiological colonic conditions 
are the incorporation of mucosal environment devices inside the 
fermentation vessels in order to differentiate between microbial biofilms 
adhering to the devices and luminal microbiota (Macfarlane et al., 2005; 
Van den Abbeele et al., 2012). More recently, the Host-Microbiota 
Interaction (HMI) module has been developed (Marzorati et al., 2014), 
consisting of two compartment devices separated by a functional double-
layer composed of an upper mucus layer and a lower semi-permeable 
membrane allowing molecules and oxygen transport. In the upper part, a 
complex microbial community colonises the mucus, simulating the luminal 
side of the colon while the lower part contains enterocyte human cells 
(Marzorati et al., 2014). This combination of in vitro models closely 
represents the ideal experimental model described by Fritz and colleages 
(2013) for studying host-microbiota interactions. They stated that 
physiological pH, fluid retention times and dissolved oxygen 
concentrations have to be maintained and that the model should include 
the mucus layer, epithelial cells and complex gut microbiota in 
anaerobic/microaerophilic conditions. 
Overall, to get the complete picture, combining both in vitro and in 
vivo studies could represent an appropriate approach to understand how 
microbiota interacts with the host. The use of animal models is an 
excellent tool for this purpose. For example, diet-induced alterations in 
microbiota composition of zebrafish have shown to influence fat 
absorption (Semova et al., 2012). Moreover, development of germ-free 
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mice (Reyniers et al., 1959) has helped to understand the microbiota-host 
interactions and have allowed highly controlled working conditions. 
Transplantation of human faecal microbiota into germ-free mice can be 
viewed as capturing an individual’s microbial community at a fixed 
moment in time (Goodman et al., 2011; Kau et al., 2011; Ridaura et al., 
2013). 
Nevertheless, clinical trials are required to confirm results obtained 
through all of these study models. As it has been exemplified above, until 
date, several human trials have been performed in order to test the 
microbiota modulatory effects of probiotics (Savard et al., 2011; Johnston 
et al., 2011), prebiotics (Roberfroid et al., 2010) and other components of 
the diet such as polyphenols (Etxeberria et al., 2013). 
The growing evidence about the important role of the human 
microbiota in health leads to the development of new dietary ingredients 
and approaches for modulating the microbiota. Thus, it is necessary to 
perform both in vitro and in vivo experiments to deeper understand the 
dynamic interactions inside the human microbial community and with the 
host. Further, it remains essential to conduct more studies combining 
biochemical, microbiological and clinical parameters in order to know the 
effectiveness of the microbial modulatory strategies and their impact on 
health.  
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OBJECTIVES AND WORKING PLAN 
Diet plays an important role in the oral microbiota, being at the 
same time the most significant external factor affecting the intestinal 
microbiota. In both ecosystems, a correct balance between microbiota 
and host is crucial for maintenance of health status. Some food 
ingredients, such as polyphenols, probiotic bacteria and prebiotics, have 
been demonstrated interesting features for approaching microbial 
modulation studies. Due to the different antimicrobial activities exerted by 
polyphenols, based on their chemical structures and the bacterial species 
studied, it seems appropriate to evaluate the effect of polyphenols on the 
human microbiota. Besides, some bacteria are able to metabolize 
polyphenols, which could represent an additional advantage inside the 
complex intestinal ecosystem and could give rise to more bioactive 
metabolites with potential beneficial effects on human health. Concerning 
prebiotics, currently there is increasing interest in the search of new 
compounds able to reach the distal colon regions, where exert their 
intestinal microbiota modulatory effect. 
In this context, the objectives of this PhD Thesis have been as 
follows: 
1. To evaluate the impact of different dietary polyphenols 
on the human intestinal microbiota. 
In order to achieve this objective, it has been performed batch 
incubations of colonic microbiota with different polyphenolic extracts, 
cranberry, grape seed (Vitaflavan®) and red wine (ProvinolsTM) extracts. 
Chapters III and IV. 
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2. To study the modulatory effect on the human intestinal 
microbiota of Lactobacillus plantarum IFPL935 associated to its 
ability to metabolize polyphenols.  
In order to achieve this objective, it has been performed incubations 
of the colonic microbiota with the extract of wine polyphenols 
(ProvinolsTM) and L. plantarum IFPL935, in batch and using a dynamic 
gastrointestinal simulator. Chapters IV and V. 
 
3. To analyze the impact of moderate red wine intake on the 
composition of the oral and intestinal microbiota through a human 
intervention study. Chapters VI and VII. 
 
4. To evaluate the prebiotic effect of lactulose-derived 
oligosaccharides (OsLu) on the human microbiota differentiated by 
colonic regions. 
In order to achieve this objective, it has been developed a 
computer-controlled dynamic in vitro gastrointestinal simulator, where it 
was evaluated the effect on the colonic microbiota of the dietary 
substitution of easily digestible carbohydrates by OsLu. Chapters VIII and 
IX. 
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OBJETIVOS Y PLAN DE TRABAJO 
La dieta juega un papel significativo en la microbiota oral, siendo a 
la vez el factor externo más relevante que afecta a la microbiota 
intestinal. En ambos entornos, un correcto equilibrio entre microbiota y 
hospedador es crucial para el mantenimiento de la salud. Algunos 
ingredientes alimentarios, como los polifenoles, las bacterias probióticas 
y los prebióticos, poseen características que los hacen interesantes para 
abordar estudios de modulación de la microbiota oral e intestinal. Debido 
a la variabilidad antimicrobiana que presentan los polifenoles en función 
de las diferentes estructuras químicas y especies bacterianas estudiadas, 
resulta relevante evaluar su acción sobre la microbiota humana. Por otra 
parte, la capacidad de algunas bacterias para metabolizar polifenoles 
podría aportarles ventajas dentro del complejo ecosistema intestinal, 
además de favorecer la formación de metabolitos bioactivos beneficiosos 
para el organismo. En el caso de los prebióticos, se tiende en la 
actualidad a la búsqueda de nuevos compuestos que puedan alcanzar 
zonas distales del colon donde ejercer su acción moduladora sobre la 
microbiota intestinal. 
En este contexto, los objetivos de esta Tesis Doctoral han sido los 
siguientes: 
1. Evaluar el impacto de diferentes polifenoles de la dieta 
en la microbiota intestinal humana. 
Para la consecución de este objetivo se han llevado a cabo 
incubaciones en condiciones estáticas de distintos extractos de 
polifenoles - arándano rojo, pepita de uva (Vitaflavan®) y vino tinto 
(ProvinolsTM)- con microbiota colónica. Capítulos III y IV. 
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2. Estudiar el efecto modulador sobre la microbiota 
intestinal humana de Lactobacillus plantarum IFPL935 debido a su 
capacidad para metabolizar polifenoles. 
Para la consecución de este objetivo se han realizado 
incubaciones de microbiota colónica con el extracto de polifenoles de 
vino tinto (ProvinolsTM) y L. plantarum IFPL935 en condiciones estáticas y 
en un simulador dinámico gastrointestinal. Capítulos IV y V. 
 
3. Analizar el impacto del consumo de vino tinto en la 
composición de la microbiota oral e intestinal mediante un estudio 
de intervención en humanos. Capítulos VI y VII. 
 
4. Evaluar el efecto prebiótico de oligosacáridos derivados 
de lactulosa (OsLu) en la microbiota humana de distintas regiones 
del colon. 
Para la consecución de este objetivo se ha desarrollado un sistema 
dinámico de simulación gastrointestinal in vitro controlado por ordenador, 
donde se ha evaluado el efecto sobre la microbiota colónica de dietas en 
las que se han sustituido carbohidratos fácilmente fermentables por 
OsLu. Capítulos VIII y IX. 
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III.1 ABSTRACT 
In this study, we have assessed the phenolic metabolism of a 
cranberry extract by microbiota obtained from the ascending colon and 
descending colon compartments of a dynamic gastrointestinal simulator 
(SHIME). For comparison, parallel fermentations with a grape seed 
extract were carried out. Extracts were used directly without previous 
intestinal digestion. Among the 60 phenolic compounds targeted, our 
results confirmed the formation of phenylacetic, phenylpropionic and 
benzoic acids as well as phenols such as catechol and its derivatives 
from the action of colonic microbiota on cranberry polyphenols. Benzoic 
acid (38.4 µg/mL), 4-hydroxy-5-(3’-hydroxyphenyl)-valeric acid (26.2 
µg/mL) and phenylacetic acid (19.5 µg/mL) reached the highest 
concentrations. Under the same conditions, microbial degradation of 
grape seed polyphenols took place at lesser extent than for cranberry 
polyphenols, which was consistent with the more pronounced 
antimicrobial effect observed for the grape seed polyphenols, particularly 
against Bacteroides, Prevotella and Blautia coccoides-Eubacterium 
rectale. 
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III.2 INTRODUCTION 
The first clinical study into the effect of consumption of cranberry 
(Vaccinium macrocarpon or Oxycoccus macrocarpus) in treating urinary 
tract infections (UTIs) dates back to 1966 (Papas, Brusch, & Ceresia, 
1966). Since then, most of these studies reported a preventive effect 
against UTIs (for review, see Vasileiou, Katsargyris, Theocharis, & 
Giaginis, 2013), although in some particular studies no significant effects 
were observed (Barbosa-Cesnik, Brown, Buxton, Zhang, De Busscher, & 
Foxman, 2011; Stapleton et al., 2012). 
The red cranberry is rich in several groups of phenolic compounds, 
especially flavonols (200-400 mg/kg), anthocyanins (136-1710 mg/kg) 
and proanthocyanidins (PACs) (4188 mg/kg) (Pappas & Schaich, 2009). 
PACs are oligomers and polymers of flavan-3-ol monomers [mainly 
(epi)afzelechin, (epi)catechin and (epi)galocatechin] joined by B-type (4β-
8 or 4β-6) and additional A-type (2β-O-7 or 2β-O-5) linkages. Oligomeric 
forms with at least one A-type interflavanic linkage – which awards certain 
conformational inflexibility to the molecule – predominate in cranberry 
PACs (Pappas et al., 2009). Besides polyphenols, other phytochemicals 
occurring in cranberries are terpenes, organic acids, complex 
carbohydrates, and sugars (Pappas & Schaich, 2009). The beneficial 
effects of cranberry against UTIs have been attributed, at least partly, to 
their PAC content and special composition, although which are the most 
active structures has still not been elucidated (Shmuely, Ofek, Weis, 
Rones, & Houri-Haddad, 2012; Vasileiou et al., 2013). Other foods only 
containing B-type PACs, such as grape seeds or apples, lack these 
preventive properties against UTI exhibited by cranberry. Cranberry A-
type PACs have been shown to exhibit uropathogenic Escherichia coli 
(UPEC)-anti-adhesive activity and other activities related to bacterial 
interaction with host cells to a greater extent than B-type PACs (Feliciano, 
Meudt, Shanmuganayagam, Krueger & Reed, 2014), but PACs are 
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unlikely to appear in urine at relevant concentrations as they are poorly 
absorbed at the intestine level. One leading hypothesis is that cranberry 
components, and/or their direct metabolites, present in the urine would 
operate in the phase of bacterial adherence of UPEC to the uroepithelial 
cells, preventing bacterial colonization and progression of UTIs (Vasileiou 
et al., 2013). In fact, ex vivo studies confirmed the anti-adhesive activity of 
urine samples collected from volunteers who consumed cranberry 
products in comparison to urine samples collected from the placebo 
group (Howell et al., 2010), suggesting that the compounds responsible 
for the benefits against UTIs might be products of the metabolism of the 
cranberry (and/or not-metabolized cranberry components) eliminated in 
the urine. 
With the final aim of looking into the metabolism of cranberry 
polyphenols in more depth and unravelling the potential mechanisms 
behind the selective and preventive effects of cranberry consumption 
against UTIs, we have carried out comparative batch culture 
fermentations of cranberry and grape seed extracts with colonic 
microbiota. For these fermentations, human microbiota from the colonic 
compartments of the dynamic simulator of the human intestinal microbial 
ecosystem (SHIME) (Molly, van de Woestijne, & Verstraete, 1993) was 
used. Production of phenolic acids and other related metabolites were 
monitored over 48 h to assess differences in the metabolic profiles of 
cranberry and grape seed extracts subjected to the same microbiota and 
fermentation conditions. Microbial community analyses and microbial 
metabolic activity (short-chain fatty acids and ammonium production) 
determinations were also conducted to determine the effects of both 
extracts on gut microbiota survival.   
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III.3 MATERIAL AND METHODS 
III.3.1 Phenolic standards and extracts 
Standards of phenolic compounds were purchased from Sigma-
Aldrich Chemical Co (St Louis, MO), Phytolab (Vestenbergsgreuth, 
Germany) and Extrasynthèse (Genay, France). A commercial cranberry 
extract was kindly supplied by Triarco Industries Inc. (New Jersey, USA). 
Total phenolic content of the cranberry extract was 219 mg of gallic acid 
equivalents/g, as measured by the Folin-Ciocalteu reagent (Merck, 
Darmstadt, Germany). The cranberry extract contained benzoic acids 
(9.76 mg/g), hydroxycinnamic acids (11.1 mg/g), flavan-3-ols (2.1 mg/g) 
and anthocyanins (0.055 mg/g) (sample #18 in Sánchez-Patán, 
Bartolomé, Martín-Álvarez, Anderson, Howell, & Monagas, 2012b). A 
commercial grape seed extract (Vitaflavan®) was kindly provided by Les 
Dérives Resiniques & Terpéniques (DRT), S.A. (France). Total phenolic 
content of the grape seed extract was 629 mg of gallic acid equivalents/g, 
as measured by the Folin-Ciocalteu reagent. The grape seed extract 
mainly contained flavan-3-ols (337 mg/g), including galloylated and non-
galloylated forms (Sánchez-Patán et al., 2012a). 
III.3.2 In vitro batch incubations with human colonic bacteria 
In vitro batch incubations were performed by sampling 25 mL of the 
ascending colon and descending colon compartments (AC and DC, 
respectively) ( 8 log copy number/mL) of the Simulator of the Human 
Intestinal Microbial Ecosystem (SHIME). This dynamic in vitro 
gastrointestinal model comprises a series of five double-jacketed 
fermentation vessels simulating the stomach, small intestine and the 
three-stage large intestine conditions (Molly et al., 1993). The colon 
compartments contained in vitro cultured microbiota that harboured a 
reproducible human microbial community representative of the in vivo 
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conditions, both in composition and metabolic activity (Van den Abbeele 
et al., 2010). Following sampling, the colon microbial suspensions (25 
mL) were placed into bottles containing cranberry or grape seed extracts 
(500 mg/L) and were incubated for 48 h at 37 °C. To obtain anaerobic 
conditions, L-cysteine (0.5 g/L) was added and bottles were closed with 
butyl rubber stoppers and flushed with N2 during 15 cycles of 2 min each 
at 800 mbar over pressure and 900 mbar under pressure. Before starting 
the incubation, bottles were placed at atmospheric pressure. Samples 
were taken at 0, 6, 24 and 48 h with a needle that extends beyond the 
butyl rubber stoppers that seal off the incubation bottles. Upon sampling, 
the mixture was flushed with N2 to ensure anaerobic conditions. Samples 
were immediately stored at −20 °C until further analysis. Just before 
analysis, samples were defrosted and centrifuged (10000 rpm, for 10 min 
at 4 ºC); pellets were used for DNA isolation, and supernatants were 
filtered (0.22 µm) and analysed for phenolic metabolites, short-chain fatty 
acids and ammonium. For each extract, three independent experiments 
were carried out. 
III.3.3 Targeted analysis of phenolic acids and other metabolites  
Phenolic compounds were analysed by a previous UPLC-ESI-
MS/MS method (Jiménez-Girón et al. 2013). Filtered supernatants were 
directly injected into the UPLC equipment. The liquid chromatographic 
system was a Waters Acquity UPLC (Milford, MA, USA) equipped with a 
binary pump, an autosampler thermostated at 10 ºC, and a heated 
column compartment (40 ºC). The column employed was a BEH-C18, 2.1 
x 100 mm and 1.7 µm particle size from Waters (Milford, MA, USA). The 
mobile phases were 2% acetic acid in water (A) and 2% acetic acid in 
acetonitrile (B). The gradient programme was as follows: 0 min, 0.1% B; 
1.5 min, 0.1% B; 11.17 min, 16.3% B; 11.5 min, 18.4% B; 14 min, 18.4% 
B; 14.1 min, 99.9% B; 15.5 min, 99.9% B; 15.6 min, 0.1% B. Equilibrium 
time was 2.4 min resulting in a total run-time of 18 min. The flow rate was 
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set constant at 0.5 mL/min and injection volume was 2 µL. The LC 
effluent was pumped to a Waters Acquity TQD tandem quadrupole mass 
spectrometer (Milford, MA, USA) equipped with a Z-spray electrospray 
ionization (ESI) source operated in negative polarity mode. The ESI 
parameters were set as follows: capillary voltage, 3 kV; source 
temperature, 130 ºC; desolvation temperature, 400 ºC; desolvation gas 
(N2) flow rate, 750 l/h; cone gas (N2) flow rate, 60 l/h. The ESI was 
operated in negative ionization mode. For quantification purposes, data 
were collected in the multiple reaction monitoring (MRM) mode, tracking 
the transition of parent and product ions specific to each compound. The 
MS/MS parameters (cone voltage, collision energy and MRM transition) 
of the 60 phenolic compounds targeted in the present study (mandelic 
acids, benzoic acids, phenols, hippuric acids, phenylacetic acids, 
phenylpropionic acids, cinnamic acids, 4-hydroxyvaleric acids and 
valerolactones) were previously reported (Jiménez-Girón et al. 2013). All 
metabolites were quantified using the calibration curves of their 
corresponding standards, except for 4-hydroxy-5-(3´,4´-dihydroxyphenyl)-
valeric, 4-hydroxy-5-(3´-hydroxyphenyl)-valeric and 4-hydroxy-5-(phenyl)-
valeric acids, which were quantified using the calibration curves of 3-
(3´,4´-dihydroxyphenyl)-propionic, 3-(3´-hydroxyphenyl)-propionic and 
propionic acids, respectively. Data acquisition and processing were 
realized with MassLynx 4.1 software.  Injections were carried out in 
duplicate. 
III.3.4 Microbial community analyses 
Quantitative PCR (qPCR) on total bacteria and different groups and 
genera of bacteria (Lactobacillus, Bifidobacterium, Bacteroides, 
Prevotella, Enterobacteriaceae, Blautia coccoides-Eubacterium rectale 
group, Clostridium leptum subgroup and Ruminococcus) was performed 
following the methodology described in Barroso et al. (2013). Briefly, 
bacterial DNA was extracted using hexadecyltrimethylammonium bromide 
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(CTAB) buffer and phenol-chloroform-isoamyl alcohol and bead-beating. 
The DNA was precipitated with polyethelene glycol (PEG-6000), washed 
in ice-cold 70% ethanol and dried in a Speed-Vac, prior to resuspension 
in distilled water. The DNA concentration and quality of the samples were 
assessed with a NanoDrop spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA). 
Bacterial numbers in the DNA samples were quantified by qPCR 
using SYBR green methodology (Kappa Biosystems, Woburn, MA, USA) 
with the IQ5 Multicolor Real-Time PCR Detection System and data 
analyses (Bio-Rad Laboratories Inc., Hercules, CA, USA). Primers, 
amplification conditions and calculation of copy numbers have been 
detailed previously (Barroso et al., 2013). DNA from Escherichia coli 
DH5α, L. plantarum IFPL935, Bifidobacterium breve 29M2 and 
Bacteroides fragilis DSM2151 was used for quantification of total bacteria, 
Lactobacillus, Bifidobacterium and Bacteroides, respectively. For the rest 
of the groups analyzed, samples were quantified using standards derived 
from targeted cloned genes using the pGEM-T cloning vector system kit 
(Promega, Madison, WI, USA), as described previously (Barroso et al., 
2013). Samples were subjected to DNA extraction and analysed in 
duplicate. 
III.3.5 Analysis of short-chain fatty acids (SCFA), branched-chain 
fatty acids (BCFA) and ammonium  
The SCFA and BCFA were extracted from the samples with diethyl 
ether, after the addition of 2-methyl hexanoic acid as an internal standard 
and extracts were analysed as described previously (Alander, De Smet, 
Nollet, Verstraete, Von Wright, & Mattila-Sandholm, 1999). Briefly, one 
microlitre of the diethyl ether layer was injected and measured in a Di200 
gas chromatograph (GC; Shimadzu, 's-Hertogenbosch, The Netherlands) 
equipped with a capillary-free fatty-acid packed column [EC-1000 Econo-
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Cap column (Alltech, Laarne, Belgium), 25 m × 0.53 mm, film thickness 
1.2 µm], a flame ionization detector and a Delsi Nermag 31 integrator 
(Thermo Separation Products, Wilrijk, Belgium). Nitrogen was used as the 
carrier gas at a flow rate of 20 mL/min. The column temperature and the 
temperature of the injector and detector were set at 130 °C and 195 °C 
respectively. The concentration of SCFA and BCFA was calculated in 
mg/L. Total SCFA were calculated based on the amounts of acetate, 
propionate, butyrate, valerate and caproate and BCFA based on the 
amounts of isobutyrate, isovalerate and isocaproate. Samples were 
analysed in duplicate. 
Ammonium determination was performed as earlier described by 
Bremner and Keeney (1965). Briefly, ammonium was released from 
samples as ammonia by the addition of MgO and distillation into a boric 
acid-indicator solution using an auto distillation Vapodest 30´ (Gerhardt 
Analytical Systems, Brackley Northants, UK). Ammonia was determined 
by titration with standard HCl using a 685 Dosimat and 686 
Titroprocessor (Metrohm, Berchem, Belgium). Ammonium ion 
concentration was expressed as mg/L. Samples were analysed in 
duplicate. 
III.3.6 Statistical analysis 
Mean values and standard deviations were calculated based on the 
values for the different variables during the incubation period (phenolic 
metabolites, microbial groups, SCFA, BCFA, acetate, propionate, 
butyrate, and ammonium). Concerning data of phenolic metabolites, 
three-way analysis of variance (ANOVA) was used to test the main 
effects of three factors studied (time, compartment, and phenolic extract 
added).  Concerning data of fatty acids, ammonium, and microbial 
groups, one-way ANOVA and posterior least significant difference (LSD) 
test, and the corresponding non-parametric Kruskal-Wallis test were used 
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to detect differences along the incubation time, for each compartment and 
containing either the cranberry or the grape seed extract. The t-test for 
independent samples, together with the corresponding non-parametric 
Mann-Whitney test, were used to evaluate differences between the 
phenolic extracts at a certain time of incubation and in each compartment. 
The significance level considered was p = 0.05. Principal component 
analysis (PCA), from matrix correlation (where variables were previously 
standardized using all samples) was used to summarize changes in the 
concentration of microbial-derived phenolic metabolites. All statistical 
analyses were carried out using the STATISTICA program for Windows, 
version 7.1 (StatSoft. Inc. 1984−2006, www.statsoft.com). 
III.4 RESULTS 
III.4.1 Production of phenolic acids and other metabolites 
A total of 27 phenolic compounds were identified and quantified in 
the supernatants from the incubations of cranberry and grape seed 
extract with human microbiota obtained from the ascending colon and 
descending colon compartments (AC and DC, respectively) of the SHIME 
system (Table III.1). They corresponded to phenylacetic, phenylpropionic, 
benzoic and cinnamic acids and phenols, and other metabolites 
exclusively derived from the catabolism of flavan-3-ols, such as phenyl--
valerolactones and phenylvaleric acid derivatives. Among them, benzoic 
acid (38.4 µg/mL), 4-hydroxy-5-(3’-hydroxyphenyl)-valeric acid (26.2 
µg/mL, quantified as 4-(3´-hydroxyphenyl)-propionic acid) and 
phenylacetic acid (19.5 µg/mL) reached the highest concentrations (Table 
III.1). A three-way ANOVA analysis was applied to assess the main 
factors (time, phenolic extract and microbiota) that had significant effect 
(p < 0.05) on the concentration of each phenolic compound quantified 
(Table III.1, Figures III.1 and III.2) (Supporting Information, Figures S1-
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S4). A first result to be noted is that incubation of both extracts with AC 
and DC microbiota led to a general and steady release of phenylacetic 
and phenylpropionic acids up to 48 h (Figures III.1 and III.2), the time 
factor being significant in all cases, except for 4-hydroxyacetic and 3-(3’-
hydroxyphenyl)-propionic acids (Table III.1). For all these phenolic acids, 
maximum concentrations were found in incubations with the DC 
microbiota, either because the initial faecal suspension exhibited higher 
concentration (e.g. phenylacetic acid), or because they were released to 
a greater extent in the presence of a phenolic extract [e.g. 3,4-
dihydroxyphenylacetic and 3-(3´,4´-dihydroxyphenyl)-propionic acids]. 
The cranberry extract (500 mg/L) led to a significantly higher production 
of main metabolites, such as 3,4-dihydroxyphenylacetic, 3-(3´,4´-
dihydroxyphenyl)-propionic, 3-(4´-hydroxyphenyl)-propionic and 
phenylpropionic acids when incubated with both AC and DC microbiota, 
in comparison to the grape seed extract.  
Some benzoic and cinnamic acids were present in the phenolic 
extract per se, as confirmed from the concentration values at t=0 ) 
(Supporting Information, Figures S1 and S2). The grape seed extract 
contained a relevant quantity of gallic acid (3,4,5-trihydroxybenzoic acid) 
(Sánchez-Patán et al., 2012a) whereas the cranberry extract was 
specially rich in benzoic, p-coumaric (4-hydroxycinnamic),  protocatechuic 
(3,4-dihydroxybenzoic) and vanillic (4-hydroxy-3-methoxybenzoic) acids 
(sample #18 in Sánchez-Patán et al., 2012b). Time and phenolic extract 
factors resulted as significant factors for the concentrations of all these 
benzoic and cinnamic acids during the incubation of the two extracts with 
the two microbiota (Table III.1). Interestingly, gallic acid (grape seed 
extract) suffered a sharp decrease during the first 6 h of incubation with 
the AC microbiota, whereas its degradation by the DC was only 
noticeable after 24 h of incubation (Supporting Information, Figure S1). 
The same was observed for protocatechuic acid, although to a lesser 
extent. Similarly, concentrations of cinnamic acids (cranberry extract) 
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constantly decreased over the first 24 h of incubation in the presence of 
both AC and DC microbiota (Supporting Information, Figure S2). On the 
other hand, other compounds, such as 2-hydroxybenzoic acid (salicylic 
acid) and benzoic acid, increased consistently up to 24 h of incubation 
with both microbiota, but more so in the case of the cranberry extract 
(Supporting Information, Figure S1). 
Another group of metabolites formed during the incubation of the 
extracts with the colon microbiota included catechol/pyrocatechol (1,2-
dihydroxybenzene) and its derivatives 4-metylcatechol and 4-
ethylcatechol. For all of them, the amount released was greater in the 
presence of the cranberry extract and their incubation followed similar 
trends (Supporting Information, Figure S3), although only catechol 
showed significant differences by time and phenolic extract (Table III.1). 
Finally, other metabolites derived from the catabolism of flavan-3-
ols such as phenyl--valerolactones and phenylvaleric acid derivatives 
were only detected in the incubations of the grape seed extract with the 
colonic microbiota (Supporting Information, Figures S4). In the 
incubations with the DC microbiota, 1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-
trihydroxyphenyl)-propan-2-ol, which is considered a first intermediate in 
the catabolism pathway of flavan-3-ols, became detectable at 6 h. The 
phenyl- -valerolactones and phenylvaleric acids were subsequently 
formed afterwards, again only in the case of the DC incubations. The 
three main factors (time, phenolic extract and microbiota) were found 
significant for most of these compounds (Table III.1). 
Principal component analysis (PCA) was performed in order to 
summarize changes in the concentrations of phenolic acids and other 
metabolites resulting from the batch culture fermentations of the 
cranberry and grape seed extracts with the colonic microbiota. Two 
principal components (PC1 and PC2), which explained 52.3% of the total 
variance of the data, were obtained. To show the changes over time, 
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main values of the scores of the triplicate incubations in the different time 
periods (0, 6, 24 and 48 h) were plotted in the plane defined by the first 
two principal components (Figure III.3). PC1 (27.3 % of total variance 
explained) was directly correlated (loadings ≥ 0.7) with 3,4-
dihydroxyphenylacetic acid (0.961), 3-(3´,4´-dihydroxyphenyl)-propionic 
acid (0.941), 3-(4´-hydroxyphenyl)-propionic acid (0.932), phenylpropionic 
acid (0.917), benzoic acid (0.779) and catechol (0.866), all microbial-
derived phenolic metabolites produced during the incubation of phenolic 
extracts. PC2 (25.0% of total variance explained) was inversely correlated 
with syringic acid (-0.835), vanillic acid (-0.932), caffeic acid (-0.863), 
ferulic acid (-0.902), trans-p-coumaric acid (-0.891), and trans-cinnamic 
acid (-0.919), all initially present in the cranberry extract. Main differences 
among samples were due to the phenolic extract (cranberry/grape seeds) 
employed, with low PC2 scores for incubations with the cranberry extract 
(higher concentrations in benzoic and cinnamic acids). Also, changes in 
the phenolic content during the incubation time were reflected in both 
PC1 and PC2, as phenolic metabolites were produced (higher scores for 
PC1) and initial benzoic and cinnamic acids were degraded (higher 
scores for PC2). Samples from incubations with AC and DC microbiota 
were closely located for each phenolic extract and followed a similar trend 
over time, especially for the cranberry extract. Overall, as time 
progressed, incubations of the cranberry extract with both AC and DC 
microbiota led to relatively greater changes in their phenolic profile in 
comparison to the grape seed extract which suffered phenolic metabolism 
to a lesser extent. 
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Table III.1. Range of variation (minimum and maximum values) of the 
concentration of main phenolic metabolites measured during incubations of the 
cranberry/grape seeds extract with the microbiota taken from the ascending 
colon (AC) and descending colon (DC) compartments, and significant main 
effects of the factors. 
 
 1 
   Factors´ main  effects 
 Minimum 
(µg/mL) 
Maximum 
(µg/mL) 
Time Phenolic 
extract 
Microbiota 
Phenylacetic acids      
3,4-Dihydroxyphenylacetic acid 0.00 4.55 * * * 
3-Hydroxyphenylacetic acid 0.00 0.19 * - * 
4-Hydroxyphenylacetic acid 0.55 5.75 - - * 
Phenylacetic acid 4.80 19.54 * - * 
      
Phenylpropionic acids      
3-(3´,4´-Dihydroxyphenyl)-propionic acid 0.00 5.32 * * * 
3-(3´-Hydroxyphenyl)-propionic acid 0.00 1.88 - - - 
3-(4´-Hydroxyphenyl)-propionic acid 0.00 11.32 * * - 
Phenylpropionic acid 0.00 1.81 * * * 
      
Benzoic acids      
Gallic acid 0.00 7.42 * * * 
Protocatechuic acid 0.04 6.74 * * * 
Syringic acid 0.00 0.14 * * - 
Vanillic acid 0.03 2.54 *  * - 
4-Hydroxybenzoic acid 0.13 0.46 * * * 
2-Hydroxybenzoic acid 0.08 0.47 * * * 
Benzoic acid 0.22 38.39 * * * 
      
Cinnamic acids      
Caffeic acid 0.00 0.92 * * - 
Ferulic acid 0.00 0.82 * * - 
Trans-p-coumaric acid 0.00 5.18 * * - 
Trans-cinnamic acid 0.00 0.80 * * - 
      
Phenols      
Catechol/Pyrocatechol 0.00 6.24 * * - 
4-Metylcatechol 0.00 0.04 - - - 
4-Ethylcatechol 0.00 0.06 - - - 
      
Other metabolites      
1-(3',4'-Dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-
propan-2-ol 
0.00 6.09 * * * 
5-(3',4'-Dihydroxyphenyl)-γ-valerolactone 0.00 10.22 * * * 
4-Hydroxy-5-(3´,4´-dihydroxyphenyl)-valeric acid 0.00 15.66 * * * 
4-Hydroxy-5-(3´-hydroxyphenyl)-valeric acid 0.00 26.20 - - - 
4-Hydroxy-5-(phenyl)-valeric acid 0.00 15.00 - - - 
*  Statistical significance of the main effects of the factors (p < 0.05).  2 
 122 
Results 
 
Figure III.1. Mean values of the concentrations of phenylacetic acids (µg/mL) 
during incubations of phenolic extracts with colonic microbiota: 3,4-
dihydroxyphenylacetic acid,  3-hydroxyphenylacetic acid, 4-hydroxyphenylacetic 
acid and phenylacetic acid. The error bars are 95% confidence intervals (n=3). 
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Figure III.2. Mean values of the concentrations of phenylpropionic acids (µg/mL) 
during incubations of phenolic extracts with colonic microbiota:  3-(3´,4´-
dihydroxyphenyl)-propionic acid, 3-(3´-hydroxyphenyl)-propionic acid, 3-(4´-
hydroxyphenyl)-propionic acid and phenylpropionic acid. The error bars are 
95% confidence intervals (n=3). 
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Figure III.3. Representation of the samples in the plane defined by the first two 
principal components (PC1 and PC2) resulting from a PCA of phenolic 
compounds from the incubations of phenolic extracts with colonic microbiota at 
different times (0, 6, 24 and 48 h). 
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III.4.2 Changes in microbial counts and metabolism 
The impact of the cranberry and grape seed extracts on the AC and 
DC microbiota from the SHIME was analysed by qPCR, targeting total 
bacteria and specific phylogenetic groups (Table III.2). Significant 
differences (p < 0.05) in microbiological counts were observed between 
the AC and DC batches at the incubation onset; Lactobacillus, 
Bacteroides, Prevotella and Enterobacteriaceae being representative of 
the AC microbiota, whereas C. leptum and Ruminococcus prevailed in the 
DC microbiota. Similar results were obtained with the nonparametric 
Mann-Whitney test. During the batch incubations, counts from all the 
analysed bacterial groups generally decreased over time (p < 0.05). The 
reduction of microbial counts could be partially associated with the 
limitation of substrates during the batch incubations. Moreover, 
differences in the evolution of microbial groups were observed, depending 
on the polyphenolic extract analysed. The decrease of 
Enterobacteriaceae counts was faster when the samples were incubated 
with cranberry rather than with grape seed, showing a decrease in 1.5 log 
copy numbers/mL after 24 h of incubation in both the AC and DC batches 
added with the cranberry extract (Table III.2). However, for most of the 
microbial groups assayed, the highest decrease in counts was observed 
in the DC batches after 48 h of incubation with the grape seed extract, 
showing an average decrease in counts of 2 log copy numbers/mL for 
Bifidobacterium, Lactobacillus, Enterobacteriaceae, C. leptum and 
Ruminococcus and of 3 log copy numbers/mL for Bacteroides, Prevotella 
and B. coccoides-E. rectale. On the other hand, the decrease of the 
microbial groups in the AC batches was similar during the incubation with 
both phenolic extracts, showing Prevotella as having the highest 
decrease in counts (about 4 log copy numbers/mL after 48 h of 
incubation; Table III.2). The same significant differences during the batch 
incubations indicated in the Table III.2 were obtained using the 
nonparametric Kruskal-Wallis test, although some for a value of p < 0.08. 
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Table III.2. Means ± standard deviation values of the quantitative PCR data (log 
copy number/mL) for the microbial groups analyzed during incubations of the 
cranberry/grape seeds extract with the microbiota taken from the ascending 
colon (AC) and descending colon (DC) compartments. 
 
 
a-c For a given microbial group analyzed, different letters denote significant differences (p < 0.05) from 
LSD test during the incubation time (for a given compartment) with the grape seed and cranberry extracts. 
* Denotes differences (p < 0.05) between the two compartments for a given incubation time and each 
extract.  
  0 h
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
AC
DC
  3.66 ± 0.04b   2.24 ± 0.68a
*5.28 ± 0.20c   4.17 ± 0.46b   3.11 ± 0.69a
Ruminococcus Cranberry   3.98 ± 0.06c   3.57 ± 0.05b   3.01 ± 0.32a
*5.24 ± 0.19b   4.53 ± 0.42ab *4.15 ± 0.42a
Grape seed   3.97 ± 0.04b
  5.98 ± 0.47b   5.11 ± 0.61ab   4.37 ± 0.29a
Grape seed   5.09 ± 0.25b   5.10 ± 0.26b   3.79 ± 0.30a
*6.09 ± 0.20b   4.59 ± 0.63a   3.70 ± 0.92a
  7.01 ± 0.13b   5.96 ± 0.19a
  6.95 ± 0.30b *5.70 ± 0.62b *4.23 ± 0.85a
Clostridium leptum  Cranberry   5.00 ± 0.06b   5.21 ± 0.44b   4.08 ± 0.61a
B. coccoides-E. rectale Cranberry   7.34 ± 0.02b   6.97 ± 0.21b   5.82 ± 0.49a
  6.94 ± 0.19c   6.21 ± 0.43b   5.45 ± 0.36a
Grape seed   7.27 ± 0.03b
*7.52 ± 0.30b *6.01 ± 0.52a   5.56 ± 0.43a
Grape seed   8.83 ± 0.03c   8.18 ± 0.11b   6.16 ± 0.26a
*7.52 ± 0.43c *6.38 ± 0.47b   5.15 ± 0.72a
  6.56 ± 0.28b   4.34 ± 0.10a
*6.41 ± 0.39c *4.23 ± 0.55b *3.04 ± 0.57a
Enterobacteriaceae Cranberry   8.56 ± 0.13c   7.13 ± 0.17b   5.78 ± 0.45a
Prevotella Cranberry   7.74 ± 0.24c   5.38 ± 0.33b   4.15 ± 0.40a
*6.15 ± 0.20b *4.44 ± 0.35a   3.98 ± 0.50a
Grape seed   7.87 ± 0.09c
*6.87 ± 0.06b *5.99 ± 0.25ab   5.64 ± 0.89a
Grape seed   7.51 ± 0.19c   7.22 ± 0.06b   5.62 ± 0.04a
*7.04 ± 0.15c *5.81 ± 0.17b   4.01 ± 0.97a
  7.25 ± 0.18b   6.13 ± 0.16a
  6.78 ± 0.59b   5.92 ± 0.82ab   4.84 ± 0.82a
Bacteroides Cranberry   7.43 ± 0.02c   6.82 ± 0.31b   5.74 ± 0.27a
Bifidobacterium Cranberry   7.53 ± 0.03b   7.11 ± 0.01b   5.96 ± 0.38a
  6.90 ± 0.45b   6.62 ± 0.65ab   5.83 ± 0.32a
Grape seed   7.51 ± 0.14b
*6.78 ± 0.22b   5.68 ± 0.51a   5.54 ± 0.63a
Grape seed   7.40 ± 0.10c   6.92 ± 0.17b   5.79 ± 0.08a
*6.80 ± 0.29c *5.55 ± 0.50b   4.52 ± 0.57a
  8.38 ± 0.34b   6.64 ± 0.02a
  8.18 ± 0.41b *7.06 ± 0.51b   5.34 ± 0.80a
Lactobacillus Cranberry   7.37 ± 0.06c   6.74 ± 0.06b   5.80 ± 0.44a
Total bacteria Cranberry   8.71 ± 0.09c   7.72 ± 0.11b   6.71 ± 0.45a
  8.32 ± 0.33b   7.17 ± 0.40a   6.56 ± 0.50a
Grape seed   8.61 ± 0.24b
Bacterial group Compartment Incubation time  
    24 h 48 h
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The effect of the cranberry and grape seed extracts on the 
fermentative and proteolytic activities of the AC and DC microbial groups 
was evaluated by the formation of short-chain (SCFA) and branched-
chain (BCFA) fatty acids, and ammonium (Table III.3). The initial content 
of SCFA was higher in the samples originated from the DC vessel of the 
SHIME than those from the AC compartment, whereas the BCFA and 
ammonium contents showed no significant differences within colonic 
compartments. Acetic, propionic and butyric acids represented more of 
the 90% of the SCFA analysed while isovaleric and isobutyrate acids 
were the predominant BCFA. During incubation, an increase in the 
formation of SCFA was only observed in the incubations with the AC 
microbiota, but no significant differences were observed in the effect of 
the added polyphenolic extract. The AC batches were characterized as 
containing the major proportion of saccharolytic bacteria (Bacteroides, 
Lactobacillus and Prevotella; Table III.2), which are mainly responsible of 
the formation of SCFA. Likewise, the formation of BCFA and ammonium 
only increased during incubation of the phenolic extracts with the AC 
microbiota (Table III.3). The results obtained with the nonparametric 
Kruskal-Wallis test matched those of the one-way ANOVA, although four 
comparisons were statistically significant but for a value of p < 0.08. 
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Table III.3. Mean ± standard deviation data for acetate, propionate, butyrate, 
total SCFA, BCFA and ammonium during incubation of the ascending colon 
(AC) and descending colon (DC) compartments with the cranberry and grape 
seed extracts. 
 Data are expressed as means ± standard deviation. For a given compound analysed, different lower-case 
letters, in the same row (compartment), denote significant differences (P < 0.05) along the incubation time; 
and * denotes differences between the two compartments (P < 0.05), for each incubation time, and each 
extract. aData at time 0 h correspond to the values analysed from the AC and DC compartment samples 
before addition of the phenolic extracts.  
0 h* 24 h 48 h
AC   1877
a
 ± 281a 1923 ± 317a 2141 ± 49a
DC  2497 ± 254a 2586 ± 380a 2370 ± 344a
AC   1877 ± 282a 1963 ± 213a 2011 ± 70a
DC 2497 ± 254a 2387 ± 602a 2351 ± 226a
AC  761 ± 66a   946 ± 139ab 1014 ± 64b
DC 993 ± 96a 1006 ± 108a 929 ± 124a
AC   761 ± 66a 936 ± 124b 975 ± 55b
DC 993 ± 96a 976 ± 198a 944 ± 39a
AC 399 ± 71a 582 ± 66b 640 ± 58b
DC 481 ± 12a 486 ± 25a 529 ± 75a
AC 399 ± 71a 579 ± 57b   604 ± 45b
DC 481 ± 12a 458 ± 72a *482 ± 18a
AC   3244 ± 453a 3740 ± 568a 4100 ± 156a
DC 4526 ± 397a 4656 ± 533a 4580 ± 633a
AC   3244 ± 453a 3762 ± 392a 3905 ± 163a
DC 4526 ± 397a 4385 ± 946a 4438 ± 390a
AC 255 ± 64a 315 ± 35a 329 ± 22a
DC 356 ± 21a 356 ± 27a 363 ± 47a
AC 255 ± 64a 319 ± 24a 330 ± 13a
DC 356 ± 21a 371 ± 54a 367 ± 19a
AC 238 ± 60a 305 ± 19ab 321 ± 30b
DC 381 ± 8a 348 ± 36a 369 ± 36a
AC 238 ± 60a   296 ± 6ab 327 ± 11b
DC 381 ± 8a *380 ± 24a 358 ± 38a
Ammonium Cranberry
Grape seed 
SCFA Cranberry
Grape seed 
BCFA Cranberry
Grape seed 
Propionate Cranberry
Grape seed 
Butyrate Cranberry
Grape seed 
Compound Compartment
Incubation time
Acetate Cranberry
Grape seed 
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III.5 DISCUSSION 
Consumption of cranberry is widely recommended as a prophylaxis 
against UTIs, although the mechanisms behind these preventive effects 
are still poorly understood. These preventive effects associated with 
cranberry consumption may be due to the combination of different 
polyphenols rather than to the action of an individual or single phenolic 
group alone (Wang, Zuo, Vinson, & Y. Deng, 2012). Therefore, 
experimentation with cranberry extracts/products rather than with specific 
cranberry components (i.e. A-type proanthocyanidins), seems an 
accurate approach to studying their impact on human health. To our 
knowledge, this is the first in vitro study of the degradation of cranberry 
polyphenols by human microbiota, evaluating both phenolic metabolism 
by colonic microbiota and the modulation of microbiota by cranberry 
polyphenols and/or their metabolites. Our results confirmed the formation 
of phenylacetic (3,4-dihydroxy-, 3-hydroxy-, 4-hydroxy-, and 
phenylacetic), phenyl-propionic [3-(3´,4´-dihydroxy-phenyl)-, 3-(3´-
hydroxy-phenyl)-, 3-(4´-hydroxy-phenyl)- and 3-(phenyl)propionic acid] 
and benzoic (3,4-dihydroxy-, 4-hydroxy-, 2-hydroxy- and benzoic acid) 
acids, as well as phenols such as catechol and its derivatives (4-methy- 
and 4-ethyl) derived from the action of colon microbiota on cranberry 
polyphenols.  Therefore, it would be expected that these metabolites 
could be absorbed from the large intestine and be further detected in the 
plasma and urine after the ingestion of cranberry products. Effectively, 
Wang et al. (2012) found a significant increase in the content of 4-
hydroxyphenylacetic, 4-hydroxybenzoic acid, 2-hydroxybenzoic and 
benzoic acids, among other metabolites, in urine samples of healthy 
subjects after a 3-week administration of cranberry juice. In the same 
way, Khanal, Howard & Prior (2014) found that supplementation of a 
high-fructose diet with cranberry significantly increased the urinary 
excretion of 3,4-dihydroxyphenylacetic, 3-hydroxyphenylacetic, 3-(3´-
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hydroxphenyl)-propionic and 3,4-dihydroxybenzoic, among other phenolic 
acids, in rats. 
Another contribution of this study is the comparison between the 
microbial degradation sequence of cranberry and grape seed 
polyphenols. Grape seed extracts, rich in B-type proanthocyanidins, have 
been widely used for the study of the microbial metabolism of flavan-3-ols 
and their concurrent impact on gut microbiota. In a previous study using 
the same grape seed extract (Sánchez-Patán et al., 2012a), maximum 
formation of intermediate metabolites, such as 5-(3´,4-dihydroxyphenyl)-
γ-valerolactone and 4-hydroxy-5-(3´,4´-dihydroxyphenyl)-valeric acid, and 
of several phenolic acids, including 3-(3,4-dihydroxyphenyl)-propionic 
acid, 3,4-dihydroxyphenylacetic acid, 4-hydroxymandelic acid, and gallic 
acid was observed at 5–10 h of incubation with faecal microbiota; later 
phases of the incubations (10–48 h) showed the appearance of mono- 
and non-hydroxylated forms of previous metabolites by dehydroxylation 
reactions. Formation of all these metabolites was also detected in the 
present study, but to a lesser extent, which was attributed to differences 
in the microbiota and in the incubation conditions used. In any case, in 
comparison to grape seed polyphenols, microbial degradation of 
cranberry polyphenols led to a different phenolic metabolic fingerprint, 
characterized by a relatively higher production of 3,4-
dihydroxyphenylacetic, 3-(3´,4´-dihydroxyphenyl)-propionic, 3-(4´-
hydroxyphenyl)-propionic and phenylpropionic acids (Table III.1, Figures 
III.1 and III.2) (Supporting Information, Figures S1-S4).  When all 
metabolites detected were considered in a statistical multivariable 
analysis (PCA), we concluded that the extent of microbial degradation 
was greater in the case of cranberry polyphenols (Figure III.3). These 
comparative results concerning phenolic metabolism were associated 
with changes in microbial counts and metabolic activity for both cranberry 
and grape seed extracts. The lower extent of phenolic metabolism was 
related with a higher decrease in microbial counts observed in the DC 
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batches incubated with the grape seed extract (Table III.2), and agrees 
with previous results that demonstrated a certain antimicrobial capacity 
for this same grape seed extract (Cueva et al. 2013; Tabasco et al., 
2011). A comparison of the effect of grape seed and cranberry extracts in 
the growth of pure cultures of lactic acid bacteria revealed a higher 
reduction in growth parameters caused by the incubation with grape seed 
extract (Tabasco et al., 2011) than with cranberry extract (Sánchez-Patán 
et al., 2012c), showing procyanidin B2 (B-type linkage) to be a higher 
inhibitory capacity than procyanidin A2 (A-type linkage) (Sánchez-Patán 
et al., 2012c). Monomeric flavan-3-ols and B-type procyanidin dimers 
have been described as showing a wide spectrum and higher 
antimicrobial activity in comparison with other polyphenols (Daglia, 2012).  
During the incubation of the colonic microbiota with the phenolic 
extracts, the groups most affected were Bacteroides, Prevotella and B. 
coccoides-E. rectale. In a previous study we observed that Bacteroides 
and the B. coccoides-E. rectale group were the most inhibited groups 
after feeding the SHIME colonic microbiota with red wine polyphenols 
(Barroso et al., 2014). In vitro fermentation studies with faecal microbiota 
have also revealed that (+)-catechin and (epi)gallocatechins were able to 
inhibit Clostridium and Bacteroides (Tzounis et al., 2008). On the other 
hand, the higher counts of microbial groups registered in the AC batches 
corresponded with a time-dependent increase of the fermentative and 
proteolytic metabolism observed in these batches (Table III.3). 
Bacteroides and Lactobacillus are characterized by exhibiting 
saccharolytic and proteolytic activities (Ravcheev, Godzik, Osterman, & 
Rodionov, 2013; Davila et al., 2013).  
Additionally, this study confirms differences in the metabolic activity 
of colon microbiota from different regions (i.e, ascending and descending 
colon).  Formation of phenolic acids from the microbial conversion of 
cranberry and grape seed polyphenols was higher with the DC 
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microbiota, which is in agreement with previous studies (Barroso et al. 
2013). Within the microbial groups assayed, the clostridial cluster IV, 
represented by C. leptum and Ruminococcus, prevailed in the DC 
batches. So far, only a few bacterial species, some of them belonging to 
the class Clostridiales, such as Eubacterium sp. and Flavonifractor sp., 
and Eggerthella spp., have been reported to be able to initiate the 
metabolism of flavanol-3-ols (Wang et al. 2001; Kutschera, Engst, Blaut, 
& Braune, 2011; Jin & Hattori 2012). Although batch incubations with 
faecal microbiota are limited by substrate depletion and the accumulation 
of the end products, they are appropriate for comparison of the microbial 
consequences of exposure to different sources or doses of compounds, 
such as the cranberry and grape seed extracts used in this study. 
In summary, this study reports for the first time the formation of 
phenolic acids and other metabolites after in vitro incubations of cranberry 
polyphenols with colon microbiota, to a relatively greater extent in 
comparison to polyphenols from other sources (i.e., grape seeds). These 
microbial-derived metabolites may play a key role in explaining the 
preventive effects of cranberry consumption against UTIs. Recently, the 
anti-adhesive activity against uropathogenic E. coli by some microbial-
derived metabolites, such as catechol, benzoic acid, vanillic acid, 
phenylacetic acid and 3,4-dihydroxyphenylacetic acid, has been proven in 
cultures of epithelial bladder cells (González de Llano, Esteban-
Fernández, Sánchez-Patán, Martín-Álvarez, Moreno-Arribas, & 
Bartolomé, 2014). 
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Figure S1. Mean values of the concentrations of benzoic acids (µg/mL) during 
incubations of phenolic extracts with colonic microbiota:  gallic acid, 
protocatechuic acid, syringic acid, vanillic acid, 4-hydroxybenzoic acid, 2-
hydroxybenzoic acid and benzoic acid. The error bars are 95% confidence 
intervals (n=3). 
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Figure S2. Mean values of the concentrations of cinnamic acids (µg/mL) during 
incubations of phenolic extracts with colonic microbiota: caffeic acid, ferulic 
acid, trans-p-coumaric acid and trans-cinnamic acid. The error bars are 95% 
confidence intervals (n=3). 
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Figure S3. Mean values of the concentrations of phenols (µg/mL) during 
incubations of phenolic extracts with colonic microbiota: catechol/pyrocatechol, 
4-metylcatechol and 4-ethylcatechol. The error bars are 95% confidence 
intervals (n=3). 
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Figure S4. Mean values of the concentrations of other metabolites (µg/mL) 
during incubations of phenolic extracts with colonic microbiota: 1-(3',4'-
dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol,5-(3',4' 
dihydroxyphenyl)-γ-valerolactone, 4-hydroxy-5-(3´,4´-dihydroxyphenyl)-valeric 
acid, 4-hydroxy-5-(3´-hydroxyphenyl)-valeric acid and 4-hydroxy-5-(phenyl) 
valeric acid. The error bars are 95% confidence intervals (n=3).
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IV.1 ABSTRACT 
This work aimed to unravel the role of the potential probiotic 
Lactobacillus plantarum IFPL935 strain in the colonic metabolism of a 
polyphenolic red wine extract, when added to a complex human intestinal 
microbiota from the dynamic Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME). The microbial metabolism of phenolic compounds, 
microbial community changes along with fermentative and proteolytic 
activities was monitored. The results showed that L. plantarum IFPL935 
significantly increased the concentration of the initial microbial ring-fission 
catabolite of catechins and procyanidins, diphenylpropanol and similarly, 
4-hydroxy-5-(3’-hydroxyphenyl)-valeric acid production. Furthermore, the 
addition of this strain raised an increase of butyrate production. In 
summary, the data highlighted that L. plantarum IFPL935 may have an 
impact on the bioavailability of these dietary polyphenols and therefore on 
its biological in vivo effects. Also, L. plantarum IFPL935 may possible 
influence SCFAs production, and in particular butyrate, which have 
numerous documented effects promoting bowel large function. 
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IV.2 INTRODUCTION 
There is increased epidemiological evidence that associates a 
moderate consumption of red wine to several health benefits in humans 
such as protection against cardiovascular and neurodegenerative 
diseases and certain types of cancer including colon, basal cell, ovarian, 
and prostate carcinoma (Del Rio et al., 2013). This protective effect has 
been mainly linked to the presence of polyphenol compounds in wine. 
Polyphenols are secondary plant metabolites widely diverse and 
abundantly present in our diet in different food and beverages. Flavonoids 
are the most abundant, and among the most bioactive polyphenols 
present in red wine, mainly including flavan-3-ols (also known as 
flavanols), flavonols and anthocyanins (Waterhouse et al,2002). Unlike 
other classes of flavonoids, which exist in plants primarily in glucoside 
forms, flavanols are usually present in the aglycone form as monomers or 
oligomers (condensed tannins or proanthocyanidins) or esterified with 
gallic acid giving rise to epigallocatechin (EGC), epicatechin gallate 
(ECG) and epigallocatechin gallate (EGCG). Nevertheless, it is becoming 
clear that their resulting in vivo bioactivity is dependent on its 
bioavailability, absorption, and metabolism.  
Gut microbiota may play a crucial role in the potential health effects 
of the polyphenols (Crozier, 2009). Absorption of polyphenols from the 
upper intestinal tract is highly variable although it is established that many 
of them are poorly absorbed. Bioavailability of flavan-3-ols is largely 
influenced by their degree of polymerization; while monomers are readily 
absorbed in the small intestine, oligomers and polymers need to be 
biotransformed by the colonic microbiota before absorption (Hackman et 
al., 2008). The human intestinal microbiota is a highly complex and 
dynamic ecosystem that harbors over a thousand different strains. In the 
colon, bacterial numbers can reach 100 trillion bacteria and such large 
numbers have enormous and diverse metabolic activity with significant 
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implication for plant polyphenol metabolism (van Duynhoven et al., 2011). 
This metabolic activity, which exceeds that of the liver in a factor of 100, 
is responsible for the major transformations of polyphenols in compounds 
that may have higher bioactivity and/or biological significance than their 
precursors (Possemiers et al., 2011). Microbial enzymes can hydrolyze 
glycosides, glucuronides, sulfates, amides, esters, and lactones and are 
able to break down the polyphenolic skeleton and perform reactions of 
reduction, decarboxylation, demethylation, and dehydroxylation (Aura 
2008). 
Parallel to this microbial metabolism, polyphenols could also modify 
the intestinal bacterial population composition and/or activity, thus 
establishing a bi-directional interaction between intestinal microbiota and 
dietary polyphenols (Selma et al., 2009; Requena et al., 2010). Related to 
this, batch fermentations performed with human feces inoculated with 
catechin have shown to have a positively effect on the growth of the 
Blautia coccoides-Eubacterium rectale group and Bifidobacterium, while 
inhibiting the growth of the Clostridium histolyticum group (Tzounis et al., 
2008). In vivo studies conducted in animals have shown an increase in 
Lactobacillus and Bifidobacterium species following administration of red 
wine-polyphenols while a decrease in Clostridium and Bacteroides was 
reported (Dolara et al., 2005). Recently, a pilot human intervention study 
(n=8) has shown a significant increase in the number of Enterococcus, 
Prevotella, Bacteroides, Bifidobacterium, Bacteroides uniformis, 
Eggerthella lenta, and B. coccoides–E. rectale groups in fecal samples 
after the consumption of red wine polyphenol for 4 weeks in comparison 
to baseline (Queipo-Ortuño et al., 2012). 
In previous studies, we have reported that some strains of 
Lactobacillus plantarum, Lactobacillus casei and Lactobacillus delbrueckii 
subsp. bulgaricus were able to grow in the presence of a flavan-3-ol 
extract from grape seeds. In addition, L. plantarum IFPL935 was also 
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capable of metabolizing these polyphenolic extracts through galloyl-
esterase, decarboxylase and benzyl alcohol dehydrogenase enzyme 
activities leading to the formation of gallic acid, pyrogallol and catechol, 
respectively (Tabasco et al.,2011). Interestingly, L. plantarum IFPL935 
showed the potential to cleave the heterocyclic ring of monomeric flavan-
3-ols, giving rise to 1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-
propan-2-ol (i.e. diphenylpropanol), which is the first metabolite in the 
microbial catabolic pathway of flavan-3-ols (Sánchez-Patán et al., 2012). 
This activity has only been reported in a few intestinal bacteria to date 
(Wang et al., 2011; Kutschera et al., 2011). 
The aim of this work was to unravel the role of the potential 
probiotic L. plantarum IFPL935 strain in the colonic metabolism of 
polyphenols carrying out in vitro batch incubations containing a human 
intestinal microbiota from the colonic compartments of the dynamic 
Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and a 
commercial polyphenolic red wine extract. The study was undertaken by 
monitoring changes in the main microbial groups along with metabolic 
activity (short-chain fatty acids and ammonium production) and 
polyphenolic catabolism analyses.  
IV.3 MATERIALS AND METHODS 
IV.3.1 Bacterial strains, media and phenolic extract 
L. plantarum IFPL935 isolated from raw milk cheeses (Fontecha, et 
al., 1990) (CIAL Collection, CSIC, Spain) was grown at 37 °C in MRS 
broth (Pronadisa, Madrid, Spain). Growth of bacterial cultures was 
routinely monitored by measuring the optical density at 600 nm (OD600). 
A commercial alcohol-free red wine extract, ProvinolsTM, which 
contains at least 95% of polyphenols was used (Safic-Alcan 
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Especialidades, Barcelona, Spain). As indicated by the supplier, 100 mg 
of Provinols™ correspond to the polyphenol content of one glass of red 
wine (125 mL). Phenolic composition of this red wine extract was reported 
before (Sánchez-Patán et al., 2012), being flavan-3-ols and anthocyanins 
as the main phenolic compounds.  
IV.3.2 In vitro batch incubations with intestinal bacteria 
In vitro batch incubations were performed by sampling 25 mL of the 
colon ascendens, colon descendens and effluent compartments (AC, DC 
and EC, respectively) of the Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME) (Molly et al., 1993). This dynamic in vitro 
gastrointestinal model comprises a series of five double-jacketed 
fermentation vessels simulating the stomach, small intestine and the 
three-stage large intestine conditions. The colon compartments contained 
in vitro cultured microbiota that were isolated from human feces and 
harbored a reproducible microbial community representative of the in vivo 
conditions both in composition and metabolic activity (Van den Abbeele et 
al., 2010). Detailed information about the SHIME system, the SHIME feed 
and its in vivo validation can be found (Molly et al., 1993; Molly et al., 
1994; Possemiers et al., 2006). Following sampling, the colon microbial 
suspensions (25 mL) were placed into penicillin bottles containing 
Provinols™ (500 mg/L) or Provinols™ (500 mg/L) plus L. plantarum 
IFPL935 (107 ufc/mL) and were incubated for 48 h at 37 °C. To obtain 
anaerobic conditions, L-cystein (0.5 g/L) was added and bottles were 
closed with butyl rubber stoppers and flushed with N2 during 15 cycles of 
2 min each at 800 mbar overpressure and 900 mbar underpressure. 
Before starting the incubation, bottles were placed on atmospheric 
pressure. Samples were taken at 0, 6, 24 and 48 h with a needle that 
extends beyond the butyl rubber stoppers that seal off the incubation 
bottles. Upon sampling, the mixture was flushed with N2 to ensure 
anaerobic conditions. Samples were immediately stored at −20 °C until 
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further analysis. Two independent experiments, each of them analyzed in 
triplicate, were carried out. 
IV.3.3 Microbial community analyses 
Quantitative PCR (qPCR) on total bacteria and different groups and 
genera of bacteria (Table III.1) was performed to study the effect of the 
incubation of the intestinal bacteria with the wine phenolic extract. 
Genomic DNA was extracted from samples (1 mL) by a method based on 
the protocols described previously (Griffiths et al., 2000; Kowalchuk et al., 
1998). Extractions were performed by the addition of 0.5 mL of 
hexadecyltrimethylammonium bromide (CTAB) extraction buffer (pH 8.0) 
and 0.5 mL of phenol-chloroform-isoamyl alcohol (25:24:1). Samples 
were lysed with glass beads (150-212 µm-diameter) by using a FastPrep 
equipment (BIO 101, Savant Instruments, Holbrook, NY) for 30 s (3 
times) at a machine speed setting of 4.5 m/s. The aqueous phase 
containing nucleic acids was separated by centrifugation (3,000 × g) for 5 
min at 4°C and mixed with an equal volume of chloroform-isoamyl alcohol 
(24:1) followed by centrifugation (16,000 × g) for 5 min at 4 °C. Total 
nucleic acids were subsequently precipitated from the extracted aqueous 
layer with 2 volumes of polyethelene glycol PEG-6000 (Merck, 
Hohenbrunn, Germany) for 2 h at room temperature, followed by 
centrifugation (18,000 × g) at 4°C for 10 min. Pelleted nucleic acids were 
washed in ice cold 70% (vol/vol) ethanol and dried in a Speed-Vac (SPD 
111 V; Savant Instruments), prior to resuspension in 100 μL of distilled 
water. 
Triplicate samples of 10-fold diluted genomic DNA were analyzed 
for total bacteria, Enterobacteriaceae, Bacteroides, Lactobacillus, 
Bifidobacterium, Prevotella, the specific phylogenetic groups Blautia 
coccoides-Eubacterium rectale Cluster XIVa, Ruminococcus Cluster IV, 
Clostridium leptum subgroup specific cluster IV and the gene encoding 
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butyryl-CoA:acetate CoA transferase (BcoAT). Assays were performed 
using SYBR green methodology (Kappa Biosystems, Woburn, MA, USA) 
with the IQ5 Multicolor Real-Time PCR Detection System (Biorad) and 
data analyses were performed with iQ5 Optical System Software Version 
1.1. Target microbial groups and functional genes, primers, amplicon 
size, annealing temperature, pure bacteria culture or clone for standard 
curves and references are listed in Table IV.1. When samples were 
quantified using standards derived from one clone, each specific target 
sequence was cloned separately using the pGEM-T cloning vector 
system kit (Promega, Madison, WI, USA) according to the manufacturer's 
instructions. The recombinant vector was transformed into chemically 
competent E. coli DH5α cells. Transformed colonies were picked and 
processed for plasmid isolation. Plasmid purification was done using a 
Plasmid Mini kit (Qiagen, Hilden, Germany). The presence of the insert in 
the recombinant clones was confirmed by sequence analysis. Linearized 
plasmid was quantified using a spectrophotometer and copy numbers 
were calculated for all standards by the following formula (Godornes et 
al., 2007): 
                    
                                                        
                                   
 
  
 Table IV.1. Primer sets used in this study for quantitative PCR 
  
Target gene/group Primer name Primer sequence 5'-3' Amplicon size 
Annealing 
temperature 
Standard Reference 
Total bacteria 968 F AACGCGAAGAACCTTAC 
489 55 
Escherichia coli DH5α Nübel et al., 1996 
  1401 R CGGTGTGTACAAGACCC   Nübel et al., 1996 
Lactobacillus  LactoF TGGAAACAGRTGCTAATACCG 
192 55 
Lactobacillus plantarum IFPL 935 Byun et al., 2004 
  LactoR GTCCATTGTGGAAGATTCCC   Byun et al., 2004 
Bifidobacterium  G Bifid F CTCCTGGAAACGGGTGG 
593 55 
Bifidobacterium breve 29M2 Matsuki et al., 2002 
  G Bifid R GGTGTTCTTCCCGATATCTACA   Matsuki et al., 2002 
Bacteroides  Bac303F   GAAGGTCCCCCACATTG 
103 60 
Bacteroides fragilis DSM2151  Bartosch et al., 2004 
  Bfr-Fmrev  CGCKACTTGGCTGGTTCAG  Ramirez-Farias et al., 2009 
Prevotella g-Prevo-F CACRGTAAACGATGGATGCC 
513 55 
Clone Matsuki et al., 2002 
  g-Prevo-R GGTCGGGTTGCAGACC   Matsuki et al., 2002 
Enterobacteriaceae F-Ent ATGGCTGTCGTCAGCTCGT 
385 58 
Clone Leser et al., 2002 
  R-Ent CCTACTTCTTTTGCAACCCACTC   Sghir et al., 2000 
Clostridium coccoides-Eubacterium rectale group  CcocErec-F CGGTACCTGACTAAGAAGC 
429 55 
Clone Rinttilä et al., 2004 
(Cluster XIVa) CcocErec-R AGTTTYATTCTTGCGAACG   Rinttilä et al., 2004 
Clostridium leptum subgroup-specific sg-Clept F GCACAAGCAGTGGAGT  
239 55 
Clone Matsuki et al., 2004 
(Cluster IV) sg-Clept R3 CTTCCTCCGTTTTGTCAA    Matsuki et al., 2004 
Ruminococcus  Rflbr730F  GGCGGCYTRCTGGGCTTT  
157 60 
Clone Ramirez-Farias et al., 2009 
(Cluster IV) Clep866mR  CCAGGTGGATWACTTATTGTGTTAA   Ramirez-Farias et al., 2009 
Butyryl-CoA:acetate-CoA transferase gene BCoATscrF GCIGAICATTTCACITGGAAYWSITGGCAYATG 
557 53 
Clone Louis et a., 2007 
  BCoATscrR CCTGCCTTTGCAATRTCIACRAANGC   Louis et a., 2007 
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IV.3.4 Short-chain fatty acids (SCFAs) and ammonium 
determination analyses 
The SCFAs were extracted from the samples with diethyl ether, 
after the addition of 2-methyl hexanoic acid as an internal standard and 
extracts were analysed as described previously (Alander et al., 1999). 
Briefly, one microliter of the diethyl ether layer was injected and 
measured in a Di200 gas chromatograph (GC; Shimadzu, 's-
Hertogenbosch, The Netherlands) equipped with a capillary free fatty acid 
packed column [EC-1000 Econo-Cap column (Alltech, Laarne, Belgium), 
25 m × 0.53 mm; film thickness 1.2 µm], a flame ionization detector and a 
Delsi Nermag 31 integrator (Thermo Separation Products, Wilrijk, 
Belgium). Nitrogen was used as carrier gas at a flow rate of 20 mL/min. 
The column temperature and the temperature of the injector and detector 
were set at 130 °C and 195 °C respectively. The concentration of SCFAs 
was calculated in mg/L.  
Ammonium determination was performed as described (Bremner et 
al.,1965). Chiefly, ammonium from the samples (1 mL) was released as 
ammonia by addition of magnesium oxide (MgO) using an autodistillation 
Vapodest 30´ (Gerhardt Analytical Systems, Brackley Northants, UK); 
thus, ammonia was separated by steam distillation, collected in boric 
acid-indicator solution and determined by titration with standard acid 
using a 685 Dosimat and 686 Titroprocessor (Metrohm, Berchem, 
Belgium). Ammonium ion concentration was expressed as mmol/L. 
IV.3.5 Targeted analysis of phenolic metabolites  
Phenolic metabolites were analysed by a previously-reported 
UPLC-ESI-MS/MS method (Sánchez-Patán et al., 2011). The liquid 
chromatographic system was a Waters Aquity UPLC (Milford, MA) 
equipped with a binary pump, autosampler thermostated at 10 ºC and a 
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heated column compartment (40 ºC). The column employed was a BEH-
C18, 2.1 x 100 mm and 1.7 µm particle size from Waters (Milford, MA). 
The mobile phases were 2% acetic acid in water (A) and 2% acetic acid 
in acetonitrile (B). The gradient program was as follows: 0 min, 0.1% B; 
1.5 min, 0.1% B; 11.17 min, 16.3% B; 11.5 min, 18.4% B; 14 min, 18.4% 
B; 14.1 min, 99.9% B; 15.5 min, 99.9% B; 15.6 min, 0.1% B. Equilibrium 
time was 2.4 min resulting in a total run time of 18 min. The flow rate was 
set constant at 0.5 mL min-1 and injection volume was 2 µL. 
The LC effluent was pumped to an Acquity TQD tandem 
quadrupole mass spectrometer equipped with a Z-spray electrospray 
ionization (ESI) source operated in negative polarity mode. The ESI 
parameters were set as follows: capillary voltage, 3 kV; source 
temperature, 130 ºC; desolvation temperature, 400 ºC; desolvation gas 
(N2) flow rate, 750 L/h; cone gas (N2) flow rate, 60 L/h. The ESI was 
operated in negative mode. For quantification purposes, data were 
collected in the multiple reaction monitoring (MRM) mode, tracking the 
transition of parent and product ions specific for each compound, and 
using external calibration curves. Data of the MS/MS parameters (MRM 
transitions, cone voltages and collision energies) for phenolic metabolites 
(phenols, mandelic acids, benzoic acids, hippuric acids, phenylacetic 
acids, phenylpropionic acids, valeric acids, cinnamic acids, valerolactones 
and other metabolites) (n=60) and for flavan-3-ols (monomers, 
procyanidin dimers, procyanidin trimers and gallates) were previously 
optimized (Jiménez-Gir n et al., 2013). Quantification was made on the 
basis of pure standards [from Sigma-Aldrich Chemical Co. (St. Louis, 
MO), Phytolab (Vestenbergsgreuth, Germany) and Extrasynthèse 
(Genay, France)] except for valeric acids (4-hydroxy-5-(3’,4’-
dihydroxyphenyl)-valeric, 4-hydroxy-5-(3’-hydroxyphenyl)-valeric and 4-
hydroxy-5-(phenyl)-valeric acids) that were quantified using the calibration 
curves of 3-(3,4-dihydroxyphenyl)-propionic, 3-(3-hydroxyphenyl)-
propionic acids and propionic acids, respectively. Injections were carried 
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out in duplicate. Data acquisition and processing was realized with 
MassLynx 4.1 software. 
IV.3.6 Statistical analysis 
Mean values, standard deviations and correlation coefficients were 
calculated on the basis of normalized values for the different variables 
during the incubation period (microbial groups, SCFAs, acetate, 
propionate, butyrate, ammonium and phenolic metabolites). Analysis of 
variance (ANOVA) was used for multiple comparisons of the different 
variables taken into account different factors (time, compartments, and 
addition of L. plantarum IFPL935) (P < 0.05). Principal Component 
Analysis (PCA), from standardized variables, was used to summarize 
changes in the concentration of microbial-derived phenolic metabolites. 
All statistical analyses were carried out using the STATISTICA program 
for Windows, version 7.1 (StatSoft. Inc. 1984−2006, www.statsoft.com). 
IV.4 RESULTS 
IV.4.1 Microbial community analyses 
Quantitative PCR (qPCR) was used to analyze the microbial 
community composition by targeting general bacteria and specific 
phylogenetic and functional groups (Table IV.2). The microbiological 
results of the batches at the incubation onset reproduced the variations in 
bacterial populations of the SHIME colonic compartments. Bacteroides, 
Bifidobacterium and Prevotella were predominant in the AC (ascending 
colon) batches whereas C. leptum and Ruminococcus prevailed in DC 
(descending colon) incubations. Microbiota found in EC (effluent 
compartment) batches, more representative of the fecal microbiota, was 
more similar to the DC batches than to the AC ones. Besides, qPCR data 
showed that counts of all microbial groups assessed decreased along the 
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incubation with the polyphenolic extract. Reduction of microbial counts 
was also associated to the fact that batch culture incubations used in this 
study were static and closed systems in which the substrate was limited. 
These in vitro systems, however, have been stated as useful for short 
time course experiments (Gibson et al., 2000). 
Inoculation of the colonic microbial batches with L. plantarum 
IFPL935 did not increase the total bacteria nor the Lactobacillus counts, 
although a slightly increase of Lactobacillus numbers was observed 
during incubation of the DC and EC batches inoculated with L. plantarum 
IFPL935 (Table IV.2). Similarly, DC batches inoculated with L. plantarum 
IFPL935 showed significantly higher counts of Bifidobacterium, 
Bacteroides and Ruminococcus after 48 h incubation than DC batches 
without IFPL935. Nevertheless, for the other microbial groups analyzed, 
no significant differences were found in the batches inoculated with a 
colon region-specific microbiota when IFPL935 was added.  
In addition to Clostridium clusters IV and XIVa counts, a molecular 
approach based on the enumeration of the butyryl-CoA:acetate CoA 
transferase (BCoAT) gene was used for estimating the number of 
butyrate-producing bacteria. Data analysis showed that BCoAT gene 
copy number decreased along the incubation in all batches representing 
the distinct colon region microbiota, along with the reduction of bacteria 
populations also found at 48 h (Table IV.2). Relating these findings to the 
microbial groups analyzed, it was found a significant (P < 0.05) 
correlation between this functional gene and the presence of C. leptum 
(r= 0.91), B. coccoides-E. rectale group (r= 0.84) and to a lesser extent to 
Ruminococcus (r= 0.79). 
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Table IV.2. Quantitative-PCR data (log copy number/mL)  
 
Data are expressed as means and standard deviation (SD). For a given microbial group analyzed, different 
capital letters denote significant differences (P < 0.05) between compartments in the presence/absence of 
L. plantarum IFPL935. For the same row, different lowercase letters denote significant differences (P< 
0.05) along the incubation time (for a given compartment) 
AC 8.53 (0.32) B c 7.81 (0.10) BC b 6.76 (0.33) B a
Total bacteria DC 7.80 (0.48) A b 7.08 (0.37) A b 5.68 (0.67) A a
EC 8.52 (0.31) B b 7.95 (0.31) C b 7.02 (0.67) B a
AC 8.24 (0.36) B c 7.36 (0.41) AB b 6.49 (0.02) B a
DC 8.11 (0.54) AB b 6.97 (0.48) A a 6.46 (0.59) AB a
EC 8.48 (0.38) B b 8.07 (0.47) C b 6.90 (0.64) B a
AC 7.25 (0.33) B c 6.63 (0.01) CD b 5.65 (0.37) B a
Lactobacillus DC 6.49 (0.53) A b 5.79 (0.40) A b 4.57 (0.50) A a
EC 7.05 (0.14) AB b 6.64 (0.30) CD b 5.66 (0.70) B a
AC 7.05 (0.44) AB c 6.43 (0.40) BC b 5.67 (0.05) B a
DC 6.88 (0.58) AB b 5.90 (0.51) AB a 5.52 (0.51) B a
EC 7.31 (0.20) B b 7.12 (0.41) D b 6.07 (0.63) B a
AC 7.31 (0.32) B b 7.09 (0.10) B b 5.94 (0.20) B a
Bifidobacterium DC 6.59 (0.71) A b 6.31 (0.60) A b 4.94 (0.69) A a
EC 6.66 (0.15) A b 6.37 (0.27) AB b 5.46 (0.75) AB a
AC 7.10 (0.43) B b 6.71 (0.57) AB b 5.70 (0.03) B a
DC 6.90 (0.80) A b 6.19 (0.79) A ab 5.73 (0.53) B a
EC 6.59 (0.27) A b 6.45 (0.29) AB b 5.54 (0.55) AB a
AC 7.58 (0.29) C c 6.80 (0.30) B b 5.81 (0.35) B a
DC 6.75 (0.19) A b 6.21 (0.10) A b 4.53 (0.84) A a
EC 7.18 (0.16) BC b 6.69 (0.30) B b 5.70 (0.62) B a
AC 7.29 (0.28) BC c 6.54 (0.40) AB b 5.68 (0.05) B a
DC 7.09 (0.35) AB b 6.14 (0.26) A a 5.48 (0.87) B a
EC 7.12 (0.11) B b 6.71 (0.35) B b 5.57 (0.47) B a
AC 7.40 (0.33) C c 5.67 (0.21) C b 4.21 (0.13) A a
Prevotella DC 5.61 (0.46) A b 3.93 (0.14) A a 3.40 (1.61) A a
EC 6.40 (0.60) B c 5.04 (0.17) B b 4.30 (0.47) A a
AC 7.56 (0.52) C c 5.24 (0.40) BC b 3.94 (0.10) A a
DC 6.24 (0.73) AB b 4.32 (0.47) A a 3.66 (0.62) A a
EC 6.25 (0.42) AB c 5.11 (0.29) B b 4.18 (0.61) A a
Enterobacteriaceae
DC 7.22 (0.62) A b 6.28 (0.32) A ab 5.10 (1.31) A a
EC 8.22 (0.45) BC b 7.49 (0.66) BC b 6.48 (0.64) B a
AC 8.15 (0.70) BC b 6.91 (0.35) AB a 6.15 (0.40) AB a
DC 7.46 (0.58) AB b 6.67 (0.94) AB ab 5.70 (0.97) AB a
EC 8.43 (0.66) C b 7.94 (0.29) C b 6.29 (0.66) AB a
AC 7.08 (0.27) B c 6.65 (0.13) B b 5.53 (0.29) B a
DC 6.36 (0.53) A b 5.82 (0.30) A b 4.20 (0.90) A a
EC 7.05 (0.14) B b 6.73 (0.25) B b 5.28 (1.07) B a
AC 6.75 (0.41) AB b 6.33 (0.26) B b 5.31 (0.08) B a
DC 6.74 (0.64) AB b 5.76 (0.45) A a 5.05 (0.63) AB a
EC 6.97 (0.21) B b 6.75 (0.42) B b 5.43 (0.71) B a
Clostridium leptum
DC 5.49 (0.56) B b 4.95 (0.38) A b 3.53 (0.53) A a
EC 6.35 (0.18) D b 5.90 (0.31) B b 4.73 (0.91) B a
AC 4.49 (0.30) A b 4.44 (0.27) A b 3.68 (0.06) A a
DC 5.77 (0.61) BC b 4.90 (0.54) A ab 4.34 (0.53) AB a
EC 6.31 (0.18) CD b 6.00 (0.42) B b 4.75 (0.74) B a
AC 3.01 (0.19) A c 2.44 (0.14) A b 1.33 (0.20) A a
Ruminococcus DC 4.56 (0.62) B b 4.14 (0.32) B b 2.50 (2.55) B a
EC 5.54 (0.13) D b 5.20 (0.34) C b 3.90 (1.01) C a
AC 2.77 (0.22) A c 2.23 (0.35) A b 1.44 (0.14) A a
DC 4.91 (0.69) BC b 4.11 (0.65) B ab 3.44 (0.50) C a
EC 5.37 (0.20) CD b 5.39 (0.58) C b 3.95 (0.82) C a
AC 6.33 (0.04) A c 5.91 (0.17) A b 5.42 (0.11) A a
Butyryl-CoA:acetate-CoA 
transferase gene
DC 6.27 (0.37) A b 5.89 (0.27) A ab 5.50 (0.43) A a
EC 7.01 (0.35) C b 6.40 (0.25) B a 5.96 (0.31) B a
AC 6.28 (0.27) A c 5.83 (0.20) A b 5.51 (0.07) A a
DC 6.46 (0.52) AB b 5.85 (0.39) A ab 5.55 (0.24) AB a
EC 6.91 (0.22) BC b 6.53 (0.18) B b 5.76 (0.31) AB a
Provinols + L. plantarum  IFPL935
Provinols
Provinols + L. plantarum  IFPL935
Provinols
Provinols + L. plantarum  IFPL935
Provinols
Provinols + L. plantarum  IFPL935
a
Provinols
Provinols + L. plantarum  IFPL935
Bacterial Group Assays
Provinols
Provinols + L. plantarum  IFPL935
Provinols + L. plantarum  IFPL935
Provinols
Provinols + L. plantarum  IFPL935
(0.14) A b 3.81 (0.31) A
a
Provinols + L. plantarum  IFPL935
Blautia coccoides-
Eubacterium rectale  group
Provinols
AC 4.80 (0.71) A b 4.77
(0.20) BC b 6.29 (0.60) ABAC 8.40 (0.41) C c 7.42
Compartment
Incubation Time
0 h 24 h 48 h
Bacteroides 
Provinols
Provinols + L. plantarum  IFPL935
Provinols
Provinols
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IV.4.2 Fermentative and proteolytic activities 
An important metabolic activity of the gut microbiota is the 
formation of short-chain fatty acids (SCFAs). Initial SCFAs content was 
higher in the batches containing human intestinal microbiota from the DC 
and EC vessels (Fig. IV.1a). During incubation, the higher increase in 
SCFAs production was measured in the AC vessels although SCFAs 
increased in all batches indicating that microbiota remained metabolically 
active. The increase in SCFAs production was attributed mainly to an 
increase in acetate(r= 0.95), propionate (r=0.86) and butyrate(r=0.23). In 
general, acetate content was lower in the batches incubated with L. 
plantarum IFPL935 and this was found to be significant in the DC and EC 
batches (data not shown). This remark correlates with the significantly 
lower levels of SCFAs found in the DC and EC batches (48 h) when L. 
plantarum IFPL935 was added (Fig. IV.1a). In contrast, and although the 
differences were not significant, a higher butyrate production (up to 29%) 
was found in all the batches incubated with L. plantarum IFPL935. Also, 
the higher increase in the butyrate production was detected in the AC 
batches (Fig. IV.1b).  
Ammonium concentration, a marker for proteolytic activity, was 
higher in the batches inoculated with the DC and EC microbiota (average 
20.62 ± 1.12 mmol/L) than in the AC batches (average 12.14 ± 2.21 
mmol/L) at the onset of the incubation. However, a marked increase in 
ammonium production was noticed in the course of the incubation (48 h) 
in the batches containing the AC microbiota in contrast to that of DC and 
EC batches, where the figures remained stable (data not shown). 
Furthermore, ammonium concentration was not found to be significantly 
different in the batches incubated with IFPL935, except for EC batches 
(24 h) where this concentration was lower (P < 0.05) in batches with 
IFPL935 (16.08 ± 1.49 mmol/L) than in the control ones (21.55 ± 0.43 
mmol/L) (results not shown). 
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Figure IV.1. Average total SCFAs (a) and butyrate (b) production during the 
incubation of the microbiota representing the different colon compartments 
(ascendens, AC; descendens DC; effluent, EC) with Provinols (black circles) 
and Provinols plus L. plantarum IFPL935 (gray squares). For the batches 
containing microbiota for the same colon compartment, an asterisk indicates 
significant differences when L. plantarum IFPL935 was added. 
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Results 
IV.4.3 Microbial metabolism of phenolic compounds 
A total of 28 microbial-derived phenolic metabolites, including 
benzoic acids, phenols, phenylacetic acids, phenylpropionic acids, valeric 
acids, valerolactones and cinnamic acids, were found when incubating 
the commercial wine extract with the microbiota from the three different 
colonic compartments (AC, DC and EC) (Table IV.3). The total 
concentration of phenolic metabolites (sum of individual metabolite 
concentration) increased along the incubation period and turned out to be 
significantly higher in the DC and EC batches with regard to the AC 
batches (Fig. IV.2a). Overall, the addition of L. plantarum IFPL935 to the 
colonic microbiota did not have an impact on total concentration of 
phenolic metabolites, except for the EC batches where the figures were 
significantly higher when IFPL935 was added (24h). In this regard, a 
three-way ANOVA analysis showed that the main factors that have a 
significant effect (P< 0.05) on the total concentration of phenolic 
metabolites were the incubation time and the colon region-specific 
microbiota (AC, DC and EC) (Table IV.3). 
When analyzing specific phenolic metabolites, the highest 
concentrations were found for phenylacetic and 4-hydroxy-5-(phenyl)-
valeric acids (21 and 119 µg/mL, respectively), followed by other 
phenylacetic (3,4-dihydroxy- and 4-hydroxy-) and phenylpropionic (3,4-
dihydroxy- and 4-hydroxy-) acids (<8 µg/mL) (Table IV.3). Furthermore, 
addition of L. plantarum IFPL935 resulted to have a significant effect on 
the 1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol 
(i.e. diphenylpropanol) and 4-hydroxy-5-(3’-hydroxyphenyl)-valeric acid 
concentrations measured. Thus, as depicted in Fig. IV.2b, addition of L. 
plantarum IFPL935 significantly increased the concentration of the initial 
microbial ring-fission catabolite of catechins and procyanidins, 
diphenylpropanol, in the batches containing DC and EC microbiota (6 h) 
and in those harboring AC microbiota (48 h). Similarly, the production of 
 
Lactobacillus plantarum IFPL935 initiates the metabolism of a polyphenolic red 
wine extract in a complex intestinal human microbiota 
161 
4-hydroxy-5-(3’-hydroxyphenyl)-valeric acid, an intermediate metabolite 
derived from 4-hydroxy-5-(3’,4'-dihydroxyphenyl)-valeric acid which in turn 
comes out from the diphenylpropanol (Monagas et al., 2010), followed the 
same trend (results not shown). Moreover, (-)-epicatechin, one of the 
main flavan-3-ols present in the wine extract, was completely degraded 
by the DC and EC microbiota at 24 h of incubation, while degradation of (-
)-epicatechin was only noticeable at 48 h in the AC batches, being greater 
in the presence of L. plantarum IFPL935 (Fig. IV.2c). Similar trends were 
observed for other compounds present in the wine extract such as (+)-
catechin and procyanidin dimers and trimers (results not shown). 
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Table IV.3. Concentration of the Phenolic Metabolites Measureda and Main 
Effects of the Factorsb 
 
a
Mean, standard deviation (SD), and range of variation (minimum and maximum) of the phenolic 
metabolites concentration measured after incubation of the wine extract with the different colon region 
microbiota. 
b
Statistical significance (*) (P < 0.05) of the main effects of the factors: time (0, 6, 24, and 48 
h), microbiota (AC, DC and EC), and addition of L. plantarum IFPL935 is also shown 
  
Mean Minimum Maximum Time Microbiota L. plantarum
(µg/mL) (µg/mL) (µg/mL) IFPL935
Benzoic acids  
Gallic acid 0.85 (0.53) 0.00 2.27 *
Protocatechuic acid 0.60 (0.21) 0.23 1.07 * *
4-Hydroxybenzoic acid 0.23 (0.04) 0.15 0.33 * *
Vanillic acid 0.16 (0.08) 0.04 0.33 * *
Syringic acid 0.32 (0.15) 0.04 0.72 * *
Benzoic acid 0.39 (0.08) 0.23 0.61 * *
Salicylic acid 0.16 (0.05) 0.09 0.30 * *
Phenols
Phloroglucinol 0.04 (0.10) 0.00 0.60 *
Pyrogallol 0.08 (0.20) 0.00 0.90 * *
Catechol/Pyrocatechol 0.13 (0.11) 0.00 0.39 * *
Phenylacetic acids
3,4-Dihydroxyphenylacetic acid 0.43 (0.67) 0.00 5.01 *
4-Hydroxyphenylacetic acid 4.18 (1.73) 0.63 7.79 *
3-Hydroxyphenylacetic acid 0.09 (0.05) 0.00 0.19 * *
4-Hydroxy-3-methoxyphenylacetic acid 0.01(0.02) 0.00 0.06 * *
Phenylacetic acid 14.66 (4.11) 5.10 21.08 * *
Phenylpropionic acids
3-(3,4-Dihydroxyphenyl)-propionic acid 1.97 (1.52) 0.00 5.22 * *
3-(4-Hydroxyphenyl)-propionic acid 2.34 (1.45) 0.22 5.33 * *
3-(3-Hydroxyphenyl)-propionic acid 0.20 (0.54) 0.00 2.75 * *
Phenylpropionic acid 0.66 (0.39) 0.00 1.47 * *
Valeric acids
4-Hydroxy-5-(3’,4’-dihydroxyphenyl)-valeric acid 0.50 (1.06) 0.00 4.08 *
4-Hydroxy-5-(3’-hydroxyphenyl)-valeric acid 0.06 (0.19) 0.00 1.04 * *
4-Hydroxy-5-(phenyl)-valeric acid 17.03 (34.31) 0.00 119.27 * *
Valerolactones
5-(3',4'-dihydroxyphenyl)-γ-valerolactone 0.45 (0.89) 0.00 3.37 *
Cinnamic acids
Caffeic acid 0.27 (0.43) 0.00 1.29 *
p -Coumaric acid 0.16 (0.23) 0.00 0.78 *
Ferulic acid 0.02 (0.03) 0.00 0.11 *
Isoferulic acid 0.02 (0.03) 0.00 0.11 * *
Other metabolites
1-(3',4'-Dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol 0.07 (0.19) 0.00 0.99 * * *
∑ Phenolic metabolites 43.90 (39.33) 7.52 153.95 * *
Factors Effects
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Figure IV.2. Production of total microbial-derived phenolic metabolites (a) and 1-
(3′,4′-dihydroxyphenyl)-3-(2″,4″,6″-trihydroxyphenyl)propan-2-ol (b) and the 
disappearance of (−)-epicatechin (c) during the incubation of the wine extract 
with the three different colon region microbiota (AC, DC, and EC) with Provinols 
(black circles) and Provinols plus L. plantarum IFPL935 (gray squares). For the 
batches containing microbiota for the same colon compartment, an asterisk 
denotes significant differences with regard to the batches where L. plantarum 
IFPL935 was added 
  
a
b
c
0
1
2
3
4
5
6
0 h 6h 24 h 48 h 0 h 6h 24 h 48 h 0 h 6h 24 h 48 h
AC DC EC
(-
)-
Ep
ic
at
e
ch
in
(µ
g/
m
L)
To
ta
l m
e
ta
b
o
lit
e
s
(µ
g/
m
L)
0
20
40
60
80
100
120
140
0 h 6h 24 h 48 h 0 h 6h 24 h 48 h 0 h 6h 24 h 48 h
AC DC EC
*
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
0 h 6h 24 h 48 h 0 h 6h 24 h 48 h 0 h 6h 24 h 48 h
AC DC EC
D
ip
h
e
n
yl
p
ro
p
an
o
l(
µ
g/
m
L)
*
 164 
Results 
Principal Component Analysis (PCA) was performed to obtain a 
simplified view of the changes in phenolic microbial metabolism under the 
different conditions. Two principal components, PC1 and PC2, which 
explained 49% of the total variance, were found. For a better 
understanding of the data, mean values of the scores of the triplicate 
assays in the different time periods (0, 6, 24 and 48 h), considering the 
distinct colon region-specific microbiota and the addition of L. plantarum 
IFPL935, were plotted in the plane delimited by the first two principal 
components (Figure IV.3). PC1, which explained 36.1% of the variance, 
reflected overall changes occurring during the time-course of the 
microbial catabolism of the wine polyphenols. This component was 
negatively correlated (loadings > 0.72) with 3-(4-dihydroxyphenyl)-
propionic acid (-0.85), phenylpropionic acid (-0.85), salicylic acid (-0.82), 
protocatechuic acid (-0.79), 3-(3,4-dihydroxyphenyl)-propionic acid (-
0.79), catechol/pyrocatechol (-0.76) and phenylacetic acid (-0.73). 
Therefore, lower values of PC1 corresponded to higher concentrations of 
the compounds, which were measured at longer incubation times, mainly 
in the vessels containing the DC and EC microbiota. Interestingly, PC2, 
which explained 12.9% of the variance, showed differences in the 
phenolic metabolic profile of the batches containing the same colon 
region-specific microbiota when L. plantarum IFPL935 was added. These 
differences in the metabolites profiles were detected at 6 h for DC and EC 
batches, and for the AC batches at 24-48 h of incubation. In all cases, 
higher values of PC2 were related to the addition of IFPL935. 
  
 
Lactobacillus plantarum IFPL935 initiates the metabolism of a polyphenolic red 
wine extract in a complex intestinal human microbiota 
165 
 
Figure IV.3. Representation of the samples in the plane defined by the first two 
principal components (PC1 and PC2) resulted from a PCA of microbial-derived 
phenolic metabolites for the different colonregion-specific microbiota (AC, DC, 
and EC) and considering the addition of L. plantarum IFPL935 at different 
incubation times (0, 6, 24, and 48 h). 
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IV.5 DISCUSSION 
Bearing in mind that the composition and metabolic activity of the 
intestinal microbiota is colon-region dependent, this study was aimed to 
evaluate the contribution of L. plantarum IFPL935 to the colonic 
metabolism of wine polyphenols using in vitro batch fermentations 
inoculated with human microbiota developed in different colonic 
compartments of the SHIME. The SHIME has been reported to be able to 
simulate reproducible and highly diverse microbial communities which are 
colon region specific (Van den Abbeele et al., 2010). 
The colonic microbiota plays an important role in the microbial 
catabolism of dietary polyphenols. It has been estimated that 90-95% of 
dietary polyphenols are not absorbed in the small intestine and therefore 
accumulate in the colon (Clifford et al., 2004). Therefore, the bioactivity of 
these compounds is largely dependent on the microbiota activity. In this 
study, a wide range of potential phenolic metabolites arising from flavan-
3-ols catabolism, including first and intermediate metabolites 
(diphenylpropanol, 4-hydroxy-5-(3’-hydroxyphenyl)-valeric acid) and end 
products (hydroxypropionic acid, hydroxyacetic acids, cinnamic acids) 
were targeted during the course of the batch fermentations. Besides, 
other metabolites detected such as O-methylated benzoic acids including 
syringic and vanillic acids, could also arise from the catabolism of 
anthocyanins and other flavonoids also present in the red wine extract, as 
it has been previously reported (Sánchez-Patán et al., 2012). 
Furthermore, the microbial metabolic activity on the red wine extract 
polyphenols appears to vary according the specific colon region 
microbiota as different phenolic metabolite profiles were detected in the 
distinct batch fermentations. Thus, production of phenolic intermediate 
metabolites and phenolic acids were detected earlier during the 
incubation and reached higher concentrations in the batches containing 
human intestinal microbiota simulating the distal colon regions (DC and 
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EC) when compared to the batches inoculated with microbiota from the 
ascending colon region (AC) (Fig. IV.2), suggesting that bacterial 
conversion of wine polyphenols was more favorable in the distal colon. 
This colon site specificity of the microbial transformations is in agreement 
with previous studies where a higher microbial conversion of phenolic 
compounds was found in the distal compartments (Possemiers et al., 
2006; Van Dorsten et al., 2012). 
Microbial catabolism of polyphenols comprises a series of chain 
reactions, leading to numerous intermediate metabolites and end 
products (Aura et al., 2008; Requena et al., 2010; Monagas et al., 2010). 
The catabolism of flavan-3-ols starts with the reductive cleavage of the 
heterocyclic C ring, resulting in the formation of diphenylpropan-2-ol, 
followed by the breakdown of the A ring and further lactonization into 
phenylvalerolactones derivatives, specifically into 5-(3,4-
dihydroxyphenyl)-γ-valerolactone. However, knowledge about intestinal 
bacteria involved in the cleavage of the C-ring conversion is limited to 
only a few strains isolated from human feces such as Eubacterium sp. 
strain SDG-2 and Eggerthella lenta rK3 (Wang  et al., 2011; Kutschera et 
al., 2011). Previous findings showed that besides other polyphenol 
metabolic activities, L. plantarum IFPL935 was capable in pure culture of 
cleaving the heterocyclic ring of monomeric flavan-3-ols, giving rise to the 
first metabolite of the microbial catabolic pathway (Tabasco et al., 2011; 
Sánchez-Patán et al., 2012). Hence, the results here presented 
demonstrate the capability of L. plantarum IFPL935 of initiating wine 
polyphenol catabolism in the complex environment of colonic microbiota, 
as seen for the quicker disappearance of flavan-3-ols (i.e., (-)-
epicatechin), and production of diphenylpropanol and other intermediate 
metabolites immediately-derived from it in the batches incubated with L. 
plantarum IFPL935 (Fig. IV.2). Moreover, changes in the profile of these 
compounds observed at the first stages of phenolic degradation (after 6 h 
of incubation in the DC and EC batches, and at 24-48 h of incubation in 
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the AC batches) (Fig. IV.2) might be associated with the differences 
observed in microbial communities between the colon region-specific 
compartments (Table IV.2).  
In this regard, the analysis of the microbial communities in the 
batches representing the AC, DC and EC microbiota further indicate 
higher variations between in vitro batches harboring a different colon 
region microbiota than those found when L. plantarum IFPL935 was 
added. Thus, AC batches, where the fermentation is very intense with 
high production of short chain fatty acids (SCFAs), were shown to harbor 
the major proportion of saccharolytic bacteria (Bacteroides, 
Bifidobacterium, Prevotella). Therefore, most of the oligosaccharides 
used as prebiotics in the functional food industry are predominantly 
fermented in the proximal colon (Roberfroid et al., 2010). By contrast, the 
microbial community, represented by Clostridium groups was found in 
major numbers in the batches inoculated with microbiota simulating the 
distal regions (DC and EC vessels) where the putrefactive processes 
become quantitatively more important, although proteolysis occurs along 
the entire colon. 
Although knowledge about specific gut bacteria capable to degrade 
wine polyphenols such as flavan-3-ols is still scarce, it may be difficult to 
identify a single bacterium capable of exhibiting the whole catabolic 
pathway, but rather the catabolism may be carried out by different 
bacteria species acting at some steps of the different degradation 
pathways. The formation of diphenylpropanol and other intermediate 
metabolites and its further transformation into phenylpropionic, 
phenylacetic, and benzoic acids could be critical steps delimiting the rate 
and extent of red wine polyphenols catabolism, thus influencing 
bioavailability and bioactivity of these compounds in vivo. However, total 
production of phenolic metabolites seemed not to be affected by the 
presence of L. plantarum IFPL935 at further degradation steps or longer 
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incubation times (Fig. IV.2a), suggesting that the colonic bacteria that 
undergo further flavan-3-ol degradation exhibit limited catabolism 
capability. This limited bacterial activity in phenolic metabolism at further 
degradation steps, could be explained, at least partly, because of the 
decrease in nutrient concentration that occurs in batch culture model as 
incubation time progresses. Further studies will be performed using 
gastrointestinal dynamic models where microbial populations and 
microbe-mediated metabolic effects can be dynamically monitored in the 
different colon regions and along the incubation time avoiding the 
limitation of nutrients and phenolic substrates. 
Besides polyphenol catabolism, special attention was given to the 
butyrate-producing bacteria as they play an important role in the human 
colon, supplying energy to the gut epithelium and regulating host cell 
responses (Macfarlane and Macfarlane 2012). Butyrate-producing 
bacteria represent a functional group rather than a phylogenetic group 
and, as their distribution within bacterial clusters is uneven. A molecular 
approach based on the enumeration of the butyryl-CoA:acetate CoA 
transferase gene (BCoAT) was used for estimating the number of 
butyrate-producing bacteria in samples containing a complex microbiota 
(Louis et al., 2010). BCoAT gene copy numbers significantly decreased 
along the incubation (48 h) in all batches representing the distinct colon 
region-specific microbiota, in agreement with the decrease in bacterial 
population numbers along the incubation (Table IV.2). More meaningfully, 
data analysis showed a significant correlation (P< 0.05) between counts 
of this functional gene and the presence of C. leptum, B. coccoides-E. 
rectale group and to a lesser extent to Ruminococcus, confirming 
previous studies in which bacteria belonging to Clostridium (Cluster IV 
and XIVa) were pointed out as important butyrate producers playing a key 
role in butyric acid production (Louis et al., 2010). 
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Despite the decrease of butyrate producers, a higher butyrate 
production was detected in the batches containing the ascending colon 
microbiota (AC) at the end of the incubation compared to DC and EC 
batches (Fig. IV.1b). This is in agreement with the fact that most of the 
fermentative metabolism takes place in the AC but the results also 
showed that the presence of L. plantarum IFPL935 tended to increase 
butyrate production while in turn decrease acetate and in general total 
SCFAs concentration (Fig. IV.1a). In this regard, when analyzing the 
SCFAs production, cross-feeding interactions between colon bacteria 
should be taken into account. On one hand, bifidobacteria and lactobacilli 
strains are potentially able to produce lactate that can be further turned 
into butyrate and propionate through cross-feeding by other bacteria such 
as Eubacterium hallii within B. coccoides cluster (Belenguer et al., 2006). 
This could explain the favorable effect of the presence of L. plantarum 
935 on butyric acid production. On the other hand, bacteria of the B. 
coccoides cluster can also convert acetate produced by the main acetate 
producers such as Bacteroides and Prevotella (Macfarlane and 
Macfarlane, 2012) into butyric acid (Belenguer et al., 2006; Barcenilla et 
al., 2000). 
In summary, the results highlighted confirm the capability of L. 
plantarum IFPL935 to initiate flavan-3-ols catabolism when added to a 
complex human intestinal microbiota, which may have an impact on the 
bioavailability of these dietary polyphenols and therefore on its biological 
in vivo effects. Besides, L. plantarum IFPL935 may have an impact on 
SCFAs production, and in particular butyrate, which is known to play an 
important role for maintenance of gut health. 
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V.1 ABSTRACT  
The colonic microbiota plays an important role in the bioavailibility 
of dietary polyphenols. This work has evaluated the impact on the gut 
microbiota of long-term feeding with both a red wine polyphenolic extract 
and the flavan-3-ol metabolizer strain Lactobacillus plantarum IFPL935. 
The study was conducted in the dynamic Simulator of the Human 
Intestinal Microbial Ecosystem (SHIME). The feeding of the gut 
microbiota model with red wine polyphenols caused an initial decrease in 
the counts of total bacteria in the ascending colon (AC), being 
Bacteroides, Blautia coccoides/Eubacterium rectale and Bifidobacterium 
the most affected bacterial groups. The bacterial counts recovered to 
initial numbers faster than the overall microbial fermentation and 
proteolysis, which seemed to be longer affected by polyphenols. Addition 
of L. plantarum IFPL935 helped to promptly recover total counts, 
Lactobacillus and Enterobacteriaceae and led to an increase in lactic acid 
formation in the AC vessel at the start of the polyphenol treatment as well 
as butyric acid in the transverse (TC) and descending (DC) vessels after 
5 days. Besides, L. plantarum IFPL935 favoured the conversion in the DC 
vessel of monomeric flavan-3-ols and their intermediate metabolites into 
phenylpropionic acids and in particular 3-(3´-hydroxyphenyl) propionic 
acid. The results open possibilities of using L. plantarum IFPL935 as a 
food ingredient for helping individuals showing a low polyphenol-
fermenting metabotype to increase their colonic microbial capacities of 
metabolizing dietary polyphenols. 
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V.2 INTRODUCTION 
Moderate consumption of red wine and/or regular consumption of 
other polyphenol-rich beverages and foods has proved in epidemiological 
studies to reduce the incidence of certain chronic diseases (Arranz et al. 
2012; Kishimoto et al. 2013). Although the health effects of food 
polyphenols have been repeatedly associated with their free radical 
scavenging and antioxidant activity, recent evidence has, however, 
indicated that the effects of antioxidants are less relevant than expected 
(Tomás-Barberán and Andrés-Lacueva 2012). The bioavailability, 
absorption and metabolism of polyphenolic compounds are, indeed, key 
issues required to explain their role in human health. Depending on their 
chemical structure and food matrix, a high percentage of dietary 
polyphenols are not absorbed in the small intestine, reaching the colon 
where they are metabolized by the gut microbiota before being absorbed. 
Likewise, polyphenols and their resultant metabolites may selectively 
modulate the gut microbial composition by their antimicrobial or 
eventually prebiotic-like properties (Queipo-Ortuño et al. 2012; Tzounis et 
al. 2008). In this sense, an increase in Lactobacillus and Bifidobacterium 
species following administration of red wine polyphenols has been 
reported (Dolara et al. 2005; Queipo-Ortuño et al. 2012). Moreover, a 
significant correlation of moderate wine consumption with human 
microbiome composition, but not with enterotype partitioning, has been 
established (Wu et al., 2011).  
Flavonoids are the most abundant polyphenols present in red wine, 
mainly including flavan-3-ols and anthocyanins (Waterhouse 2002). There 
are several metabolic pathways proposed for the catabolism of 
monomeric flavan-3-ol and dimeric procyanidins by the intestinal 
microbiota (Monagas et al. 2010; Selma et al. 2009). However, bacterial 
degradation of flavan-3-ols is hindered by the inherent antibacterial 
effects of these molecules. In previous studies, we have reported that L. 
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plantarum IFPL935 was capable to metabolize galloylated flavan-3-ols 
leading to the formation of gallic acid, pyrogallol and catechol through 
galloyl-esterase, decarboxylase and benzyl alcohol dehydrogenase 
enzyme activities, respectively (Tabasco et al. 2011). The most 
remarkable feature of L. plantarum IFPL935 was its ability to cleave the 
heterocyclic ring of monomeric flavan-3-ols, giving rise to 1-(3',4'-
dihydroxyphenyl)-3-(2'',4'',6''-trihydroxyphenyl)-propan-2-ol (i.e. 
diphenylpropanol), which is the first metabolite in the microbial catabolic 
pathway of flavan-3-ols (Sánchez-Patán et al. 2012b). This activity has 
only been reported in a few intestinal bacteria to date, such as 
Eubacterium sp. SDG-2, Eggerthella lenta, and Flavonifractor plautii (Jin 
and Hattori 2012; Kutschera et al. 2011; Wang et al. 2001). The capability 
of L. plantarum IFPL935 to initiate the catabolism of flavan-3-ols via the 
formation of diphenylpropanol has also been demonstrated when the 
strain was incubated in batches with a complex human intestinal 
microbiota (Barroso et al., 2013). It was also observed that the addition of 
this strain had an impact on the formation of butyric acid, probably 
through cross-feeding with colonic butyrate-producing bacteria (Barroso 
et al., 2013). 
To get a deeper insight on the potential use of L. plantarum 
IFPL935 to benefit polyphenols metabolism we have monitored the effect 
on the gut microbiota upon addition of 1010 cfu of the strain to a daily 
intake of a polyphenolic extract (equivalent to two 125 ml-glasses of 
alcohol-free red wine) in a long-term feeding experiment. The study was 
conducted in the dynamic multireactor gastrointestinal Simulator of the 
Human Intestinal Microbial Ecosystem (SHIME). 
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V.3 MATERIALS AND METHODS 
V.3.1 Simulator of the Human Intestinal Microbial Ecosystem 
(Twin-SHIME) 
In this study, a Twin-SHIME® (UGent/ProDigest) setup was used 
by operating two parallel SHIME systems, each one consisting of five 
consecutive reactors, simulating the stomach, small intestine, ascending 
colon (AC), transverse colon (TC), and descending colon (DC), as 
described by Van den Abbeele et al. (2010). At the beginning of the 
experiment, the AC, TC and DC vessels from the Twin-SHIME systems 
were all simultaneously inoculated with the same fecal sample from a 
healthy human volunteer previously identified as a flavan-3-ol metabolizer 
(unpublished results) to enable comparison of the results between the two 
parallel experiments. The colonic microbiota was allowed for stabilization 
reaching the steady state after 3 weeks. The inoculum preparation and 
the SHIME feed composition during the stabilization period were 
essentially as described by De Boever et al. (2004). After stabilization of 
the colonic microbiota, both Twin-SHIME systems were subjected to a 2-
week experiment by daily feeding the stomach compartments  with 200 
mg of a commercial red wine extract, ProvinolsTM (Safic-Alcan 
Especialidades, Barcelona, Spain), which corresponds to a daily 
polyphenol intake of two small glasses of red wine (250 ml). The total 
phenolic content of the red wine extract was 474 mg of gallic acid 
equivalents per g (2.79 mmol/g) and its composition was reported before 
(Sánchez-Patán et al. 2012a), being flavan-3-ols the main phenolic 
compounds. In addition, one of the Twin-SHIME systems was 
simultaneous fed with a daily dose of 1010 cfu of Lactobacillus plantarum 
IFPL935. Finally, a 1-week wash-out period was included at the end of 
the experiment for both systems. During the whole study, samples were 
collected at regular time points from the three colon vessels and stored at 
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−20 °C until further analysis, excepting for microbiological plate counts 
that were performed at the time of sampling. 
V.3.2 Bacterial culture conditions and plate counts 
Lactobacillus plantarum IFPL935 (CECT 4599) was routinely grown 
aerobically at 37 °C in MRS broth. To reach the daily supplementation of 
1010 cfu of IFPL935, 10 ml of L. plantarum IFPL953 grown to 109 cfu/ml 
were added daily to the stomach compartment in one of the SHIME 
systems, right after the addition of the red wine extract. Numbers of 
lactobacilli in the inoculum were counted using MRS-agar plates and in 
the AC, TC and DC vessels using LAMVAB agar (Hartemink et al. 1997), 
and plates were incubated aerobically at 37 °C for 48 h. Total aerobes 
and total anaerobes were determined by plating on BHI agar and 
incubation at 37 °C for 24 h aerobically or 72 h anaerobically, 
respectively. Total coliforms were enumerated in MacConkey agar 
incubated for 24 h aerobically at 37 °C. 
V.3.3 DNA extraction and analysis 
Bacterial DNA was extracted using hexadecyltrimethylammonium 
bromide (CTAB) buffer and phenol-chloroform-isoamyl alcohol and bead-
beating, as described previously (Griffiths et al. 2000; Kowalchuk et al. 
1998). The DNA was precipitated with polyethelene glycol (PEG-6000), 
washed in ice cold 70% ethanol and dried in a Speed-Vac, prior to 
resuspension in distilled water. The concentration and quality of the 
samples were assessed with a Nanodrop spectrophotometer (Thermo 
Fisher Scientific, Wilmington, DE, USA). 
V.3.4 Quantitative PCR (qPCR) 
Bacterial numbers in the AC, TC and DC vessels were quantified 
by qPCR using SYBR green methodology (Kappa Biosystems, Woburn, 
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MA, USA) with the IQ5 Multicolor Real-Time PCR Detection System and 
data analyses (Bio-Rad Laboratories Inc., Hercules, CA, USA). The 
bacterial groups targeted for qPCR were total bacteria, Lactobacillus, 
Bifidobacterium, Bacteroides, Enterobacteriaceae, and the specific 
phylogenetic groups Blautia coccoides-Eubacterium rectale Cluster XIVa, 
Ruminococcus Cluster IV, and Clostridium leptum subgroup specific 
cluster IV. Butyrate-producing bacteria were also estimated by quantifying 
the gene encoding butyryl-CoA:acetate CoA transferase (BcoAT). 
Primers, amplification conditions and calculation of copy numbers have 
been detailed previously (Barroso et al. 2013). DNA from Escherichia coli 
DH5α, L. plantarum IFPL935, Bifidobacterium breve 29M2 and 
Bacteroides fragilis DSM2151 was used for quantification of total bacteria, 
Lactobacillus, Bifidobacterium and Bacteroides, respectively. For the rest 
of groups analyzed, samples were quantified using standards derived 
from targeted cloned genes using the pGEM-T cloning vector system kit 
(Promega, Madison, WI, USA), as described previously (Barroso et al., 
2013). 
V.3.5 PCR-DGGE 
The diversity of the Lactobacillus community in the AC, TC and DC 
vessels and the presence of L. plantarum were assessed by PCR-DGGE 
and using the primers Lab-159F and Uni-515-GC-R, as described by 
Heilig et al. (2002). DGGE was performed with a DCode system (Bio-
Rad) using a 9% polyacrylamide gel with a 30–50% gradient of 7 M urea 
and 40% formamide. The obtained band patterns were analyzed using 
InfoQuest FP software version 5.1 (Bio-Rad). Clustering was performed 
with Pearson correlation and the UPGMA method. 
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V.3.6 Bacterial metabolism 
V.3.6.1 Analysis of short and branched-chain fatty acids (SCFA 
and BCFA), lactic acid and ammonium 
The SCFA and BCFA were extracted from the samples with diethyl 
ether, after the addition of 2-methyl hexanoic acid as an internal standard 
and extracts were analysed by GC as described previously (Possemiers 
et al. 2004). SCFA were separated using a capillary free fatty acid packed 
column (EC-1000 Econo-Cap, 25 m × 0.53 mm x 1.2 µm) and detected 
with a flame ionization detector. Nitrogen was used as carrier gas. Lactic 
acid was measured spectrometrically with an enzymatic D-/L-lactic acid 
Kit (R-Biopharm, Darmstadt, Germany), according to the manufacturer's 
instructions. 
Ammonium was released from samples as ammonia by addition of 
MgO and distillation into boric acid-indicator solution using an 
autodistillation Vapodest 30´ (Gerhardt Analytical Systems, Brackley 
Northants, UK), as earlier described by Bremner and Keeney (1965). 
Ammonia was determined by titration with standard HCl using a 685 
Dosimat and 686 Titroprocessor (Metrohm, Berchem, Belgium). 
V.3.6.2 Analysis of phenolic metabolites 
Phenolic metabolites were analyzed by a previous UPLC-ESI-
MS/MS method (Sánchez-Patán et al. 2011) further implemented 
(Jiménez-Girón et al. 2013). The liquid chromatographic system was a 
Waters Acquity UPLC (Milford, MA, USA) equipped with a binary pump, 
an autosampler thermostated at 10 ºC, and a heated column 
compartment (40 ºC). The column employed was a BEH-C18, 2.1 x 100 
mm and 1.7 µm particle size from Waters (Milford, MA, USA). The mobile 
phases were 2% acetic acid in water (A) and 2% acetic acid in acetonitrile 
(B). The gradient program was as follows: 0 min, 0.1% B; 1.5 min, 0.1% 
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B; 11.17 min, 16.3% B; 11.5 min, 18.4% B; 14 min, 18.4% B; 14.1 min, 
99.9% B; 15.5 min, 99.9% B; 15.6 min, 0.1% B. Equilibrium time was 2.4 
min resulting in a total runtime of 18 min. The flow rate was set constant 
at 0.5 ml/min and injection volume was 2 µl. The LC effluent was pumped 
to an Acquity TQD tandem quadrupole mass spectrometer equipped with 
a Z-spray electrospray ionization (ESI) source operated in negative 
polarity mode. The ESI parameters were set as follows: capillary voltage, 
3 kV; source temperature, 130 ºC; desolvation temperature, 400 ºC; 
desolvation gas (N2) flow rate, 750 l/h; cone gas (N2) flow rate, 60 l/h. 
The ESI was operated in negative ionization mode. For quantification 
purposes, data were collected in the multiple reaction monitoring (MRM) 
mode, tracking the transition of parent and product ions specific to each 
compound. The MS/MS parameters (cone voltage, collision energy and 
MRM transition) of the 60 phenolic compounds targeted in the present 
study (mandelic acids, benzoic acids, phenols, hippuric acids, 
phenylacetic acids, phenylpropionic acids, cinnamic acids, 4-
hydroxyvaleric acids and valerolactones) were previously reported 
(Jiménez-Girón et al. 2013). All metabolites were quantified using the 
calibration curves of their corresponding standards, except for 4-hydroxy-
5-(3’,4’-dihydroxyphenyl)-valeric, and 4-hydroxy-5-(phenyl)-valeric acids) 
which were quantified using the calibration curves of 3-(3’,4’-
dihydroxyphenyl)-propionic, and propionic acids, respectively. Data 
acquisition and processing was realized with MassLynx 4.1 software. 
V.3.7 Statistical analysis 
Mean values, standard deviations and correlation coefficients were 
calculated on the basis of the values for the different variables during the 
incubation period (microbial groups, SCFAs, acetate, propionate, 
butyrate, ammonium and phenolic metabolites). Analysis of variance 
(ANOVA) was used for multiple comparisons of the different variables 
taken into account different factors (time, compartments, and addition of 
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L. plantarum IFPL935) (P < 0.05). All statistical analyses were carried out 
using the STATISTICA program for Windows, version 7.1 (StatSoft. Inc. 
1984−2006, www.statsoft.com). 
V.4 RESULTS 
V.4.1 Microbiological changes 
The colonic microbiota was allowed to reach the steady-state 
conditions during the 3-weeks period of stabilization in each of the three 
colon vessels of the Twin-SHIME systems (Day 0, Table V.1). After this 
stabilization period, impact of daily feeding with either the phenolic extract 
or the phenolic extract and L. plantarum IFPL935 on log numbers of total 
bacteria, Lactobacillus, Bifidobacterium, Bacteroides and 
Enterobacteriaceae, is shown in Table V.1. Figure V.1 shows the log 
numbers for the butyrate- producing phylogenetic groups B. coccoides-E. 
rectale Cluster XIVa, C. leptum subgroup specific Cluster IV, and 
Ruminococcus Cluster IV. Feeding the SHIME with the phenolic extract 
caused a decrease of approx. 1 log numbers of total bacteria in the AC 
vessels after 24 h treatment (Table V.1). This initial decrease of numbers 
affected mostly to the counts of Lactobacillus, Bifidobacterium, 
Bacteroides, Enterobacteriaceae (Table V.1) and B. coccoides/E. rectale 
(Fig. V.1). In most cases, bacterial numbers were readily recovered after 
the first week of treatment. The largest reduction in numbers was 
recorded for Bacteroides, showing a decrease of 2 log numbers in the AC 
vessels at the first day of treatment. The inhibitory effect of the red wine 
extract was less pronounced but more persistent for Bifidobacterium, 
which numbers continuously fell down during the first week of treatment 
and did not recover until the second week. Addition of L. plantarum 
IFPL935 to one of the Twin-SHIME systems together with the phenolic 
extract resulted in relative stable numbers throughout the treatment of 
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total bacteria, Lactobacillus and Enterobacteriaceae (Table V.1). In these 
bacterial groups, no impact of phenolic extract on the log numbers after 1 
day of treatment was observed with the presence of L. plantarum 
IFPL935. The diversity of lactobacilli in the AC, TC and DC vessels was 
followed by PCR-DGGE targeting the Lactobacillus genus. The cluster 
analysis of the DGGE profiles grouped the samples during the treatment 
period mainly based on the addition of L. plantarum IFPL935 to the 
SHIME feeding medium (Fig. S1 in the supplemental material). 
Additionally, agar plate counts revealed higher lactobacilli values during 
the treatment and first days of wash out in the colonic vessels of the 
SHIME unit supplemented with L. plantarum IFPL935 (results not shown). 
 Table V.1. Mean (SD) q-PCR counts (log copy number/ml) of bacterial groups in the ascending (AC), transverse (TC) and 
descending colon (DC) of the Twin-SHIME during the treatment with the red wine phenolic extract (Provin) and the extract 
supplemented with L. plantarum IFPL935 (Provin+Lp935) and the was out period 
Day 0 Week 3
(steady state) (wash out)
Total counts AC Provin 8.28 (0.32) 7.20 (0.08) 8.28 (0.34) 7.86 (0.29) 8.03 (0.21)
Provin+Lp935 8.17 (0.06) 8.66 (0.07) 8.26 (0.38) 8.00 (0.31) 7.99 (0.14)
TC Provin 8.60 (0.12) 8.49 (0.03) 8.20 (0.38) 8.06 (0.50) 8.22 (0.30)
Provin+Lp935 8.42 (0.30) 8.00 (0.10) 8.23 (0.43) 8.19 (0.11) 8.06 (0.15)
DC Provin 8.43 (0.13) 8.33 (0.07) 8.42 (0.30) 8.34 (0.50) 8.37 (0.44)
Provin+Lp935 8.34 (0.25) 8.08 (0.05) 8.57 (0.14) 8.33 (0.06) 8.14 (0.42)
Lactobacillus AC Provin 7.79 (0.41) 6.30 (0.16) 7.09 (0.29) 7.12 (0.67) 7.29 (0.30)
Provin+Lp935 7.57 (0.62) 7.62 (0.34) 7.40 (0.13) 7.16 (0.57) 7.69 (0.15)
TC Provin 7.63 (0.11) 7.16 (0.16) 6.76 (0.20) 7.29 (0.25) 7.31 (0.18)
Provin+Lp935 7.51 (0.13) 6.94 (0.37) 7.44 (0.05) 7.74 (0.24) 7.54 (0.29)
DC Provin 7.32 (0.06) 6.89 (0.02) 6.87 (0.10) 7.21 (0.41) 7.33 (0.35)
Provin+Lp935 7.44 (0.12) 7.03 (0.31) 7.11 (0.12) 7.55 (0.16) 7.42 (0.41)
Bifidobacterium AC Provin 6.74 (0.40) 6.04 (0.20) 5.91 (0.68) 6.94 (0.21) 6.50 (0.80)
Provin+Lp935 6.73 (0.60) 6.36 (0.54) 5.44 (0.91) 6.74 (0.67) 5.96 (0.63)
TC Provin 6.97 (0.17) 7.01 (0.30) 6.57 (0.22) 7.31 (0.58) 7.17 (0.87)
Provin+Lp935 6.72 (0.15) 6.75 (0.23) 6.07 (0.17) 7.23 (0.26) 6.86 (0.70)
DC Provin 7.03 (0.45) 6.69 (0.39) 6.43 (0.17) 7.23 (0.43) 6.92 (0.82)
Provin+Lp935 6.69 (0.29) 6.52 (0.65) 6.47 (0.10) 7.13 (0.46) 6.92 (0.73)
Bacteroides AC Provin 8.23 (0.07) 6.20 (0.05) 8.09 (0.52) 8.28 (0.08) 8.33 (0.32)
Provin+Lp935 8.20 (0.46) 6.23 (0.01) 8.27 (0.32) 8.11 (0.01) 8.46 (0.26)
TC Provin 8.47 (0.12) 7.95 (0.02) 8.28 (0.52) 8.27 (0.35) 8.37 (0.24)
Provin+Lp935 8.32 (0.23) 7.19 (0.07) 8.35 (0.53) 8.32 (0.08) 8.39 (0.49)
DC Provin 8.31 (0.14) 7.98 (0.03) 8.49 (0.24) 8.04 (0.40) 8.41 (0.25)
Provin+Lp935 8.37 (0.13) 7.49 (0.01) 8.68 (0.34) 8.04 (0.47) 8.00 (0.28)
Enterobacteriaceae AC Provin 7.35 (0.21) 6.37 (0.21) 7.34 (0.33) 6.59 (0.73) 7.28 (0.19)
Provin+Lp935 7.15 (0.20) 7.06 (0.23) 7.52 (0.55) 6.44 (0.35) 7.25 (0.10)
TC Provin 7.63 (0.09) 7.40 (0.02) 7.31 (0.23) 7.15 (0.51) 7.35 (0.12)
Provin+Lp935 7.54 (0.26) 6.84 (0.24) 7.09 (0.29) 7.16 (0.29) 7.26 (0.27)
DC Provin 7.44 (0.17) 7.43 (0.23) 7.04 (0.54) 7.31 (0.34) 7.35 (0.09)
Provin+Lp935 7.40 (0.29) 7.01 (0.22) 6.69 (0.76) 7.25(0.28) 7.13 (0.42)
Bacteria Colonic vessel Treatment
Intervention period 
Day 1 Week 1 Week 2
  
Figure V.1. Changes in q-PCR counts (log copy number/ml) of butyrate-producing groups belonging to Clostridium clusters IV and 
XIVa in the ascending (AC), transverse (TC) and descending colon (DC) of the Twin-SHIME during the treatment with the red wine 
phenolic extract (grey squares) and the extract supplemented with L. plantarum IFPL935 (black circles) and the was out period. The 
dotted line indicates the end of the polyphenol treatment 
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The numbers of the butyrate-producing bacteria group B. 
coccoides-E. rectale was equally represented in the three colonic vessels 
at the start of the treatment (about 7 log), whereas C. leptum and 
Ruminococcus prevailed in TC and DC vessels (about 6-7 log) (Fig. V.1), 
being almost under the detection limit in the AC vessels. Impact of 
feeding the Twin-SHIME units with the phenolic extract on these three 
bacterial groups was more pronounced in the AC vessels for B. 
coccoides-E. rectale and in the TC vessels for C. leptum and 
Ruminococcus, where the effects appeared earlier in time. The BCoAT 
gene numbers corresponded with the results of butyrate producing 
bacteria counts, showing higher values in the TC and DC vessels than in 
the AC ones and, particularly, in the DC from the SHIME unit 
supplemented with L. plantarum IFPL935 (results not shown).  
V.4.2 Wine polyphenols supplementation affects microbial 
metabolism 
Evolution of the microbial metabolism (fermentation and 
proteolysis) expressed as the content in SCFA, lactic acid, BCFA and 
ammonium is shown in Fig. V.2. Daily intake of the polyphenolic extract 
caused a sharp decrease in both fermentation and proteolysis measured 
during the first days of treatment in all the AC, TC and DC vessels. 
Proteolysis rate measured by ammonium and BCFA content showed the 
minimum values in all vessels during the first week of treatment, 
particularly for ammonium. No differences were observed between both 
treatments with and without L. plantarum IFPL935 (Fig. V.2A). Regarding 
the fermentation profile, acetic and propionic acid values decreased 
similarly, reaching minimum values in all three vessels during the first 
three days for both treatments (Fig. V.2B). Butyric acid was lessened to 
no detectable levels during the first two days of treatment in all the 
vessels excepting the DC and TC vessels added with phenolic extract 
and L. plantarum IFPL935 (Fig. V.2C). On the other hand, the lactic acid 
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content was not negatively affected by any of the treatments. Moreover, 
the AC vessel of the SHIME supplemented with the phenolic extract and 
L. plantarum IFPL935 showed an increase of lactic acid at the starting of 
the intervention period and a decrease associated to the recovery of 
butyrate content to initial levels (Fig. V.2C). The addition of L. plantarum 
IFPL935 also caused differences in the production of butyric acid in the 
DC vessels where the highest values for this acid were found. In general, 
the microbial metabolic activity present at the start of the feeding was 
recovered in all vessels for both treatments after 5 days of the 
experiments, except for the production of butyric acid in the DC vessel 
without L. plantarum IFPL935, which only returned to initial values at the 
end of the wash-out period (Fig. V.2C). 
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Figure V.2. Changes in concentration (mM) of ammonium (circles), BCFA 
(squares), acetic acid (diamonds), propionic acid (triangles), butyric acid (dots) 
and lactic acid (asterisks) in the ascending (AC; A), transverse (TC; B) and 
descending colon (DC; C) of the Twin-SHIME during the treatment with the red 
wine phenolic extract (grey symbols) and the extract supplemented with L. 
plantarum IFPL935 (black symbols) and the was out period. The vertical dotted 
line indicates the end of  the polyphenol treatment  
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V.4.3 Changes in phenolic metabolism 
Within the 60 phenolic metabolites targeted, a total of 26 
compounds including benzoic acids, phenols, phenylacetic acids, 
phenylpropionic acids, valeric acids, valerolactones and cinnamic acids, 
exhibiting different substitutions in the aromatic ring, were quantified in 
the AC, DC and TC contents during the 2-weeks period of treatments and 
the wash-out period (Table S1 in the supplemental material). Formation of 
these metabolites was in accordance with disappearance of wine 
phenolic precursors (Table S2 in the supplemental material), mainly 
flavan-3ols (monomers and dimeric procyanidins), but also anthocyanins, 
flavonols and stilbenes. To better summarize these changes, Fig. V.3 
displays the sum of concentrations of the precursor monomers (+)-
catechin and (-)-epicatechin, and procyanidins B1, B2, B3, B4 (Fig. V.3A), 
the intermediate metabolites phenyl-γ-valerolactones and phenylvaleric 
acid derivatives (Fig. V.3B) and the phenylpropionic and phenylacetic 
acid derivatives (Fig. V.3C) during the continuous feeding of the Twin-
SHIME with the red wine polyphenolic extract. 
Flavan-3-ol monomers and procyanidins were mainly detected in 
AC vessels and starting from day 2 of the wine polyphenol treatment. The 
concentration of these precursor compounds in the AC vessels increased 
during the intervention, followed by a return to baseline during the wash-
out period (Figure V.3A). Precursors were also detected in the TC 
compartments, but their concentration diminished earlier than in the AC 
vessels. Interestingly, the content of these flavan-3-ol monomers and 
procyanidins in TC and DC vessels were lower in the SHIME unit 
supplemented with L. plantarum IFPL935. 
The formation of 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone and 4-
hydroxy-5-(3′,4′-dihydroxyphenyl)-valeric acid, intermediate metabolites 
arising from first steps in the microbial degradation of flavan-3-ols, was 
mainly observed in the TC vessels and their concentration increased after 
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day 4 of both treatments (Fig. V.3B). These compounds were also 
present in the DC vessels but to a much lesser extent and only in those 
with no addition of L. plantarum IFPL935. In accordance with these 
results, 4-hydroxy-5-(phenyl)-valeric acid content increased with time and 
was mainly detected in the DC vessels (Table S1 in the supplemental 
material). 
Also, and as derived from galloylated flavan-3-ols, an increase in 
the content of gallic acid was only detected in the AC vessels, whereas 3-
O-methylgallic acid was also measured in the TC vessels (Table S1 and 
Fig S2 in the supplemental material). Likewise, pyrogallol formation was 
only observed in the AC vessels whereas pyrocatechol was measured 
mainly in the AC and TC compartments. Supplementation with L. 
plantarum IFPL935 did not cause differences in the metabolism of these 
compounds. 
The evolution of 3-(4´-hydroxyphenyl) propionic acid, 4-
hydroxyphenylacetic acid and phenylacetic acid, which can also be 
derived from aromatic amino acid catabolism, followed the same trends 
as the microbial metabolites released from proteolysis depicted in Fig. 
V.2A (Table S1 in the supplemental material). The extent of formation of 
microbial phenolic metabolites from the flavan-3-ol compounds was 
estimated in the SHIME vessels during the treatment and wash-out 
periods by computing the formation of phenylpropionic acids [3-(3´,4´-
dihydroxyphenyl)-propionic, 3-(3´-hydroxyphenyl)-propionic, and 3-
phenylpropionic] and phenylacetic acids [3,4-dihydroxyphenylacetic and 
3-hydroxyphenylacetic] derivatives (Fig. V.3C). The highest values of 
these metabolites were observed in the DC vessels, being still detected 
during the wash-out period. In the SHIME unit supplemented with L. 
plantarum IFPL935 the phenylpropionic acid derivatives, mainly 
represented by 3-(3´-hydroxyphenyl)propionic acid, appeared at earlier 
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stages than the phenylacetic acid metabolites and their concentration was 
the highest when comparing values from the two SHIME units. 
 
  
Figure V.3. Changes in concentration (µg/ml) of the sum of (A) precursor monomers (+)-catechin and (-)-epicatechin (circles) and 
procyanidins B1, B2, B3, B4 (squares), (B) the intermediate metabolites phenyl-γ-valerolactones (diamonds) and phenylvaleric acid 
derivatives (triangles) and (C) the phenylpropionic (dots) and phenylacetic acid (asterisks) derivatives in the ascending (AC), 
transverse (TC) and descending colon (DC) of the Twin-SHIME during the treatment with the red wine phenolic extract (grey 
symbols) and the extract supplemented with L. plantarum IFPL935 (black symbols) and the was out period. The vertical dotted line 
indicates the end of the polyphenol treatment. 
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V.5 DISCUSSION 
The human gut microbiota contributes to many of the important 
host metabolic functions, including the increase of bioavailabilityof dietary 
polyphenols (van Duynhoven et al. 2011). Conversely, polyphenols and 
their resultant metabolites can modify the gut bacterial population 
composition and activity (Requena et al. 2010). Most of the studies that 
have examined the antimicrobial effect of dietary polyphenols have 
focused on single polyphenol molecules and/or single strains. In this 
work, we have studied the effect on the gut microbiota of the long-term 
feeding with a red wine polyphenolic extract and the impact of the 
supplementation of L. plantarum IFPL935, previously characterized as a 
flavan-3-ol metabolizer (Barroso et al. 2013; Sánchez-Patán et al. 2012b). 
We have conducted the study in the in vitro model of the human intestinal 
microbiota SHIME, which has demonstrated to allow nutritional 
interventions with repeated doses to evaluate long-term effect of food 
ingredients on the microbiota allocated in three consecutive colon regions 
(Grootaert et al. 2009; Marzorati et al. 2010; Van de Wiele et al. 2007; 
Van den Abbeele et al. 2013).  
The present study shows that the initial addition of red wine 
polyphenols exerted an overall antimicrobial effect on the gut microbiota 
in the AC, but the effect disappeared during continuous feeding with 
polyphenols, probably due to the onset of microbial metabolism of 
polyphenols. The antimicrobial effect of red wine and grape polyphenolic 
extracts following either a single dose or a continuous feeding of the 
SHIME has recently been described (Kemperman et al. 2013). These 
authors reported a more pronounced antimicrobial effect on the colonic 
microbiota, which did not fully recover until the wash-out period. 
Differences between studies could be due to the fact that the amount of 
polyphenolic compounds daily supplemented by Kemperman et al. (2013) 
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was 5-times higher than in the present study. Besides, grape extracts 
have demonstrated higher antimicrobial capacity than extracts obtained 
from red wine (Cueva et al. 2013), probably because of a higher content 
of proanthocyanidins and gallate derivatives (Xia et al. 2010).   
Among polyphenols, flavan-3-ols and flavonols have received most 
attention due to their wide spectrum and higher antimicrobial activity in 
comparison with other polyphenols (Daglia 2012). In our study, all 
bacterial groups analyzed in the AC vessels were initially affected by the 
supplementation with red wine polyphenols. Among them, Bacteroides 
and the butyrate-producers B. coccoides/E. rectale were the most 
affected groups, whereas Bifidobacterium showed a more persistent 
effect. Bacteroides and Bifidobacterium have been described previously 
(Kemperman et al. 2013) as the genera most affected after feeding the 
SHIME colonic microbiota with black tea and red wine polyphenols. 
Additionally, intake of flavan-3-ol-rich sources for prolonged periods of 
time has generally correlated with the decrease of Clostridium groups 
(Dolara et al. 2005; Tzounis et al. 2011; Wu et al. 2011). On the other 
hand, counts of lactobacilli are generally unaffected or moderately 
increase after intake of diets enriched in flavanols (Tzounis et al. 2011). 
Nevertheless, a different sensitivity to the presence of flavan-3-ols in the 
growth medium has been described for several Lactobacillus species 
(Tabasco et al. 2011), ranging from the optimal growth observed for L. 
plantarum, L. casei, and L. bulgaricus strains and the growth inhibition of 
L. fermentum, L. acidophilus and L. vaginalis. Among the strains assayed, 
however, only L. plantarum IFPL935 was able to metabolize flavan-3-ol 
compounds (Fernández-Patán, 2012b; Tabasco et al. 2011).  
Although the antimicrobial effect caused by daily feeding the 
SHIME with red wine polyphenols was predominantly observed during the 
first 1-2 days of treatment and it was more distinguished in the AC 
vessels, the inhibitory effect on the overall microbial metabolism, 
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however, was similar in the three vessels and it lasted for the first 5 days 
of treatment (Fig. V.2). These results indicate a more pronounced effect 
of the polyphenol compounds in the microbial functionality than in its 
viability. The initial exposure to polyphenols may up-regulate polyphenol-
induced stress responses related to defensive mechanisms while 
simultaneously down-regulating various metabolic functions, for example, 
carbon and energy metabolism (Stevenson and Hurst 2007). Decreased 
rate of microbial fermentation and proteolysis, determined as reduction in 
the formation of SCFA and BCFA, is associated with high tannin-rich 
feeds intake in ruminant livestock (Bodas et al. 2012). The effects of 
some plant extracts have been described to last only a few days, 
indicating that ruminal microorganisms adapt to the compounds with time 
(Busquet et al. 2005). Similarly, the regular feeding of the SHIME with a 
red wine polyphenolic extract was able to introduce microbial and 
metabolic changes until the microbiota adapted its metabolism and 
returned to steady state similar conditions during the treatment.  
In terms of microbial metabolism, the addition of L. plantarum 
IFPL935 caused an increase in the formation of lactic acid at the start of 
the polyphenol treatment in the AC vessel and of butyric acid in the TC 
and DC vessels after the day 5 of treatment (Fig. V.2). The increased 
formation of butyric acid in the DC vessel supplemented with L. plantarum 
IFPL935 was also associated with a lower content of lactic acid. Both 
phenomena can partially be explained by the recovery at this point of the 
counts of butyrate-producing bacteria from clostridial cluster XIVa and 
eventually by bacterial cross-feeding production of butyric acid from lactic 
acid. In fact, the only vessels where the content of butyric acid did not 
decrease to zero values at the start of the polyphenol treatment were the 
TC and DC vessels of the SHIME supplemented with L. plantarum IFPL 
935 (Fig. V.2). Duncan et al. (2004) reported that most of the faecal 
species that utilize lactate to produce butyrate via the butyryl CoA:acetate 
CoA transferase route, belong to the clostridial cluster XIVa 
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(Lachnospiraceae). The results obtained in this study confirm the 
previously observed effect of L. plantarum IFPL935 to increase the 
formation of butyric acid during batch incubations with different colonic 
microbiota (Barroso et al. 2013). This compound has been described as 
beneficial for human health since low prevalence in the gut has been 
associated with chronic immune or metabolic-related diseases including 
inflammatory bowel disease (Frank et al. 2007) and obesity (Le Chatelier 
et al. 2013).The capability of L. plantarum IFPL935 to initiate the 
catabolism of polyphenols either via galloyl-esterase, decarboxylase and 
benzyl alcohol dehydrogenase activities (Tabasco et al. 2011) or mostly 
by the cleavage of the heterocyclic ring of monomeric flavan-3-ols 
(Sanchez-Patán et al. 2012b), might have contributed to diminish the 
inhibitory effect of the red wine extract when both were added to the 
SHIME units. So far and besides this strain, only a few bacterial strains, 
such as Eubacterium sp. SDG-2, Eggerthella sp. CAT-1, Eggerthella 
lenta rK3, and Flavonifractor plautii aK2 have been reported to be able to 
initiate the metabolism of flavanol-3-ols by cleavage of the heterocyclic C-
ring (Jin and Hattori 2012; Kutschera et al. 2011; Wang et al. 2001). 
A lower concentration of monomeric flavan-3-ols and first and 
intermediate metabolites (5-(3′-hydroxyphenyl)-γ-valerolactone and 4-
hydroxy-5-(3′-hydroxyphenyl)valeric acid), mainly represented in the AC 
and TC vessels, was observed in the vessels of the SHIME unit 
supplemented with L. plantarum IFPL935. In addition, further metabolism 
of the polyphenol intermediate compounds to the formation of 
phenylpropionic acids was detected earlier and reached higher 
concentrations in the DC vessel containing the strain when compared to 
the other colonic vessels (Fig. V.3C). For both treatments, bacterial 
conversion of red wine polyphenols was more favorable in the distal 
colon, which is in agreement with previous studies where a higher 
microbial conversion of phenolic compounds was found in the distal 
compartments (Barroso et al. 2013; Van Dorsten et al. 2012).  
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Discussion 
Phenyl propionic acid and 3-(3´-hydroxyphenyl)propionic acid were 
the microbial metabolites that accounted most for the differences between 
treatments. Phenylpropionic acid derivatives are considered to arise from 
β-oxidation of phenylvaleric acid derivatives (Monagas et al. 2010), 
except for 3-(4´-hydroxyphenyl)propionic acid that can result from the 
microbial catabolism of tyrosine (Russell et al. 2013). The evolution of this 
compound during the SHIME treatment with red wine polyphenols 
indicated that 3-(4´-hydroxyphenyl)propionic acid aroused mostly from 
amino acid catabolism (Table S1 in the supplemental material). The 
phenyl propionic metabolite produced at a higher concentration was 3-(3´-
hydroxyphenyl) propionic acid, which has been identified as a strong 
urinary marker of red wine and grape extracts intake (Jacobs et al. 2012; 
Ward et al. 2004). This microbial metabolite has been shown to reduce 
the inflammatory response of human peripheral blood mononuclear cells 
stimulated with lipopolysaccharide (Monagas et al. 2009) and to have 
anti-thrombotic activity (Rechner and Kroner 2005). In conclusion, this 
study provides data supporting the potential use of L. plantarum IFPL935 
to increase gut butyrate formation and favour polyphenol metabolism in 
an in vitro gastro intestinal system. This opens possibilities of using the 
strain as a food ingredient for helping individuals showing a low 
polyphenol-fermenting metabotype (Bolca et al. 2013) to increase their 
gut capacities of metabolizing dietary polyphenols. 
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V.7 SUPPLEMENTAL MATERIAL 
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Descending colon 
 
Figure S1. Clustering tree of the Lactobacillus DGGE-profiles in the ascending, 
transverse and descending colon of the Twin- SHIME during the treatment 
(days 0, 1, 5, 9) with the red wine phenolic extract (black lanes) and the extract 
supplemented with L. plantarum IFPL935 (grey lanes) and the wash-out period 
(days 16, 19, 23). Lp, DNA from L. plantarum IFPL935. 
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Figure S2. Changes in concentration (μg/ml) of galloylated compounds and their metabolites in the ascending (AC), transverse 
(TC) and descending colon (DC) of the Twin-SHIME during the treatment with the red wine phenolic extract (grey symbols) and the 
extract supplemented with L. plantarum IFPL935 (black symbols) and the wash-out period. The dotted line indicates the end of 
treatment
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Table S1. Concentration (mean values in µg/mL) of the phenolic metabolites 
measured. 
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Table S2. Concentration (mean values in µg/mL) of the phenolic 
compounds from the wine extract. 
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VI.1 ABSTRACT 
This study has evaluated the effect of regular and moderate red 
wine consumption on the diversity and occurrence of different groups of 
bacteria that are representative in human saliva. Saliva was obtained 
from individuals before and after consumption of red wine (250 mL/day) 
during 4 weeks. The evolution and composition of the microbial 
community in saliva was evaluated by PCR-DGGE and quantitative PCR. 
In general, the inter-individual variability observed in the PCR-DGGE 
band patterns was higher than the differences observed after the 4-weeks 
period of red wine intake. Bifidobacterium dentium, Bifidobacterium spp. 
and Alloscardovia omnicolens were the most representative 
bifidobacterial species, whereas the Streptococcus mitis-Streptococcus 
oralis group predominated within Streptococcus. This genus was the most 
numerous of the bacterial groups assayed, reaching average counts 
above 8 log copy numbers/mL. On the other hand, the lowest counts 
were recorded for Actinomyces, Fusobacterium, Haemophilus, Neisseria 
and Veillonella, which showed average values of 5 log copy numbers/mL. 
The results showed no significant differences (P>0.5) in bacterial counts 
after the period of red wine intake. In conclusion, the overall diversity and 
stability of representative bacterial groups of the human saliva is not 
disturbed due to regular-moderate red wine consumption. 
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Introduction 
VI.2 INTRODUCTION 
Regular intake of polyphenol-rich beverages and foods has 
demonstrated to exert beneficial effects in human health, such as 
decreased incidence of cardiovascular disease, cancer and protection 
against neurodegenerative diseases, among others [1-3]. Nevertheless, 
the beneficial effects of polyphenols seem to be more linked to microbial 
phenolic metabolites produced in the human gut than to the original forms 
present in food [4]. Accordingly, regular and moderate intake of red wine 
(a characteristic polyphenol-rich beverage) has demonstrated to exert 
modulating effects in the human gut microbiota [5-7]. It is reasonable to 
presume that besides their effect on gut microbiota, these polyphenols 
can exert an effect on the overall oral cavity microbiota (saliva and 
gingival margins). This is worth considering that diversity of the microbial 
populations in the oral cavity is even larger than in the gut or the skin, 
harboring viruses, archea, protozoa, fungi and over 700 species of 
bacteria [8, 9]. Similarly to human gut or skin microbiome, the oral 
microbial community is an interacting ecosystem with the host that helps 
to maintain the health status, although certain ecological shifts allow 
pathogens to establish and cause disease [10, 11]. Despite its relevance 
to human health, little information is currently available on the effect, if 
any, of daily habits as regular red wine consumption on both saliva and 
gingival dental microbiota. 
The antimicrobial effects of the polyphenols present in red wine and 
grape seed extracts against microorganisms responsible for periodontitis 
and dental caries have been mainly studied by incubating polyphenols 
with pure strains [12-15]. Signoretto et al. [16] evaluated the microbial 
composition of supragingival and subgingival plaque in 75 adult 
volunteers that had been drinking 400 ml red wine daily for at least two 
previous years. It was observed a lower microbial diversity in the plaque 
samples of regular wine drinkers compared with water drinkers. This 
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microbial modulating effect was speculatively attributed to the 
antimicrobial, antiadhesive, and antiplaque activities of the polyphenols 
contained in wine. In a review targeting bacterial adhesion to different 
susbstrates, the same authors considered the polyphenol-rich foods as a 
potential alternative strategy to antibiotic therapy in order to avoid caries 
and gingivitis/periodontitis [17].  
Concerning saliva, the effect of consumption of red wine on the 
antioxidant status of this human fluid has been recently investigated [18], 
but information on the effect of red wine in the microbial community of 
saliva is still scarce. Saliva is crucial to oral cavity health, containing a 
characteristic bacterial community that helps maintaining homeostasis of 
the mouth ecosystem and it is considered useful in prognosis of several 
systemic and oral dysfunctions [10, 19]. Oral health is characterized by an 
ecologically balanced and diverse microbiome and the analysis of plaque 
and saliva in healthy adults has demonstrated larger microbial biodiversity 
than in people suffering symptoms of caries or periodontitis [10]. It is 
therefore essential to health the maintenance of oral cavity homeostasis 
through a well-balanced and stable oral microbiome in which saliva plays 
a key role.  
Recent metagenomic studies have revealed that Streptococcus, 
Veillonella, Neisseira, Prevotella and Fusobacterium are among the most 
predominant microorganisms in the saliva of healthy individuals [20–22]. 
Nevertheless, under various circumstances, oral homeostasis is lost and 
certain species from these and other genera, such as Haemophylus, 
Lactobacillus and Porphyromonas, turn out to be opportunistic and can 
represent a potential threat for both oral and respiratory tract health status 
[10, 23-24]. 
The purpose of this work has been to study if the regular and 
moderate consumption of red wine during four weeks can affect somehow 
the diversity and occurrence of different groups and genera of bacteria 
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that are representative in human saliva and hence, the local homeostasis 
needed to keep oral health. 
VI.3 MATERIALS AND METHODS 
VI.3.1 Wine intervention study and sampling  
Saliva samples were obtained during the human intervention study 
with moderate intake of red wine described by [25]. Briefly, 22 healthy 
non-smokers volunteers (age range 20−48 years), included in the wine 
intervention trial (14 individuals) and in the control group (8 volunteers), 
provided saliva samples at the beginning of the study and after 4 weeks. 
The intervention group consumed daily 250 mL of red wine (equivalent to 
a daily dose of approx. 450 mg of total polyphenols) and individuals were 
asked to not consume any other alcoholic beverages and to follow a low-
polyphenols diet. The control group followed the same pattern regarding 
restrictions for alcoholic beverages and polyphenols. Previously to the 
provision of the first sample, both groups had followed an initial washout 
period of 2 weeks (baseline) with the same restrictions in alcohol and 
polyphenols. Unstimulated saliva was collected at morning from the 
subjects before brushing their teeth and consuming foods or beverages. 
Samples were placed in tightly covered sterile bottles and delivered to the 
laboratory in less than 2 h for treatment and analyses. 
VI.3.2 Sample preparation and DNA extraction 
 Saliva samples were centrifuged at 10000 ×g, 15 min at 4 °C, and 
pellets were stored at -80 °C with 40% glycerol. For DNA extraction, 
samples were thawed, mixed with 100 µL sodium phosphate buffer, pH 
7.0, and 100 mg of glass beads (150−212 μm diameter). Cells were 
mechanically lysed by using a FastPrep equipment (BIO 101, Savant 
Instruments, Holbrook, NY) for 45 s (three times) at a machine speed 
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setting of 5.5 m/s. The aqueous phase containing genomic DNA was 
separated by centrifugation, 10000 ×g for 10 min at 4 °C, and DNA was 
extracted using the NucleoSpin Tissue kit (Macherey-Nagel, Düren, 
Germany).  
VI.3.3 PCR-DGGE  
The diversity of the bacterial communities in the saliva samples and 
the effect of the red wine consumption were assessed by PCR-DGGE 
and using the primers and annealing temperatures described in Table 
VI.1. Samples were tested for total bacteria, Streptococcus, Veillonella, 
Neisseria, Lactobacillus, Bifidobacterium and the group 
Prevotella/Porphyromonas/Bacteroides. For Lactobacillus and 
Bifidobacterium, a nested PCR step was included that was carried out as 
described by Heilig et al. [26] and Satokari et al. [27], respectively. DGGE 
was performed with a DCode system (Bio-Rad) using a 
9%polyacrylamide gel and a genus-specific gradient (Table VI.1) of 7 M 
urea and 40 % formamide. The obtained band patterns were analyzed 
using InfoQuest FP software version 5.1 (Bio-Rad). Selected DGGE 
bands were sequenced after excision from the gel and PCR 
reamplificated with each specific primer set. 
VI.3.4 Quantitative PCR (qPCR) 
Total bacteria and different groups and genera of bacteria that are 
representative in human saliva (Table VI.1) were quantified by qPCR 
using SYBR green methodology (Kappa Biosystems, Woburn, MA, USA) 
with the IQ5 Multicolor Real-Time PCR Detection System and data 
analyses (Bio-Rad Laboratories Inc., Hercules, USA). DNA from 
Escherichia coli DH5α, Lactobacillus plantarum IFPL935, Bifidobacterium 
lactis Bb12 and Streptococcus thermophilus ATCC 1987 was used for 
quantification of total bacteria, Lactobacillus, Bifidobacterium and 
 232 
Materials and methods 
Streptococcus, respectively. For the rest of the groups analyzed  
(Actinomyces, Fusobacterium, Haemophilus, Neisseria, Veillonella and 
Prevotella), samples were quantified using standards derived from 
targeted cloned genes using the pGEM-T cloning vector system kit 
(Promega, Madison, WI, USA), as described previously Barroso et al. 
[28]. 
VI.3.5 Statistical analysis 
Mean values and standard deviations were calculated on the basis 
of the qPCR values for the different bacterial groups before and after the 
4-week study period, for both the control and intervention groups. The t-
test for dependent samples and its corresponding nonparametric 
Wilcoxon matched-pairs test was used to evaluate differences in the 
counts of bacterial groups before and after the 4-week period. Statistical 
analyses were carried out using the IBM SPSS Statistics 21 package 
(SPSS Inc., Chicago, IL, USA). 
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Table VI.1. Primer sets used in this study for PCR-DGGE and quantitative PCR. 
 
GC clamp at 5': CGCCCGCCGCGCCCCGCGCCCGGCCCGCCGCCCCCGCCCC 
  
Target group Primer sequence  5'-3' Annealing (°C) Gradient (%) reference
Total bacteria F: AACGCGAAGAACCTTAC+GC
R: CGGTGTGTACAAGACCC
Lactobacillus F: GGAAACAGGTGCTAATACCG
R: ATCGTATTACCGCGGCTGCTGGCAC+GC
F: GTTTGATCCTGGCTCAG
R: CACCGCTACACATGGAG
Bifidobacterium F: GGGTGGTAATGCCGGATG
R: GCCACCGTTACACCGGGAA
F: CGGGTGCTICCCACTTTCATG
R: GATTCTGGCTCAGGATGAACG
Streptococcus F: AGATGGACCTGCGTTGT+GC
R: GTGAACTTTCCACTCTCACAC
Veillonella F: A(C/T)CAACCTGCCCTTCAGA
R: CGTCCCGATTAACAGAGCTT+GC
Prevotella-Porphiromonas- F: GGTGTCGGCTTAAGTGCCAT+GC
Bacterioides R: CGGA(C/T)GTAAGGGCCGTGC
Neisseria F: CTGGCGCGGTATGGTCGGTT
R: GCCGACGTTGGAAGTGGTAAAG+GC
Total bacteria F: CGGTGAATACGTTC(C/T)CGG
R: CGGTGTGTACAAGACCC
Actinomyces F: CTCCTACGGGAGGCAGCAG
R: CACCCACAAACGAGGCAG
Bifidobacterium F: CTCCTGGAAACGGGTGG
R: GGTGTTCTTCCCGATATCTACA
Fusobacterium F: C(A/T)AACGCGATAAGTAATC
R: TGGTAACATACGA(A/T)AGGG
Haemophilus F: GGAGTGGGTTGTACCAGAAGTAGAT
R: AGGAGGTGATCCAACCGC
Lactobacillus F: TGGAAACAG(A/G)TGCTAATACCG
R: GTCCATTGTGGAAGATTCCC
Neisseria F: CTGGCGCGGTATGGTCGGTT
R: GCCGACGTTGGAAGTGGTAAAG
Prevotella F: CAC(A/G)GTAAACGATGGATGCC
R: GGTCGGGTTGCAGACC
Streptococcus F: AGATGGACCTGCGTTGT
R: GTGAACTTTCCACTCTCACAC
Veillonella F: A(C/T)CAACCTGCCCTTCAGA
R: CGTCCCGATTAACAGAGCTT
62
59
60
55
54
55
62
40
27
55
55
55
nested
27
26
26
36
38
55
56
56
66
62
57
30-60
39
43
37
38
43
40
55
62
PCR-DGGE
Quantitative PCR
41
42
3930-70
40-58
40-70
68 38
38
37
nested
30-50
40-55
25-50 
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VI.4 RESULTS AND DISCUSSION  
The potential changes in the diversity of bacterial groups after daily 
consumption of 250 mL of red wine during four weeks were analyzed by 
PCR-DGGE. The usefulness of applying DGGE to monitor temporal and 
developmental changes in oral bacterial communities from saliva and 
dental plaque has been demonstrated by Rasiah et al [29]. Results using 
primers targeting total bacteria showed no apparent changes in the band 
patterns due to red wine intake (Fig. S1, supplementary material). In 
general, the inter-individual variability in the band patterns was higher 
than the differences observed after the 4-weeks period of red wine intake.   
Considering the observed differences in sensibility of specific oral 
microbial groups to wine and grape seed polyphenols [15, 30], we 
evaluated the PCR-DGGE band profiles of representative oral bacterial 
groups before and after red wine intake. As an example, Fig. VI.1 shows 
the Streptococcus and Bifidobacterium fingerprints of eight individuals 
before and after red wine intake. Results distinguished in the 
Bifidobacterium PCR-DGGE patterns three main bands that, after 
nucleotide sequencing, were identified to correspond with Bifidobacterium 
dentium, Bifidobacterium spp. and Alloscardovia omnicolens (Fig. VI.1A). 
This last species has recently been described to belong to the 
Bifidobacteriaceae family [31] and to be associated with human saliva 
[32]. Again, more differences in the Bifidobacterium fingerprints were 
observed between individuals than over the period of red wine intake in 
each individual. Similar results were observed following the specific PCR-
DGGE analysis of Streptococcus (Fig. VI.1B). In this case, the 
predominant band was sequenced and identified as belonging to the S. 
mitis-S. oralis group. S. mitis is the most common bacterium isolated from 
the oral cavity [22]. Regarding the rest of bacterial genera examined, no 
consistent fingerprint difference associated to red wine intake was either 
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observed for Lactobacillus, Veillonella, Neisseria or Prevotella-
Porphyromonas-Bacteroides group (results not shown). 
 
Figure VI.1. PCR-DGGE band profiles from eight individuals (out of fourteen) 
from the intervention group before (b) and after (a) red wine intake, obtained 
from saliva DNA and specific primers for Bifidobacterium (A) and Streptococcus 
(B). Bands 1: Bifidobacterium dentium, 2: Bifidobacterium spp., 3: Alloscardovia 
omnicolens, S: group Streptococcus mitis-Streptococcus oralis. 
A complementary approach to evaluate the effect of red wine intake 
was the evaluation by qPCR of the potential quantitative changes of 
representative bacterial groups present in the oral cavity (Table VI.2). 
Total bacterial counts in saliva showed an average of 8 log copy 
numbers/mL in all individuals before and after the timeframe of the study. 
These figures are within the range of 107 to 109 bacteria per mL described 
for human salivary microbiota [33]. Streptococcus were the most 
numerous of the bacterial groups assayed since all samples showed 
average counts above 8 log copy numbers/mL. Average counts for 
Lactobacillus and Prevotella were about 7 log copy numbers/mL (Table 
b a
2 3 4 5 6 7 81
b a b a b a b a b a b a b a
b a
2 3 4 5 6 7 81
b a b a b a b a b a b a b aA
B
1
2
3
S
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VI.2). On the other hand, among all the bacterial groups analyzed, the 
lowest counts were recorded for Actinomyces that did not reach values 
higher than 5 log copy numbers/mL, which in turn was the average value 
recorded for Fusobacterium, Haemophilus, Neisseria and Veillonella. The 
results are in agreement with metagenomic studies which reveal that the 
oral cavity is generally dominated by Streptococcus species [8, 20]. 
The t-test for dependent samples and its corresponding 
nonparametric Wilcoxon matched-pairs test showed no significant 
differences between samples before and after the 4-week study period, 
with P values higher than 0.1 in all cases (Table VI.2), indicating that no 
differences in bacterial counts could be attributable to the red wine intake. 
Due to the high variations in counts between individuals, t-test analyses 
were also performed distinguishing subjects grouped by initial counts 
being either higher or lower than the average values. Again, the results 
indicated no statistical differences in counts of any of the bacterial groups 
assayed. 
The stability of numbers and composition of the saliva microbiota 
over the 4-week period of red wine intake shown in this work is in 
agreement with metagenomic studies indicating high levels of variability 
of human-associated microbial communities among individuals and 
minimal variations over time within a given human body habitat, such as 
the oral cavity [8]. This oral stability is kept despite age, gender or daily 
ambient fluctuations including diet and mechanical forces from brushing 
and mastication. Longitudinal surveys of salivary bacterial communities in 
twins from adolescence to adulthood have shown a long term stable 
microbiome in the saliva, more related to cohabitation of individuals than 
weight class or gender [22]. In this regard, one element to be considered 
for stable oral microbiota is the short time of exposition of this community 
to polyphenols in comparison with the estimated accumulation of dietary 
polyphenols in colon [34]. Accordingly, a recent study with 12 individuals 
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showed that salivary antioxidant capacity did not increase after drinking 
125 mL of red wine [18]. Another relevant consideration is resilience of 
the oral microbiota, which implies the degree to which the microbial 
community returns to its former state after a disturbance caused for 
example by a therapeutic intervention [35]. 
Table VI.2. Quantitative PCR counts (mean ± SD and range values in copy 
number/mL) for the microbial groups analyzed in saliva from individuals before 
and after the wine intervention study 
 
a
P values evaluated with the Student t test for dependent samples and its corresponding nonparametric 
Wilcoxon matched-pairs test 
In conclusion, the results showed that daily consumption of 250 mL 
red wine during 4 weeks does not change the overall diversity and 
stability of representative bacterial groups of the human saliva. Microbial 
equilibrium and homeostasis are maintained over time in the oral cavity 
and no major perturbations can be observed due to regular-moderate red 
wine consumption. 
Bacteria
before after P
a before after P
a
8.04 ± 0.56 7.78 ± 0.38 7.98 ± 0.40 7.80 ± 0.61
(7.05-8.57) (7.44-8.56) (7.47-8.60) (6.65-8.67)
4.67 ± 0.52 4.46 ± 0.39 4.89 ± 0.32 4.77 ± 0.52
(3.94-5.29) (4.07-5.13) (4.43-5.56) (3.88-5.63)
6.52 ± 0.19 6.31 ± 0.19 7.01 ± 0.44 6.76 ± 0.45
(6.38-6.90) (6.11-6.65) (6.22-7.60) (6.12-7.57)
5.41 ± 0.89 5.13 ± 0.57 5.52 ± 0.77 5.60 ± 0.92
(4.14-6.93) (4.18-5.85) (4.37-6.89) (3.98-6.97)
5.82 ± 0.81 5.61 ± 0.55 6.09 ± 0.71 6.23 ± 0.81
(4.77-7.33) (4.87-6.38) (5.16-7.15) (4.86-7.54)
8.03 ± 0.52 7.70 ± 0.35 7.97 ± 0.37 7.77 ± 0.62
(7.12-8.58) (7.34-8.38) (7.39-8.52) (6.58-8.55)
5.57 ± 1.08 5.30 ± 0.79 5.85 ± 0.86 5.93 ± 1.08
(4.35-7.58) (4.43-6.70) (4.89-7.41) (4.10-7.64)
7.34 ± 0.89 7.40 ± 0.54 7.55 ± 0.39 7.48 ± 0.78
(5.58-8.49) (6.76-8.13) (7.10-8.24) (5.76-8.58)
8.32 ± 0.39 8.21 ± 0.41 8.52 ± 0.51 8.45 ± 0.63
(7.76-8.74) (7.64-8.97) (7.56-9.13) (7.04-9.10)
5.57 ± 0.66 5.23 ± 0.31 5.27 ± 0.61 5.38 ± 0.64
(4.35-6.18) (4.70-5.62) (4.55-6.24) (3.97-6.25)
Streptococcus 0.398 0.382
Veillonella 0.123 0.552
Neisseria 0.123 0.675
Prevotella 0.674 0.807
Haemophilus 0.262 0.463
Lactobacillus 0.116 0.116
Bifidobacterium 0.091 0.131
Fusobacterium 0.327 0.600
Control group (n=8) Intervention group (n=14)
Total bacteria 0.176 0.133
Actinomyces 0.161 0.279
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Fig. S1. PCR-DGGE band profiles from eight individuals (out of fourteen) 
from the intervention group before (b) and after (a) red wine intake 
obtained from saliva DNA and specific primers for total bacteria. 
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VII.1 ABSTRACT 
There is growing interest in understanding how microbial 
populations within the human colon can be modified by dietary habits. 
Here, we examined the influence of moderate red wine intake on the 
colonic microbiota of 15 healthy volunteers, classified into high, moderate 
and low polyphenol metabolizers (metabotypes) compared with 5 control 
subjects. We analyzed the composition, diversity and dynamics of their 
fecal microbiota before and after one month of wine consumption. The 
16S rDNA sequencing allowed detection of 2324 phylotypes, of which 
only 30 were found over the 0.5% of mean relative frequency, 
representing 84.6% of the total taxonomical assignments. The samples 
clustered more strongly by individuals than by wine intake or 
metabotypes, however an increase in diversity, after the wine intake, was 
observed when compared with the control volunteers. Some differences 
in minority microbial groups related with phenolic metabolism were found, 
but inter-individual variability was the strongest and distinguishing feature. 
This study confirms the high variability of the microbiota from different 
individuals, and that the individual microbiota composition seems 
extremely stable to small dietary changes. 
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VII.2 INTRODUCTION 
The human intestine harbors a microbial community highly diverse 
that exerts a crucial impact on the human health (Clemente et al., 2012; 
Tappenden & Deutsch 2007). Of this community, bacteria are the most 
abundant microorganisms and the colonic part of the intestine the most 
densely colonized, with approximately 1011–1014 cells/g (Ley et al., 
2006; Turnbaugh et al., 2007). The development of culture-independent 
techniques for microbial community composition analysis has opened 
new perspectives in understanding the complexity of this human intestinal 
ecosystem (Yatsunenko et al., 2012; Fraher et al., 2012; Francis & Riley, 
2014). Through recent advances in identifying unculturable intestinal 
communities by using next-generation sequencing technologies, it has 
been elucidated that the major bacterial phylotypes of the human gut 
include Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and 
Fusobacteria (Palmer et al., 2007; Lozupone et al., 2012). Due to the 
implication of the microbiota to the normal host physiology, including 
proper digestion (del Campo et al., 2014; Salonen & de Vos, 2014), 
metabolism (Cox et al., 2014) and synthesis of vitamins and co-factors, 
epithelial cell function (Sommer & Bäckhed, 2013), angiogenesis 
(Kåhrström, 2012), enteric nerve function (Fernandez et al., 2014) and 
immune system development (Maslowski et al., 2011), the study of their 
modulation has become a very important topic.  
Recent studies in humans have shown the importance of diet in 
shaping the gut microbial ecosystem (De Filippo et al., 2010; David et al., 
2014) and how intestinal microbiota allows the digestion of food 
components, otherwise inaccessible to the host enzymes (Salonen & de 
Vos, 2014). In our diet, different foods and beverages of plant origin, such 
as red wine, contain secondary metabolites namely polyphenols, claimed 
as having different biological activities, and consequently an impact on 
human health. Several epidemiologic studies have related the 
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consumption of wine or other polyphenols source foods with a lower 
incidence of cardiovascular disease, hypertension, diabetes, and cancer, 
partly due to their attributed positive effects on antioxidant capacity, lipid 
profile and the coagulation system (Diebolt et al., 2001; Lindberg and 
Amsterdam, 2008; Imhof et al., 2008; Anhê et al., 2014; Seidel el al., 
2014; Chen & Sang, 2014). But the in vivo effect of polyphenols depends 
on its bioavailability, absorption and metabolism (Chiou et al., 2014). In 
this regard, phenolic metabolites produced by bacteria in the human gut 
seem to be more available than the original forms present in food, thus 
gut microbiota would enhance their biological activity.  
Nevertheless, information about the role of plant polyphenols in the 
modulation and metabolism of the intestinal ecosystem is scarce. Most of 
the studies have been performed with single compounds or mixtures of 
polyphenols using batch-culture fermentation systems inoculated with 
fecal material (Tzounis et al., 2008; Barroso et al., 2013), and some have 
used continuous fermentation dynamic models (Kemperman et al., 2013; 
Barroso et al., 2014). For example, it has been shown that catechin has a 
positive effect on the growth of the Blautia coccoides–Eubacterium 
rectale group and Bifidobacterium while the Clostridium histolyticum 
group was inhibited (Tzounis et al., 2008). In previous in vitro studies we 
have showed that a red wine polyphenol extract affected the growth of 
Bacteroides, Bifidobacterium and the B. coccoides/E. rectale group 
(Barroso et al., 2014). This is in agreement with other in vitro studies, in 
which the effect of wine polyphenols also affected the growth of 
Bifidobacterium, B. coccoides, Anaeroglobus, Subdoligranulum and 
Bacteroides, while promoted the growth of Klebsiella, Alistipes, 
Cloacibacillus, Victivallis and Akkermansia (Kepermant et al., 2013). 
Concerning studies in vivo of polyphenol containing beverages, a human 
intervention study (n=8) has shown an increase in qPCR counts of 
Enterococcus, Prevotella, Bacteroides, Bifidobacterium, Bacteroides 
uniformis, Eggerthella lenta, and B. coccoides–E. rectale after the 
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moderate intake of red wine during 4 weeks (Queipo-Ortuño et al. 2012). 
But still, more information on the effect of consumption of polyphenol 
containing beverages, particularly red wine, on the gut microbial 
ecosystem as a whole and not limited to specific groups of bacteria, is 
needed.  
In this work we have investigated the impact of moderate regular 
consumption of red wine in the fecal microbial metagenomic profile of 
healthy individuals. An intervention study was carried out with healthy 
volunteers consuming red wine for a period of 4 weeks and 16S rRNA 
gene sequencing of the fecal samples was performed to characterize 
microbial community changes. 
VII.3 MATERIAL AND METHODS 
VII.3.1 Wine intervention study 
The randomized and controlled study involved a total of 41 healthy 
volunteers with no recent history of gastrointestinal disease. It was 
divided in two consecutive periods, an initial washout of 2 weeks, during 
which the volunteers followed a low-polyphenols diet, and an intervention 
period of 28 days, in which the volunteers consumed 2 glasses of red 
wine per day. The control group did not consume wine during the 
intervention period. More details of the study designs have been 
published previously (Muñoz-González et al 2013). Fecal samples from 
all the volunteers were collected before and after the period of 
intervention and stored at -80ºC. Based on the results of phenolic 
metabolites obtained by Muñoz-González et al (2013), the volunteers 
were classified in three metabotypes, regarding the metabolic capability 
of their microbiota, as low, moderate and high wine-phenolic-
metabolizers. In the present study a total of twenty volunteers (five 
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volunteers from each metabotype and five from the control group) were 
included. 
VII.3.2 Fecal suspension and DNA extraction 
Fecal samples were thawed at room temperature, weighted (0.1 g) 
and suspended in sterile saline solution (NaCl 0.8%) until 1 mL volume. 
The homogeneous fecal suspension was centrifuged 5 min - 13.000 rpm 
at 4°C and supernatants were removed. Microbial DNA extraction was 
performed as described by Moles et al. (2013). The pellet was 
resuspended in an extraction buffer (200 mM Tris–HCl pH 7.5, 0.5% 
SDS, 25 mM EDTA, 250 mM NaCl, 20 mg/mL lysozyme, 5 mg/mL 
lysostaphin and 3 M Na acetate), followed by mechanical lysis with glass 
beads and extraction with phenol/chloroform/isoamyl-alcohol. The DNA 
was precipitated by adding 0.6 volumes of isopropanol, washed with 70% 
ethanol, allowed to air dry, and finally resuspended in DNase, RNase free 
water (Sigma-Aldrich). The QIAEX II Gel Extraction Kit (QIAGEN, Hilden, 
Germany) was used to purify and concentrate the DNA. The DNA yield 
was measured using a NanoDropH ND-1000 UV spectrophotometer 
(Nano-Drop Technologies) and PicoGreen (Invitrogen). 
VII.3.3 16S rRNA gene Illumina MiSeq sequencing 
The DNA samples were amplified by PCR using primers 27F-DegL 
(5’-GTTYGATYMTGGCTCAG-3’) in combination with an equimolar 
mixture of two reverse primers, 338R-I (5’-GCWGCCTCCCGTAGGAGT-
3’) and 338R-II (5’GCWGCCACCCGTAGGTGT-3’) generating an 
approximately 345 bp amplicons from the V1 to V2 hypervariable regions 
of 16S rDNA genes. PCR amplification was performed using the Fast 
Start High Fidelity PCR System dNTP Pack (Roche, Mannheim, 
Germany) in a total volume of 25 μL containing 2.5 μL 10× Reaction 
Buffer and 1.25 U of Fast Start High Fidelity Enzyme Blend (Roche), 0.4 
 254 
Material and Methods 
μM of each primer, and 10 ng template DNA. Thermal cycling conditions 
were as follows: an initial denaturation at 95°C for 2 min, and 35 cycles at 
95°C for 30 s, 54°C for 30 s, and 72°C for 30 s, with a final extension at 
72°C for 5 min. Following amplification, 2 µL of PCR product was used for 
agarose gel (1%) detection. 
Barcodes used for Illumina sequencing were appended to 3’ and 5’ 
terminal ends of PCR amplicons in a second PCR to allow separation of 
forward and reverse sequences. All primers were synthesized by Isogen 
Life Sciences (Castelldefels, Spain). Barcoded PCR products from all 
samples were pooled at approximately equal molar DNA concentrations 
and run on a preparative agarose gel. The correct sized band was 
excised and purified using a QIAEX II Gel Extraction Kit (QIAGEN, 
Hilden, Germany) and quantified with PicoGreen (BMG Labtech, Jena, 
Germany). The 16S DNA amplicons were sequenced on an Illumina 
MiSeq (Illumina Inc., San Diego, CA, USA) technology reads 2x250. 
VII.3.4 Bioinformatics analysis 
In this work each read was assigned to the organism corresponding 
to the Best Blast Hit (BBH) over a threshold of similarity (e<1E-15) 
against a global 16S rRNA database specifically built for metagenomic 
data analysis by Era7 (Granada, Spain). This database contains 902,131 
16S rRNA sequences extracted from NCBI nt database because of the 
specificity of their taxonomical assignment. The direct and cumulative 
frequencies normalized to the total number of reads assigned to any node 
of the taxonomy tree have been calculated for every sample. 
The richness and diversity of the fecal microbiota were determined 
by calculating the Shannon-Weaver diversity index, which takes into 
account the number and evenness of the bacterial species. These 
calculations were performed using R i386 3.1.0 (R project, Statistical 
Software). 
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VII.3.5 Data analysis 
The data matrix of the relative frequencies of the microbial groups 
was used to perform the clustering analysis. To do that, the dendrograms 
were obtained using the Ward distance agglomeration method after 
calculating the Kendall coefficients for each sample. The Shapiro-Wilk 
test was used to assess the normality of the data, using parametric test 
when variables were normally distributed and the correspondent non-
parametric test when not. Principal component analysis (PCA), from the 
relative frequencies matrix, was performed to study variability among 
samples and microbial groups and possible trends in the variables due to 
wine consumption. The comparison of the relative frequencies of the 
microbial groups, detected at the different taxonomy levels, for the three 
previously classified metabotypes and the control group before and after 
wine intake was performed by Anova and the post-hoc LSD test or the 
correspondent non-parametric Kruskal-Wallis test. To detect microbial 
significant differences due to wine intake in each group of volunteers, the 
relative frequencies of each microbial group were analyzed before and 
after wine intake, with paired t-test when data were normally distributed or 
the Wilcoxon paired test when not. A value of P < 0.05 was fixed for the 
level of significance of the tests. Statistical analysis was performed in R 
2.13.2 (R project, Statistical Software) and STATISTICA program for 
Windows, version 7.1 (StatSoft Inc., 1984 2006, www.statsoft.com).  
VII.4 RESULTS AND DISCUSSION 
With the purpose of unravelling the impact of dietary polyphenols in 
the human intestinal microbiota, we conducted this non-targeted 
screening of the microbial intestinal content of healthy volunteers after 
consuming red wine by means of 16S rRNA gene sequencing and 
phylogenetic analysis of fecal samples. The volunteers were previously 
grouped in three metabotypes as low, moderate and high wine-phenolic-
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metabolizers according to their capacity to metabolize red wine 
polyphenols (Muñoz-Gonzalez et al., 2013). This work represents the first 
human red wine intervention study performing a metagenomic analysis to 
assess the changes in fecal microbiota.  
The microbial groups identified in this study were hierarchically 
clustered according to their phylogenetic level. The relative frequencies of 
every phylotype for all the samples (before and after the period of study) 
were analysed. Globally, Firmicutes was the most abundant phylum in all 
the samples, accounting for approximately 77.3% (Min-max: 47.9%-
93.1%) of the total phyla, followed by Actinobacteria (17.3%; 1.9%-
49.4%), Bacteroidetes (4.1%; 0.6%-21.2%) and Proteobacteria (1.5%; 
0.03%-6.8%) (Fig. VII.1). The class Clostridia (Firmicutes) was the most 
abundant in both control and intervention volunteers accounting for 37.4% 
(min-max: 22.2-55.1%) of the total classes, followed by Actinobacteria 
class (Actinobacteria) with 17.3% (min-max: 1.9-49.4%) and Bacilli 
(Firmicutes) with 3.4% (min-max: 0.04-19.1%). At genus level, a total of 
438 microbial genera were indentified, however, only 15 of them were 
found in all the samples (Table VII.1). From the total genera, the most 
abundant were Bifidobacterium and Collinsella (Actinobacteria) and 
Clostridium, Ruminococcus and Eubacterium (Firmicutes) (Table VII.1). 
On a lower taxonomic level, 2324 species-like taxa were detected. 
Among them, only 30 were found to present a mean relative frequency 
over the 0.5%, representing an 84.6% of the total taxonomical 
assignments (Fig VII.2). The dominant taxa in most of the samples 
corresponded to uncultured Firmicutes sp. except for two volunteers 
(individuals 8 and 32) in which the dominant taxa were identified as 
Catenibacterium sp. (Firmicutes) and Streptococcus sp. (Firmicutes), 
respectively. Clostridium sp., Peptostreptococcaceae sp. and 
Ruminococcus sp. showed to be the followed most abundant species in 
most of the cases. Six Bifidobacterium species (B. longum, B. 
ruminatium, B. pseudocatenulatum, B. bifidum, B. adolescentis and B. 
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catenulatum) were detected over the 0.5% mean threshold. However, 
only B. longum was present in all the samples. From the total species, 
only the taxa identified as Lachnospiraceae, Collinsella aerofaciens, 
Clostridiales, Bacteroidetes, Eubacterium sp. and Streptococcus sp. were 
also found in all the samples. To examine the similarity or distance 
between samples, we performed a cluster analysis using the Kendall 
correlation coefficient calculated based on the relative frequencies of 
microbial groups identified over the 0.5% in all samples. The generated 
dendrogram showed a high individual variability associated to microbial 
communities, which was stronger than their metabotype or the changes 
associated to the 4-weeks period of red wine intake (Fig VII.3). This is in 
agreement with previous evidences of inter-individual variability in the 
colonic microbiota (Franks et al., 1998; Ley et al., 2006b; Walker et al., 
2011). 
  
  
Figure VII.1. Relative frecuencies of the phylum-like phylotypes in the microbiota of feces from volunteers control and low, moderate 
and high metabotypes. Faecal samples from each volunteer before (b) and after (a) the intervention period are represented with 
numbers. 
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 Table VII.1. Relative frequencies (%; median) of the genera that were identified in all the samples from volunteers control and low, 
moderate and high metabotypes before and after the intervention period. 
 
 
F, Firmicutes; B, Bacteroidetes; A, Actinobacteria. 
* Differ signifficantly (P<0.05) according to ANOVA-test. 
Phylotype, genus Phyla
Control Low Moderate High Control Low Moderate High
Bifidobacterium A 8.40 10.48 8.02 23.42 * 4.96 14.91 3.11 19.58
Clostridium F 5.43 10.98 4.74 4.94 8.84 5.98 7.51 3.57
Ruminococcus F 7.66 5.26 6.29 4.20 5.71 4.63 5.32 4.80
Eubacterium F 3.62 3.68 2.53 1.08 3.08 2.52 3.72 2.92
Collinsella A 4.64 2.21 2.51 2.64 4.60 3.05 3.23 2.29
Dorea F 0.74 0.77 0.99 0.76 0.77 0.99 1.13 1.33
Roseburia F 0.56 0.88 1.01 0.88 0.68 0.93 0.84 1.11
Sporacetigenium F 1.06 1.12 0.81 0.92 1.08 1.19 0.97 0.79
Streptococcus F 0.62 1.15 0.31 0.74 0.54 3.86 0.85 0.37
Anaerostipes F 0.58 0.78 0.69 0.74 0.76 0.84 1.10 0.32
Faecalibacterium F 0.82 1.06 0.11 1.05 0.73 0.87 0.17 0.46
Bacteroides B 0.14 0.38 0.15 0.21 0.11 0.38 0.22 0.36
Enterococcus F 0.001 0.02 0.08 0.002 0.004 0.02 0.01 0.003
Catenibacterium F 0.003 0.002 0.002 0.001 0.003 0.001 0.003 0.004
Prevotella B 0.001 0.005 0.004 0.003 0.001 0.002 0.01 0.001
Before % After %
  
Figure VII.2. Relative frecuencies of the species identified in the microbiota of feces from volunteers control and low, moderate and 
high metabotypes. Faecal samples from each volunteer before (b) and after (a) the intervention period are represented with 
numbers.
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Figure VII.3. Clustering of the bacterial fingerprints of fecal samples from 
volunteers control (green) and low, moderate and high metabotypes (red) 
before and after the intervention period. The dendrogram shows the Kendall 
coefficients for each sample and was obtain using the Ward distance 
agglomeration method. 
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The diversity of the microbial communities of the different samples 
was determined using the Shannon diversity index (SDI). The results 
obtained showed an average SDI of 2.81±0.14 in the control group (N=5) 
and 2.81±0.24 in the intervention group (N=15) before the intervention 
period. The average SDI after the period of study was slightly, but not 
significantly, lower in the control group (2.79±0.13) than in the 
intervention group (2.93±0.18). Interestingly, unlike the control group 
(P=0.851), samples from the intervention group showed significantly 
higher diversity after the wine intake than before, according to the paired 
t-test (P=0.007). Conversely when calculating the SDI mean of each 
metabotype group, the differences before and after the wine intake 
remain shorter (low, p=0.156; moderate, p=0.037; high, p=0.311), 
suggesting no correlation of the different metabolic capability with 
microbial diversity (SDI). In addition, the Anova test of SDI did not group 
the samples by metabotypes. The overall microbiome differences 
between intervention and control volunteers and the differences obtained 
before and after wine consumption were then evaluated by PCA. No 
separation was observed before and after wine consumption, neither 
between metabotypes (see in Supporting Information Fig. S1). The 
principal component 1 (PC1) could explain a 17.5% of the total variance, 
suggesting that although some differences could be found among the 
groups of volunteers, the vast majority of the microbiome was not altered 
due to wine consumption. The PCA also showed the different trend on 
each volunteer included in this study (Fig VII.4). This reveals the large 
variability between volunteers. Although volunteers clustered separately, 
no outliers were noted (Supporting Information Fig. S1). Overall, the 
observed trends suggest that the responses to the wine intake are 
influenced by the specific composition of the individual’s intestinal 
microbiota. Similar results have been observed in other studies, in which 
changes in non-digestible carbohydrate intake were evaluated (Walker et 
al., 2011). 
  
Figure VII.4. Plot of the samples in the plane defined by the two principal components PC1 and PC2 and its response to wine intake 
indicated by arrows. Faecal samples from each volunteer before (b) and after (a) the intervention period are represented with 
numbers. 
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In order to deeper analyze any relation of specific microbial 
populations with the intake of red wine and the metabolic capability of 
each group of volunteers, statistic tests of the four most abundant phyla 
were performed firstly. The results showed that the relative presence in 
the high metabotype group of Firmicutes (68.68%) and Actinobacteria 
(27.10%), after the washout period and before the intake of red wine, was 
significantly different (P<0.05) from the other two metabotype groups and 
the control (Firmicutes: control, 80.3%; low, 80.3% and moderate, 82.3% 
and Actinobacteria: control, 15.2%; low, 15.3; moderate, 11.6%). In 
contrast, all of these significant differences disappeared after the period 
of wine intake. The observed differences in Actinobacteria corresponded 
at genus level with a higher (P > 0.05) relative frequency of 
Bifidobacterium in the high metabotype group than in the others, but only 
before the intervention period (Table VII.1). These observations could 
suggest that long term consumption of a moderate amount of red wine 
could reduce certain differences found between microbiotas from different 
individuals. However, the disparity in the initial Firmicutes, Actinobacteria 
and Bifidobacterium relative frequencies of the individuals with high 
metabotype could be due to the small sample of volunteers. This will 
make necessary more studies with larger number of volunteers in order to 
confirm some of the responses associated to an extended consumption of 
wine.  
The increased microbial diversity (SDI) observed within the 
intervention group after the volunteers’ wine intake was further analyzed 
at a lower taxonomic level. The analysis of the 438 genus-like bacterial 
identified groups showed that some genera present at relative 
frequencies lower than 0.5% were significantly different (P>0.05) after the 
wine intake, but that these differences were not found in the control 
group. Among them, there were some genera with documented capability 
to metabolize polyphenols that increased in the intervention group after 
the wine intake (Table VII.2). Slackia is a genus recently isolated from 
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feces (Tsuji et al., 2010) that presents trans-resveratrol metabolizing 
ability (Bode et al., 2013) and contains genes involved in the conversion 
of isoflavones, daidzein and genistein (Schröder et al., 2013). Other 
genera that significantly increased after red wine intake were Oscillatoria, 
with previously reported metabolic capabilities such laccase, polyphenol 
oxidase, peroxidase and esterase (Viswajith and Malliga, 2008; Prabha et 
al., 2010), Gordonibacter, which has showed capabilities for ellagic acid 
catabolism and urolithin formation (Selma et al., 2014), and Veillonella 
that has been related with the intestinal metabolism of dietary daidzein 
into equol (Decroos et al., 2005). The genus Oenococcus was also 
detected in higher proportions after the wine intake and due to its role as 
responsible for malolactic fermentation in wines (Dicks et al., 1995), its 
increase could be related to its presence in the red wine ingested by the 
volunteers. 
The findings reported in this study can provide approaches about 
the modulation mechanisms of the wine intake into microbial diversity, 
suggesting an increase in diversity in terms of relative frequencies of 
microbial groups. This assumption probably requires future studies with 
higher number of volunteers in order to confirm that the shifts observed 
are mainly due to the inclusion of red wine intake in the diet. The 
association of dietary changes to the colonic microbial population’s 
structure is an emerging concept (Korpela et al., 2014), however, the 
individual differences in the response associated with diet are 
acknowledged as intrinsic trait of the human intestinal microbiota 
(Martínez et al., 2010; Walker et al., 2011; Lampe et al., 2013). In 
addition, the individual microbiota composition seems extremely stable to 
small dietary changes. 
  
 Table VII.2. Relative frecuencies (%; median with minimum and maximum values in brackets) of the genera identified in the 
microbiota of feces from volunteers that showed significant differences after the wine intake. 
 
 
P values evaluated with the Wilcoxon paired-test. 
N Initial Final P N Initial Final P
0.0120 0.0119 0.0045 0.0127
(0.0009-0.2650) (0.0029-0.1811) (0.0000-0.0725) (0.0007-0.1189)
0.0027 0.0061 0.0006 0.0021
(0.0010-0.0133) (0.0020-0.0517) (0.0000-0.0346) (0.0000-0.0674)
0.0005 0.0017 0.0000 0.0016
(0.0000-0.0033) (0.0015-0.0302) (0.0000-0.0028) (0.0000-0.3750)
0.0014 0.0038 0.0009 0.0010
(0.0010-0.0019) (0.0020-0.0056) (0.0000-0.0069) (0.0000-0.0116)
0.0000 0.0015 0.0000 0.0006
(0.0000-0.0000) (0.0015-0.0015) (0.0000-0.0006) (0.0000-0.0036)
Veillonella 2 - 13 0.023
Oenococcus 1 - 6 0.074
Gordonibacter 4 0.465 13 0.046
Oscillatoria 3 0.593 11 0.026
Control group Wine group
Slack ia 5 0.138 13 0.001
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Supporting information Fig. S 1. Plot of the samples in the plane defined by (A) the two principal components (PC1 and PC2) and 
defined by (B) the PC1 and PC3. Faecal samples from volunteers control, low, moderate and high metabotypes are represented in 
blue circles, red squares, green diamonds and pink triangles, respectively. 99% colored confidence ellipses representing before 
(blue) and after  (red) wine consumption are also included. The percentages of the total variance explained by each component, 
PC1, PC2 and PC3 are 17.54, 10.34 and 9.83 respectively. 
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VIII.1 ABSTRACT 
This study presents a unique fully computer-controlled dynamic 
SIMulator of the GastroIntestinal tract, SIMGI, which has been designed 
to simulate the complete processes of digestion and fermentation. This 
model is programmable to sequentially proceed (continuously or feeding 
the system from 1 to 6 times daily) from the operation of food intake into 
the stomach throughout the delivery of distal colon content to waste. The 
system includes three-stage culture reactors that are capable to 
reproduce in vitro the microbial conditions that characterize the different 
regions of the human large intestine. The evolution and composition of 
the microbial community in the ascending (AC), transverse (TC) and 
descending colon (DC) vessels was evaluated by PCR-DGGE and real-
time PCR. An overall decrease in counts of Bifidobacterium and 
Prevotella and an increase of Enterobacteriaceae was observed between 
the inoculation with human faeces and the bacterial community stabilized 
in the colon vessels after two weeks. Regarding microbial differentiation, 
Bacteroides counts were more representative of the AC and TC vessels 
than the DC compartment. Within the butyrate producer groups, a lower 
occurrence of Clostridium leptum and Ruminoccocus was observed in the 
AC compartment than in the TC and DC vessels. Accordingly, the net 
SCFA production was highest in the AC compartment, whereas the 
results of ammonium formation indicated that proteolysis occurred 
similarly throughout the entire colon compartments. The results of 
microbial stabilization observed in the new dynamic in vitro model SIMGI 
indicate that the system can be used as a tool for studying the effects of 
diet or food components on modulating the gut microbiota and its 
metabolic activity. 
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VIII.2 INTRODUCTION 
Food digestion and fermentation are complex processes that take 
place through the gastrointestinal tract (GIT). Food digestion starts in the 
mouth and continues in the stomach and the small intestine where most 
of the available food components are absorbed. Many of the indigestible 
components of the diet, like complex carbohydrates or polyphenols, reach 
intact the large intestine where can partially be absorbed after being 
metabolized by the resident colonic microbiota (Possemiers et al. 2011). 
The human intestinal microbiota is a highly complex and dynamic 
ecosystem that harbors around 500-1000 microbial species (typically 
1011-1012 microbes/g of luminal colon content). Besides its metabolic 
role on the indigestible fractions of the diet, the gut microbiota serves for 
numerous important functions for human health, including the 
maintenance of intestinal homeostasis (Hooper et al. 2012). Several 
factors such as diet, genetic background, and immune status affect the 
composition and metabolism of the gut microbiota (Benson et al. 2010; 
Wu et al. 2011). Among them, diet appears to be one of the most 
important factors influencing the mid-long term microbial metabolism 
(David et al. 2014), and therefore can be crucial in understanding many 
health benefits related to this complex community.  
The in vivo study of the human GIT functions and its environment, 
in both health and disease conditions, is limited by ethical concerns and is 
not acceptable when potentially harmful substances are involved. 
Therefore, several in vitro models have been developed to closely 
simulate the complex multistage processes of human digestion and to 
dynamically monitor the microbial processes at the site of metabolic 
activity (Fritz et al. 2013; Guerra et al. 2012; Venema and Van den 
Abbeele 2013). These in vitro systems have allowed the screening of a 
large number of conditions, studying the separate and combined impacts 
of each stage of digestion and fermentation. Dynamic gastric models 
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have been developed and designed for real time measurement of the 
effects of the biochemical and mechanical processing of foods in the 
stomach (Kong and Singh 2010; Wickham and Faulks 2012). The TNO 
gastrointestinal model (TIM-1) is a computerized dynamic system that 
combines the physiological processes occurring within the stomach and 
the three parts of the small intestine (Minekus et al. 1995). As well as for 
the digestion models, the complexity of the in vitro fermentative models is 
diverse, ranging from batch fecal incubations using anaerobic conditions 
and dense fecal microbiota suitable for metabolic studies (Aura et al. 
2012) to more complex multi-compartmental models that represent 
different parts of the human colon and allow characterization of different 
gut microbial species and their related functionality over long-term 
periods. Multi-compartmental models are usually represented by three-
stage culture reactors as that designed by Gibson et al. (1988) that can 
reproduce differences from proximal (low pH, carbohydrate-excess 
conditions) to distal colonic regions (carbohydrate-depleted, non-acidic 
environment). Furthermore, the SHIME (Simulator of the Human Intestinal 
Microbial Ecosystem) adds two additional reactors representing the 
gastric and duodenal stages that follow a fill and flow process (Molly et al. 
1993). The duodenal content is pumped to three connected colonic 
reactors, which keep constant volumes in order to define residence times 
and have control of pH to allow differentiation of colon region-specific 
microbiota (Van den Abbeele et al. 2010). A three-stage model using 
immobilized microbiota in xanthan-gellan gum gel beads has been 
developed to represent the planktonic and sessile states of the complex 
colonic bacterial community (Cinquin et al. 2006). The TIM-2 is a dynamic 
computer-controlled model of the proximal colon (Minekus et al. 1999) 
that uses peristaltic movements to mix and transport the colonic content. 
It includes a dialysis process that simulates passive absorption of 
microbial metabolites and water, allowing the system to encompass a 
high-density microbiota. Although the TIM-1 and TIM-2 are automated 
 284 
Materials and methods 
complementary models representing the upper and distal GIT, 
respectively, they are usually not connected to operate jointly (Hatanaka 
et al. 2012). 
Therefore, most of the models have been specialized either in 
simulating the upper gastric-small intestine digestion or the colonic 
fermentation process involving gut microbiota. The dynamic SIMulator of 
the GastroIntestinal tract SIMGI described in this article goes one step 
further and represents a fully computer-controlled multi-compartmental 
system, which allows joint or separated simulation of the gastric and 
colonic fermentative processes. Thus, the SIMGI is a flexible modulating 
system that combines a gastric compartment that simulates peristaltic 
mixing movements, a reactor simulating the small intestine and three-
stage continuous reactors for reproducing the colon region-specific 
microbiota and its metabolism. Besides the engineered functioning of the 
five SIMGI compartments, the biological functioning of the system 
requires the development of a colon region-specific microbial ecosystem 
that needs to be stabilized in the simulator before starting any 
experimental approach. The microbiota stabilization observed in this 
model allows the system to be used as a tool for studying the effects of 
diet or food components on the modulation of the GIT microbiota and its 
metabolic activity. 
VIII.3 MATERIALS AND METHODS 
VIII.3.1 Description of the SIMGI Model 
The SIMGI comprises of five compartments (units), simulating the 
stomach, small intestine (SI) and the ascending (AC), transverse (TC) 
and descending colon (DC) regions, which are interconnected by pipes 
and peristaltic valve pumps (Watson-Marlow 120 U/DV) that transfer the 
content between the successive units (Fig. VIII.1). The whole system is 
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computer controlled through an operator panel and programmable logic 
controller ( nitronics Vision120™). The stomach is comprised of two 
transparent and rigid methacrylate plastic modules covering a reservoir of 
flexible silicone walls where the gastric content is mixed by peristaltic 
movements. The gastric peristalsis is achieved by pumping thermostated 
water that flows in the jacket between the plastic modules and the flexible 
reservoir, and that additionally keeps the temperature of the gastric 
content at 37 °C. The meal received by the stomach compartment is 
mixed with gastric electrolytes and enzymes and the decrease of pH is 
controlled by adding 0.5 M HCl. The computer software (SIMGI, 
Bioprocess Technology, Spain) allows the definition of pH acidification 
curves and the control of emptying times by applying the equation 
described by Elashoff et al. (1982). The other 4 units (SI, AC, TC and DC) 
consist of double-jacketed glass reactor vessels continuously stirred at 
150 rpm by means of a magnetic stirrer (RET control/t IKAMAG). The 
vessels contain different ports for transit of intestinal content, sampling 
points, continuous flushing of nitrogen and pH and temperature control. 
The pH in the colonic units was controlled by addition of 0.5 M NaOH and 
0.5 M HCl to keep values of 5.6 ± 0.2 in the AC, 6.3 ± 0.2 in the TC and 
6.8 ± 0.2 in the DC. The temperature was kept at 37 ºC by pumping water 
into the space between the double glass jackets of the reactor units. The 
computer software controls the addition of the pancreatic juice to the SI 
unit and the transit times for intestinal content transfer to the AC, TC and 
DC units. Overall, the model is programmable to sequentially proceed 
(continuously or feeding the system from 1 to 6 times daily) from the 
operation of food intake into the stomach throughout the delivery of distal 
colon content to waste. 
  
  
Figure VIII.1. Schematic diagram of the SIMulator GastroIntestinal SIMGI, including the stomach, small intestine (SI) and the 
ascending (AC), transverse (TC) and descending colon (DC) compartments 
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VIII.3.2 Microbial community development in the colonic units of 
the SIMGI  
Apart from operating with the five compartments simulating the 
whole gastrointestinal process, the SIMGI allows both the joint work of the 
stomach and the small intestine to study food digestion and the direct 
feeding of the small intestine and the transit to the colonic vessels for 
studying microbial community development and metabolism. The 
operating mode to work with units SI, AC, TC and DC was used for the 
purpose of this study. Therefore, the three colon reactors were filled and 
pre-conditioned with nutritive medium in a volume of 250, 400 and 300 
mL, respectively. The medium contained arabinogalactan (1 g/L), pectin 
from apple (2 g/L), xylan (1 g/L), potato starch (3 g/L), glucose (0.4 g/L), 
yeast extract (3 g/L), peptone (1 g/L), mucin (4 g/L) and L-cysteine (0.5 
g/L). The nutritive medium and the volumes of the colonic reactors to give 
an overall residence time of 76 h were adapted from the conditions 
standardized for the SHIME model (De Boever et al. 2000; Molly et al. 
1993; Van den Abbeele et al. 2010). The AC, TC and DC units were 
inoculated with 20 mL of a fresh 20% (w/v) fecal slurry from a healthy 
volunteer, who had no received any antibiotic treatment in the previous 3 
months of the experiment, prepared in anaerobic conditions with sodium 
phosphate buffer (0.1 M, pH 7.0), containing 1 g/L sodium thioglycolate 
as reducing agent, as described by De Boever et al. (2000). The 
inoculated colon units were allowed to equilibrate overnight in batch 
conditions at 37 °C and at the pH value defined for each compartment. 
The development and stabilization of the microbial community until 
steady-state conditions in the three colon units was approached by 
feeding the small intestine with nutritive medium (75 mL, pH 2) mixed with 
pancreatic juice (40 mL of a solution of 12 g/L NaHCO3, 6 g/L oxgall 
dehydrate fresh bile and 0.9 g/L porcine pancreatine) three times a day 
during 14 days (Van den Abbeele et al. 2010). The small intestine 
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digestion was performed during 2 h at 37 °C and the content of the vessel 
was automatically transferred to the following colon compartment (AC) at 
a flow rate of 5 mL/min, which simultaneously activated the transit of 
colonic content between the AC, TC and DC compartments at the same 
flow rate. All the vessels were maintained under anaerobic conditions by 
continuously flushing N2. During the experimental set up, samples were 
collected at regular time points (1, 3, 8, 13 and 14 days) from the three 
colon vessels and stored at −20 °C until further analysis. Microbiological 
plate counts analyses were performed at the time of sampling.  
VIII.3.3 Microbial analyses 
VIII.3.3.1 DNA extraction 
Microbial DNA extraction of the samples taken from the AC, TC and 
DC compartments was performed as described by Moles et al. (2013). 
Briefly, genomic DNA was extracted from samples (1 mL) centrifuged 
(10000 ×g, 10 min, 4 °C) and the pellet resuspended in an extraction 
buffer (200 mM Tris–HCl pH 7.5, 0.5% SDS, 25 mM EDTA, 250 mM 
NaCl, 20 mg/mL lysozyme, 5 mg/mL lysostaphin and 3 M Na acetate), 
followed by mechanical lysis with glass beads and extraction with 
phenol/chloroform/isoamyl-alcohol (Sigma-Aldrich). The DNA was 
precipitated by adding 0.6 volumes of isopropanol, washed with 70% 
ethanol, allowed to air dry, and finally resuspended in DNase, RNase free 
water (Sigma-Aldrich). The DNA yield was measured using a NanoDropH 
ND-1000 UV spectrophotometer (Nano-Drop Technologies). 
VIII.3.3.2 Quantitative PCR (qPCR) 
Quantitative PCR (qPCR) was performed on triplicate samples of 
10-fold diluted genomic DNA and analyzed using SYBR green 
methodology (Bio-Rad Laboratories) with the IQ5 Multicolor Real-Time 
PCR Detection System (Bio-Rad). Data analyses were performed with 
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iQ5 Optical System Software Version 1.1. Primers, amplicon size, 
annealing temperature for targeted microbial groups (total bacteria, 
Enterobacteriaceae, Bacteroides, Lactobacillus, Bifidobacterium, 
Prevotella, the specific phylogenetic groups Blautia coccoides-
Eubacterium rectale Cluster XIVa, Ruminococcus Cluster IV and 
Clostridium leptum subgroup specific cluster IV) have been described 
previously (Barroso et al. 2013). DNA from Escherichia coli DH5α, L. 
plantarum IFPL935, Bifidobacterium breve 29M2 and Bacteroides fragilis 
DSM2151 was used for quantification of total bacteria, Lactobacillus, 
Bifidobacterium and Bacteroides, respectively. For the rest of groups 
analyzed, samples were quantified using standards derived from targeted 
cloned genes using the pGEM-T cloning vector system kit (Promega), as 
described previously (Barroso et al. 2013). 
VIII.3.3.3 PCR-denaturing gradient gel electrophoresis (DGGE) 
Changes in the microbial community were determined using PCR-
DGGE essentially as described earlier (Muyzer et al. 1993). Briefly, the 
PCR fragments were obtained using the primers 968-F (5’ 
AACGCGAAGAACCTTAC-3’) and  ni-1401-R (5’ 
CGGTGTGTACAAGACCC-3’) (Nubel et al. 1996) to amplify regions of 16 
rDNA gene of all bacteria. For DGGE analysis of PCR products, a 40-bp 
GC clamp was attached to the 3’ end of primer 968-F. Then, amplicons 
were separated by means of a 30–60% denaturant gradient in a 
polyacrylamide gel using a DCode System (Bio-Rad). The DGGE profiles 
were digitally normalized by comparison with a home-made standard 
using InfoQuest FP software (Bio-Rad). Clustering was performed with 
Pearson correlation and the Unweighted Pair Group Method with 
Arithmetic Mean (UPGMA).  
VIII.3.3.4 Plate Counts 
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Appropriate dilutions of samples from each colon region 
compartment were poured in plates containing a range of selective agar 
media or broths supplemented with bacteriological agar (1.5%). Thus, 
dilutions were inoculated into Wilkins-Chalgren agar (Oxoid) for total 
anaerobes; PCA (Oxoid) for total aerobes; MRS fermentation medium 
(Pronadisa), which contains neither glucose nor meat extract, 
supplemented with maltose (1%) for Lactobacillus; MacConkey agar 
(Oxoid) for Enterobacteriaceae; Bryant-Burkey medium (Merck) for 
Clostridium; and MRS fermentation medium supplemented with raffinose 
(1%) and lithium chloride (0.05%) for Bifidobacterium. Plates were 
incubated at 37 °C for 48 h. For anaerobes, Clostridia and bifidobacteria, 
plates were placed in an anaerobic cabinet (BACTRON 
Anaerobic/Environmental Chamber, SHELLAB). 
VIII.3.4 Microbial metabolism analyses  
VIII.3.4.1 Short Chain Fatty-Acids (SCFA) determination 
Samples from the AC, TC and DC compartments were centrifuged 
at 13000 ×g for 5 min, the supernatant was filtered and 0.2 µL were 
injected on a HPLC system (Jasco) equipped with a UV-975 detector and 
automatic injector. SCFA were separated using a Rezex ROA Organic 
Acids column (300 × 7.8 mm) (Phenomenex) thermostated at 50 °C 
following the method described by Sanz et al. (2005). Briefly, the mobile 
phase was a linear gradient of 0.005 mM sulfuric acid in HPLC grade 
water, and the flow rate was 0.6 mL/min. The elution profile was 
monitored at 210 nm, and peaks were identified by comparing retention 
times with standards. Data acquisition and processing was carried out 
using a ChromNAV Data System software (Jasco). Calibration curves of 
acetic, propionic, butyric, formic and lactic acid were built up in the range 
concentration of 1 to 100 mM. 
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VIII.3.4.2 Ammonia determination 
Ammonia was determined from the supernatant fraction of samples 
(13000 ×g, 15 min, 4 oC) using an enzymatic kit for ammonia 
determination (R-Biopharm) based on the method of Gutmann et al. 
(1974). In this assay, ammonia reacts with 2-oxoglutarate in the presence 
of glutamate dehydrogenase and NADH. The decrease in NADH, which is 
proportional to the amount of ammonia, was determined by means of its 
absorbance at 340 nm.   
VIII.4 RESULTS AND DISCUSSION 
The computer-controlled multicompartmental dynamic model of the 
gastrointestinal tract SIMGI described in this study was tested for its 
capability to reproduce in vitro the microbial conditions that characterize 
the different regions of the human large intestine that have been validated 
with three-stage culture reactors (Macfarlane et al. 1998; Molly et al. 
1994; Van den Abbeele et al. 2010, 2013). The operating conditions of 
the SIMGI colon compartments in this study have been adapted to the 
protocols developed for the SHIME (Molly et al. 1993). This model has 
repeatedly demonstrated its suitability to evaluate long-term effect of food 
ingredients on modulating the human intestinal microbiota after an initial 
two-week stabilization period that allows microbial evolution in the 
reactors from a fecal inoculum to a colon region-specific microbiota 
(Possemiers et al. 2004; Van den Abbeele et al. 2010). After this 
stabilization period, the system provides a steady-state environment 
where the composition and metabolism of the microbial community can 
be evaluated during long-term experimental dietary interventions 
(Possemiers et al. 2010; Terpend et al. 2013; Van de Wiele et al. 2007). 
Evolution of the microbial community during the two-week 
stabilization period in the AC, TC and DC compartments of the SIMGI 
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was analyzed by PCR-DGGE (Fig. VIII.2). Results showed that samples 
from the three colon compartments clustered together after inoculation 
and overnight equilibrating conditions (day 1). Nevertheless, variation of 
the population fingerprints could be observed over time between colon 
vessels. From day 8 onwards, samples from the same colon 
compartments clustered together (Pearson correlation coefficients of 
95%, 94%, and 91% in the AC, TC and DC compartments, respectively). 
At the end of the stabilization period, rates of change dropped below 10% 
for each colon compartment, indicating steady-state microbial 
compositions (Fig. VIII.2). Differentiation of microbial communities within 
each colon compartment before reaching the steady state has been 
described in three-stage microbial reactors (Feria-Gervasio et al. 2014; 
Van den Abbeele et al. 2010).  
  
  
Figure VIII.2. Clustering tree of total bacteria DGGE profiles of samples from the ascending (AC), transverse (TC) and descending 
(DC) colon compartments at days 1, 3, 8, 13 and 14 after the inoculation of the SIMGI 
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The composition of the microbial community and the bacterial 
counts reached during stabilization in the AC, TC and DC compartments 
were evaluated by qPCR (Table VIII.1). Counts of total bacteria were 
about 9 log copy number/mL at the onset of the assay in the three colonic 
regions, remaining steady over the 14 days of the stabilization period. 
Among the bacterial groups that varied between the inoculum equilibrated 
overnight in batch conditions (day 1) and the stabilized bacterial 
community in dynamic conditions (days 13-14), it was observed an overall 
decrease in counts of Bifidobacterium and Prevotella and an increase of 
Enterobacteriaceae (Table VIII.1). The microbial community represented 
by the butyrate-producing groups (cluster IV) C. leptum and 
Ruminoccocus also decreased during stabilization, being the sharpest 
reduction measured for the C. leptum group (2.5 log copy number/mL at 
14 days). Differences were also observed within each colon 
compartment, since these butyrate-producing groups were less 
represented in the proximal colon vessel (AC) than in the distal vessels 
(TC and DC) at the end of the stabilization period. Nevertheless, the 
counts of other butyrate-producing bacteria such as B. coccoides-E. 
rectale group (cluster XIVa) remained equivalent in all colonic 
compartments (8.1-8.6 log copy number/mL at the end of the stabilization 
period). On the other hand, Bacteroides counts increased in the AC 
vessel during the time course, being more representative of the AC and 
TC vessels than the DC vessel (Table VIII.1). Similar results showing an 
increase in Proteobacteria and Bacteroides and a decrease in 
Bifidobacterium and Clostridium clusters IV and XIVa, when compared 
with the fecal inoculum, were determined with the phylogenetic 
microarray HITChip during the stabilization period of human microbiota in 
the SHIME (Van den Abbeele et al. 2010) and the TIM-2 (Rajilić-
Stojanović et al. 2010) models. Besides, a differentiation in the 
occurrence of these bacterial groups between the compartments is 
generally observed in three-stage culture models as a result of the 
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different conditions established for the three colon vessels. The acidic pH 
and carbohydrate-rich conditions of the proximal vessel (AC) favoured the 
predominance of Bacteroides, which are characterized by a marked 
ability to utilize a wide variety of polysaccharides (Ravcheev et al. 2013). 
Regarding butyrate producer groups, a high abundance of the cluster 
XVIa group B. coccoides-E. rectale in the three colon compartments and 
a lower occurrence of the cluster IV groups C. leptum and Ruminoccocus 
in the AC compartment than in the TC and DC vessels has been also 
described at the end of the stabilization period in the SHIME (Barroso et 
al. 2014; Van den Abbeele et al. 2010).  
The microbial community stabilized in the AC, TC and DC 
compartments of the SIMGI was also evaluated by plate counts. Total 
bacteria quantitatively reached the steady-state level at mean values of 8 
log cfu/mL, which were mainly represented by Clostridium and 
Enterobacteriaceae (data not shown). In general, higher counts were 
obtained with qPCR compared with plate counts, in accordance with the 
large number of gut bacterial groups that are non-culturable by 
conventional culture techniques due to their generally fastidious growth 
requirements (Allen-Vercoe 2013). 
  
 Table VIII.1. Mean ± SD of quantitative PCR counts (log copy number/ml) for the different microbial groups analyzed in the 
ascending (AC), transverse (TC) and descending colon (DC) of the SIMGI during the stabilization period 
Universal bacteria AC 8.79 ± 0.19 9.34 ± 0.45 9.19 ± 0.08 9.26 ± 0.06 9.29 ± 0.04
TC 9.03 ± 0.53 9.19 ± 0.24 9.47 ± 0.39 8.95 ± 0.03 9.13 ± 0.04
DC 9.30 ± 0.01 9.36 ± 0.39 9.21 ± 0.36 8.84 ± 0.02 9.12 ± 0.32
Lactobacillus AC 6.88 ± 1.83 7.50 ± 0.45 7.86 ± 0.06 7.38 ± 0.26 7.44 ± 0.12
TC 7.57 ± 0.03 7.33 ± 0.08 7.98 ± 0.11 7.58 ± 0.02 7.65 ± 0.03
DC 7.65 ± 1.94 7.52 ± 2.40 7.36 ± 0.15 7.64 ± 0.05 7.66 ± 0.02
Bifidobacterium AC 9.67 ± 0.04 8.60 ± 0.03 7.90 ± 0.02 7.43 ± 0.07 7.54 ± 0.06
TC 9.79 ± 0.31 9.33 ± 0.01 8.28 ± 0.36 7.34 ± 0.14 7.68 ± 0.03
DC 9.84 ± 0.03 9.40 ± 0.07 8.02 ± 0.30 7.55 ± 0.05 7.58 ± 0.01
Bacteroides AC 7.11 ± 0.14 7.07 ± 0.06 7.91 ± 0.03 8.18 ± 0.01 8.19 ± 0.16
TC 7.82 ± 0.13 7.24 ± 0.85 8.02 ± 0.07 7.88 ± 0.11 8.00 ± 0.05
DC 8.06 ± 0.74 7.71 ± 0.02 7.90 ± 0.04 7.37 ± 0.04 7.39 ± 0.01
Prevotella AC 6.43 ± 0.02 5.14 ± 0.02 4.67 ± 0.06 4.07 ± 0.01 4.16 ± 0.06
TC 6.13 ± 0.29 4.91 ± 0.06 4.30 ± 0.01 4.33 ± 0.12 4.45 ± 0.09
DC 6.59 ± 0.01 4.73 ± 0.02 4.41 ± 0.05 4.34 ± 0.02 4.36 ± 0.08
Enterobacteriacea AC 4.28 ± 0.18 8.77 ± 0.05 8.74 ± 0.16 8.70 ± 0.01 8.64 ± 0.06
TC 6.23 ± 1.02 8.62 ± 0.17 8.74 ± 0.10 8.18 ± 0.01 8.32 ± 0.00
DC 6.11 ± 0.06 7.90 ± 0.16 8.78 ± 0.10 8.04 ± 0.02 8.02 ± 0.02
AC 8.82 ± 0.05 8.82 ± 0.27 8.53 ± 0.05 8.47 ± 0.03 8.61 ± 0.02
TC 8.65 ± 0.09 9.04 ± 0.03 8.86 ± 1.17 8.17 ± 0.06 8.47 ± 0.01
DC 8.91 ± 0.08 8.85 ± 0.35 8.91 ± 0.90 8.03 ± 0.01 8.08 ± 0.06
Clostridium leptum AC 8.19 ± 0.08 7.00 ± 0.05 5.07 ± 0.02 5.66 ± 0.03 5.70 ± 0.10
TC 8.03 ± 0.03 7.66 ± 0.05 6.75 ± 0.04 6.46 ± 1.91 6.81 ± 0.01
DC 7.94 ± 0.09 7.71 ± 0.04 6.81 ± 0.08 6.70 ± 0.05 6.75 ± 0.01
Ruminococcus AC 6.57 ± 0.00 5.84 ± 0.03 5.04 ± 0.14 5.19 ± 0.03 5.06 ± 0.02
TC 6.59 ± 0.02 6.40 ± 0.02 5.53 ± 0.18 5.63 ± 0.01 5.73 ± 0.02
DC 6.87 ± 0.01 6.64 ± 0.00 5.82 ± 0.16 5.83 ± 0.00 5.83 ± 0.02
Blautia coccoides-
Eubacterium rectale 
Bacterial group Compartment
Time (days)
1 3 8 13 14
 The metabolism of the microbiota stabilized in the different colonic 
reactors of the SIMGI model was evaluated by measuring the content of 
acetic, propionic, butyric, formic and lactic acids (fermentative 
metabolism) and of ammonium (proteolytic metabolism). Overall, the total 
SCFAS average molar production up to functional stability was 55.19, 
68.14 and 78.68 mM in the AC, TC and DC compartments, respectively. 
Considering the accumulation of SCFA in the distal compartments 
observed for three-stage culture reactors without absorption steps 
(Cinquin et al. 2006; Possemiers et al. 2004), the net SCFA production 
was highest in the AC compartment in correspondence with the 
carbohydrate-excess conditions and the higher counts of fermentative 
bacterial groups, such as Bacteroides, in this compartment (Table VIII.1). 
Bacteroides are saccharolytic bacteria characterized by producing acetic, 
propionic and succinic acids (Flint et al. 2008). The production of acetic, 
propionic and butyric acids during the microbial stabilization period in the 
AC, TC and DC compartments is shown in Fig. VIII.3. The evolution 
pattern of these SCFAs was more similar between the distal 
compartments (TC and DC) compared to the AC compartment. Thus, 
acetic acid content decreased in all the vessels up to the stabilization 
period (14 days) although the initial decrease was sharper in the AC 
vessel. The decrease of acetic acid production corresponded with the 
decline of Bifidobacterium counts observed in the three compartments, 
being the fastest decrease also observed in the AC compartment (Table 
VIII.1). Bifidobacteria are characterized to increase the production of 
acetic acid when are grown on less readily fermentable substrates 
(Falony et al. 2006). The decrease in the content of acetic acid can also 
be explained in the basis of the cross-feeding interactions between colon 
bacteria (De Vuyst and Leroy 2011). In this sense, the B. coccoides–E. 
rectale group, which prevailed in the SIMGI colonic compartments during 
the whole stabilization period (Table VIII.1), contains most of the butyrate 
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producers that use acetic acid as a co-substrate for the enzyme butyryl-
CoA : acetate CoA-transferase (Louis and Flint 2009). 
  
  
Figure VIII.3. Changes in concentration (mM) of acetic acid, propionic acid and 
butyric acid in the ascending (AC; diamonds), transverse (TC; squares) and 
descending colon (DC; triangles) of the SIMGI at different times after inoculation 
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Regarding other SCFAs, formic acid was detected in the AC 
compartment from day 8 onwards reaching values of 5 mM at the steady-
state (results not shown). Lactic acid production was only detected at day 
3 of incubation both in proximal (AC; 6 mM) and distal (DC; 1 mM) colon 
compartments. In this regard, in fecal samples from healthy donors, lactic 
acid either is not detected or is present at low concentrations (< 3 mM) 
due to further metabolism within the colon (Duncan et al. 2007). Initial pH 
has been point out to play a key role pH upon lactic acid formation and 
utilization by fecal microbial communities (Belenguer et al. 2007). 
Besides, lactic acid can be further turned into butyric and propionic acids 
through cross-feeding by gut bacteria such as Eubacterium (Belenguer et 
al. 2006) and Megasphaera (Shetty et al. 2013), respectively.  
Ammonium concentration, a marker for proteolytic activity, was 
detected to be steady from day 8 of the stabilization period (results not 
shown). Average values increased along the colonic compartments with 
levels of 2.8 mM, 4.2 mM and 3.4 mM in the AC, TC and DC vessels, 
respectively, showing that proteolysis occurred throughout the entire 
colon compartments. The main pathway of ammonia formation in the 
human colon is deamination, and bacteria involved in amino acid 
deamination include species within Clostridium, Bacteroides, 
Enterobacterium, and Lactobacillus (Scott et al. 2013). 
VIII.5 CONCLUSIONS 
The fully automation of the SIMGI model allows precise control of 
the environmental parameters that simulate the gastrointestinal intestinal 
tract. In this study, we have demonstrated the suitability of this multi-stage 
dynamic model to reproduce complex and stable microbial communities, 
which can be differentiated in compartments simulating the three human 
colon regions. The microbial and functional stabilization observed in the 
SIMGI model indicates that the system can be used as a tool for studying 
 the effects of diet or food components on modulating the GIT microbiota 
and its metabolic activity. The flexible-modulating characteristics of the 
system and the computer-control of physiological parameters open 
possibilities for variation of conditions that would allow the simulation of 
microbial dysbiosis associated to pathological conditions in the SIMGI 
model. Further advances of the system are addressing the incorporation 
of devices simulating the gut microbiota-host interactions. 
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IX.1 ABSTRACT 
Dietary habits involving high energy intake are related to the 
development of overweight and obesity. Prebiotics are recognized to 
influence the gut microbiota composition and they could be consumed as 
part of a weight management diet. In this study, we have used the 
dynamic simulator of the gastrointestinal tract SIMGI to evaluate changes 
in the microbiological and metabolic characteristics of an overweight-
associated colonic microbiota after reducing the diet energy content and 
its supplementation with the lactulose derived oligosaccharides OsLu. 
The differentiation and stability of the microbial communities within each 
colon compartment was reached after two weeks of feeding the system 
with a high energy diet based on high content of fructose and readily 
fermentable starches, in order to mimic high processed food and sweet 
beverage intake. The effect of reducing the energy content loading and 
the supplementation with OsLu caused variations in bacterial counts 
generally below 1 log bacteria/mL (except for Enterobacteriaceace), 
indicating that the changes in the chabohydrate content, including the 
supply with 10 g/L of OsLu, were not able to cause a substantial effect in 
the colonic bacterial populations of the SIMGI. The reduction of the 
dietary carbohydrate content caused an effect on the microbial metabolic 
activity that was characterized by an absence of net butyrate production 
and an increase in the ammonium content. This shift from fermentative to 
proteolytic metabolism was not observed when the low-energy diet was 
supplemented with OsLu. The results obtained in this study indicate that 
the substitution of easily digestible carbohydrates by OsLu maintains the 
fermentative functionality of the colonic microbiota, allowing the net 
production of butyric acid with potential beneficial effects on health, and 
avoiding a full transition to proteolytic metabolism profiles. 
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IX.2 INTRODUCTION 
Dietary habits involving high energy intake are related to the 
development of overweight and obesity. Monosaccharides and 
disaccharides such as fructose and sugar alcohols (sorbitol, lactitol and 
other polyols), widely used for the formulation of processed foods or 
beverages, can reach the large intestine when overfeeding of these 
sugars occurs (Payne et al., 2012a). Analysis of published dietary records 
reveals that obese children were found to consume significantly more 
protein and sugars and lower fiber than normal-weight children (Aeberli, 
et al., 2007). Related to it, there is an increased interest in understanding 
the possible effects of high energy diets in the intestinal microbiota. 
However, the heterogeneous and highly personalized human microbiota 
shows a smaller dietary influence as the inter-individual variation 
decreases systematic effects even under identical diets (Wu et al., 2011; 
David et al., 2014). Salonen et al. (2014) described that studies from 14 
obese males consuming fully controlled diets supplemented with resistant 
starch or non-starch polysaccharides and a weight-loss diet revealed that 
the diet explained around 10% of the total variance in microbiota 
composition, which was substantially less than the inter-individual 
variance. All these studies have noted strong individuality of the 
responses, the extent of which appears to depend on the initial microbiota 
composition (Korpela et al., 2014). The fact that the broad phylum level 
changes (Bacteroidetes vs. Firmicuttes) have not been found consistently 
(Ley, 2010; Ravussin et al., 2012) may indicate that relevant changes 
associated to diet-induced obesity could involve lower taxonomic levels 
within these phyla (Cox and Blaser, 2013).  
In view of the fact that prebiotics are well-recognized to influence 
the gut microbiota composition, they could be consumed as part of a 
weight management diet. Genetically obese mice (Cani et al., 2009), diet-
induced obese mice and rats (Cani et al., 2007; Pyra et al., 2012), as well 
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as overweight and obese adults (Parnell and Reimer, 2009) have all been 
reported to exhibit reduced fat mass following consumption of prebiotics. 
Sarbini et al. (2014) described the potential of a novel dextran 
oligosaccharide for obesity management through in vitro experimentation. 
The degree of branching of the compound identified it as a slower-
fermenting nutrient that was considered to be advantageous for obese 
individuals, as energy would be made available more gradually. Recently, 
the enzymatic synthesis of oligosaccharides derived from lactulose 
(OsLu) has been aimed for the production of a group of more slowly 
fermenting prebiotics (Cardelle-Cobas et al., 2008). In addition, the 
compounds have demonstrated to be selectively fermented by 
bifidobacteria and lactobacilli and to increase the concentration of short 
chain fatty acids (Cardelle-Cobas et al., 2012). 
In this study we have used the dynamic simulator of the 
gastrointestinal tract SIMGI described by Barroso et al. (2015). The model 
simulates the gastric and small intestine digestion and is equipped with 
three-stage continuous reactors for reproducing the colon region-specific 
microbiota and its metabolism. The stabilization period in this study has 
been adapted to simulate an obese-associated microbiota by using a high 
energy-content medium. Changes in microbiological and metabolic 
characteristics were assessed after lowering the energy content and the 
supplementation with the lactulose derived oligosaccharides OsLu used 
as a potential prebiotic.  
IX.3 MATERIALS AND METHODS 
IX.3.1 Dynamic simulator of the gastrointestinal tract SIMGI 
The gastrointestinal simulator SIMGI was used in the operating 
mode to work with the units simulating the small intestine (SI) and the 
ascending (AC), transverse (TC) and descending colon (DC) regions 
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(Barroso et al., 2014). Therefore, the three colon reactors were filled and 
pre-conditioned with the nutritive medium that will feed the system during 
the stabilization period. In this case, the setup was made to recreate an 
obese-associated microbiota. For this purpose, a starting high energy 
(HE) medium was used as described by Payne et al. (2012b), which was 
characterized by a high content of high-glycemic index carbohydrates 
(digestible starch) and simple carbohydrates (fructose). The HE medium 
contained arabinogalactan (1 g/L), pectin from apple (2 g/L), xylan (1 g/L), 
potato starch (6 g/L), maize starch (4 g/L), fructose (6 g/L), glucose (0.4 
g/L), yeast extract (3 g/L), peptone (1 g/L), mucin (4 g/L) and L-cysteine 
(0.5 g/L), that is 45% more fermentable carbohydrates were added to the 
standard nutritive medium (Barroso et al., 2014) to create the HE diet. 
The AC, TC and DC units were inoculated with 20 mL of a fresh 20% 
(w/v) fecal sample from an overweight volunteer, homogenized in 
anaerobic conditions with sodium phosphate buffer (0.1 M, pH 7.0), 
containing 1 g/L sodium thioglycolate as reducing agent, as described by 
De Boever et al. (2000). The development and stabilization of the 
microbial community until steady-state conditions in the three colon units 
was approached by feeding the small intestine with nutritive medium (75 
mL, pH 2) mixed with pancreatic juice (40 mL of a solution of 12 g/L 
NaHCO3, 6 g/L oxgall dehydrate fresh bile and 0.9 g/L porcine 
pancreatine) three times a day during 14 days (Van den Abbeele et al., 
2010). The small intestine digestion was performed during 2 h at 37 °C 
and the content of the vessel was automatically transferred to the 
following colon compartment (AC) at a flow rate of 5 mL/min, which 
simultaneously activated the transit of colonic content between the AC, 
TC and DC compartments at the same flow rate. All the vessels were 
maintained under anaerobic conditions by continuously flushing N2. 
After the two-week stabilization period of the colonic microbiota, the 
SIMGI was subjected to a 1-week experiment consisting in removing the 
maize starch and fructose content and reducing the potato starch content 
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to 1.5 g/L (low energy medium; LE) and adding 10 g/L of an 
oligosaccharide mixture derived from lactulose (OsLu) showing prebiotic 
properties (Cardelle-Cobas et al., 2012). Finally, a 1-week wash-out 
period was included at the end of the experiment by feeding the SIMGI 
daily with the LE medium. During the whole study, samples were 
collected at regular time points from the three colon vessels and stored at 
−20 °C until further analysis 
IX.3.2 Microbiological analyses 
IX.3.2.1 DNA extraction and purification 
Microbial DNA extraction of the samples taken from the AC, TC and 
DC compartments was performed as described by Moles et al. (2013). 
Briefly, samples (1 mL) were centrifuged (10000 ×g, 10 min, 4 °C) and 
the pellet (resuspended in 200 mM Tris–HCl pH 7.5, 0.5% SDS, 25 mM 
EDTA, 250 mM NaCl and 3 M Na acetate) was incubated with 20 mg/mL 
lysozyme and 5 mg/mL lysostaphin (Sigma-Aldrich). Bacterial lysis was 
completed by mixing with glass beads. The DNA was extracted with 
phenol/chloroform/isoamyl-alcohol, precipitated by adding 0.6 volumes of 
isopropanol and finally resuspended in DNase, RNase free water (Sigma-
Aldrich). The DNA yield was measured using a NanoDropH ND-1000 UV 
spectrophotometer (Nano-Drop Technologies). 
IX.3.2.2 Quantitative PCR (qPCR) 
The quantitative microbiological analysis of samples was carried 
out by qPCR experiments that were analyzed using SYBR green 
methodology in a ViiA7 Real-Time PCR System (Life Technologies, 
USA). Primers, amplicon size, annealing temperature for total bacteria, 
Bacteroides, Bifidobacterium, Enterobacteriaceae, Lactobacillus, 
Prevotella, the specific phylogenetic groups Blautia coccoides-
Eubacterium rectale Cluster XIVa, Ruminococcus Cluster IV and 
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Clostridium leptum subgroup specific cluster IV) have been described 
previously (Barroso et al., 2013). DNA from Escherichia coli DH5α, L. 
plantarum IFPL935, Bifidobacterium breve 29M2 and Bacteroides fragilis 
DSM2151 was used for quantification of total bacteria, Lactobacillus, 
Bifidobacterium and Bacteroides, respectively. For the rest of groups 
analyzed, samples were quantified using standards derived from targeted 
cloned genes using the pGEM-T cloning vector system kit (Promega), as 
described previously (Barroso et al., 2013). For the analysis of 
Akkermansia, the samples were quantified using standards derived from 
one clone obtained from the fecal inoculum, amplified with the primers 
AM1: CAGCACGTGAAGGTGGGGAC and AM2: 
CCTTGCGGTTGGCTTCAGAT using the conditions described by Collado 
et al. (2007) and cloned using the pGEM-T cloning vector system kit 
(Promega, Madison, WI) as described previously (Barroso et al., 2013). 
The correctness of the Akkermansia insert was confirmed by sequence 
analysis. 
IX.3.2.3 PCR-DGGE 
For evaluation of the microbial community evolution, DNA was 
amplified using the universal bacterial primers 968-F and UNI 1401-R 
described by Nübel et al. (1996). The primer 968-F was synthesized with 
a 40-bp GC clamp attached to the 3’ end. Total volume for PCR reactions 
was 12.5 µL, composed by 0.75 µL 50 mM MgCl2; 1.25 µL Taq Buffer 
10X; 0.25 µL for each primer (10 µM) and dNTPs (10 mM); 0.125 µL Taq 
Polimerase (5 U/µL), about 100 ng of DNA from each sample and filled up 
to 12.5 µL with SIGMA water. Amplification protocol was as follows: 94 ºC 
for 3 min 45 s, 35 cycles of 30 s at 55 ºC (annealing temperature) and 1 
min at 72 ºC; and 10 min at 72 ºC. The PCR products (5 µL) were added 
in a 0.8% agarose gel and analyzed through DGGE by a DCode system 
equipment (BIORad Lab., USA) using a 9% polyacrylamide gel and a 
denaturalizing gradient from 30 to 60% of 7 M urea and 40% formamide. 
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For electrophoresis assay, it was used TAE buffer 0.5X (20 mM Tris, 10 
mM acetic acid and 0.5 mM EDTA), at 70 V and 60 ºC for 16 hours. The 
DGGE profiles were digitally normalized by comparison with a home-
made standard using InfoQuest FP software (Bio-Rad). Clustering was 
performed with Pearson correlation and the Unweighted Pair Group 
Method with Arithmetic Mean (UPGMA). 
IX.3.3 Microbial metabolism analyses  
IX.3.3.1 Short Chain Fatty-Acids (SCFA) determination 
Samples from the AC, TC and DC compartments were centrifuged 
at 13000 ×g for 5 min, the supernatant was filtered and 0.2 µL were 
injected on a HPLC system (Jasco) equipped with a UV-975 detector and 
automatic injector. SCFA were separated using a Rezex ROA Organic 
Acids column (300 × 7.8 mm) (Phenomenex) thermostated at 50 °C 
following the method described by Sanz et al. (2005). The mobile phase 
was a linear gradient of 0.005 mM sulfuric acid in HPLC grade water, and 
flow rate was 0.6 mL/min. The elution profile was monitored at 210 nm 
and peak identification was carried out by comparison between retention 
times and standards. For data acquisition and processing it was used a 
ChromNAV Data System software (Jasco). Calibration curves of acetic, 
propionic, butyric, formic and lactic acid were built up in the range 
concentration of 1 to 100 mM. 
IX.3.3.2 Ammonium determination 
Ammonium was determined directly from the supernatant fraction 
of samples (13000 ×g, 15 min, 4 oC) using an ammonium ion selective 
electrode (NH500/2; WTW) and following the manufacture’s instructions. 
 318 
Results and discussion 
IX.4 RESULTS AND DISCUSSION 
In addition to non-digestible polysaccharides and resistant 
starches, that reach the large intestine undigested due to resistance to 
human amylase activity (Shimaya, et al., 2009), simple sugars and 
digestible starches, when consumed abundantly in the diet, are capable 
of exceeding intestinal absorption capacity, resulting in high carbohydrate 
passage into the large intestine, where they are readily available for gut 
microbial fermentation (Tappy and Le, 2010). Thus, the design of a high 
energy diet to simulate in the SIMGI an obesity-associated microbiota 
was based on a significant increase in the content of fructose and readily 
fermentable starches to the standard nutritious medium employed to feed 
the SIMGI colonic reactors (Barroso et al., 2015). This diet design 
represents the increased prevalence of high consumption of refined 
carbohydrates and fructose-saturated sweeteners that is correlating with 
the global incidence of obesity (Payne et al. 2012a).  
The composition of the microbial community and the bacterial 
counts reached during the last 3 days of each fermentation period (HE, 
LE-OsLu and LE) in the AC, TC and DC compartments were evaluated by 
qPCR (Table IX.1). The end of the stabilization period with the HE diet 
was characterized in average by higher counts in the distal colon regions 
of Bifidobacterium, Bacteroides, B. coccoides-E. rectale group, C. leptum, 
Ruminococcus, Akkermansia and Enterobacteriacceae. The most 
noticeable differences in bacterial counts observed in the SIMGI when 
comparing the end of the stabilization period with the HE diet and the 
standard diet (Barroso et al., 2014) were the counts of Bacteroides and, 
particularly, Enterobacteriaceae in the three colon compartments that 
were higher and lower, respectively, with the HE diet in comparison with a 
standard diet (Barroso et al., 2014). The increase of Proteobacteria is a 
common feature observed in colonic models (Van den Abbeele et al., 
2010; Rajilić-Stojanović et al., 2010). This increase, however, did not take 
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place during the stabilization of the SIMGI with the HE diet (Table IX.1). 
Akkermansia was the only bacterial group that had not been assayed 
previously in the SIMGI. The results indicated a predominance of the 
species in the TC and DC compartments when compared with the AC. 
This result was already reported in the SHIME by Van den Abbeele et al. 
(2010). It is important to remark the fact that mucin added to the nutritive 
media could be relevant for development of Akkermansia, as these 
bacteria depend on mucin as a carbon and nitrogen source (Collado et 
al., 2007). 
After the 15-days stabilization period of the colonic microbiota in the 
SIMGI with the HE nutritive medium, a shift in diet was carried out by the 
suppression in the medium of simple carbohydrates and a sharp 
reduction of the content of readily fermentable starches (LE diet). The 
carbohydrate content was replaced with the oligosaccharide mixture 
derived from lactulose (OsLu) developed by Cardelle-Cobas et al. (2008). 
The incubation of fecal slurries with a similar compound has previously 
demonstrated prebiotic potential (Cardelle-Cobas et al., 2012). The 
feeding of the SIMGI with OsLu, however, showed no bifidogenic effect 
when compared with the HE and LE diets. On the other hand, it was 
observed a higher content of Ruminococcus and lower counts of 
Enterobacteriaceae when comparing with the feeding with the LE diet 
(Table IX.1). Overall, during the feeding of the SIMGI with the LE-OsLu 
diet the highest bacterial counts were recorded for the TC compartment, 
including Bifidobacterium, Bacteroides, B. coccoides-E. rectale group, C. 
leptum and Ruminococcus. Lactobacillus was also highly represented in 
the AC compartment at the end of the LE-OsLu diet. Most of the microbial 
changes observed between the HE and LE-OsLu diets persisted during 
the feeding with the LE diet, except for the increase of Bacteroides, 
Prevotella and Enterobacteriaceace observed at the end of the 
experimental study with the LE diet (Table IX.1). However, except for 
Enterobacteriaceace, differences in bacterial counts bewteen diets 
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involved variations generally below 1 log units, indicating that the 
differences in the amount of nutrients, including the supply with 10 g/L of 
OsLu, were not able to cause a substantial effect in the bacterial counts 
such as a relevant shifting between sacharolytic and proteolytic 
populations. 
Table IX.1. Mean ± SD of quantitative PCR counts (log copy number/ml) for the 
different microbial groups analyzed in the ascending (AC), transverse (TC) and 
descending colon (DC) of the SIMGI at the end of the stabilization period with 
the high energy (HE) diet and at the end of the feeding with the low energy (LE) 
diet with and without oligosaccharides derived from lactulose (OsLu). 
  
Bacterial group Compartment          Diet 
  HE LE OsLu LE 
Total bacteria AC 8.83 ± 0.29 8.92 ± 0.42 9.11 ± 0.23 
 TC 9.14 ± 0.23 9.19 ± 0.66 9.45 ± 0.17 
 DC 9.42 ± 0.18 8.87 ± 0.12 9.26 ± 0.10 
Lactobacillus AC 7.36 ± 0.32 7.74 ± 0.38 7.74 ± 0.46 
 TC 7.41 ± 0.08 7.45 ± 0.18 7.49 ± 0.23 
 DC 7.20 ± 0.13 6.83 ± 0.11 6.94 ± 0.33 
Bifidobacterium AC 6.45 ± 1.04 5.22 ± 0.04 7.10 ± 0.15 
 TC 7.30 ± 0.52 7.62 ± 0.48 7.87 ± 0.25 
 DC 7.45 ± 0.16 7.46 ± 0.25 7.92 ± 0.14 
Bacteroides AC 8.66 ± 0.38 9.00 ± 0.33 9.52 ± 0.16 
 TC 9.29 ± 0.13 9.51 ± 0.08 9.51 ± 0.10 
 DC 9.32 ± 0.22 8.98 ± 0.27 9.24 ± 0.12 
Blautia coccoides- AC 7.38 ± 1.00 7.19 ± 0.39 8.05 ± 0.41 
Eubacterium rectale TC 8.50 ± 0.14 8.46 ± 0.11 8.56 ± 0.07 
 DC 8.69 ± 0.18 7.97 ± 0.42 8.16 ± 0.18 
Clostridium leptum AC 2.70 ± 0.77 2.11 ± 0.28 2.28 ± 0.10 
 TC 7.24 ± 0.16 6.92 ± 0.10 6.96 ± 0.09 
 DC 7.00 ± 0.20 6.48 ± 0.24 6.69 ± 0.03 
Ruminococcus AC 1.73 ± 1.23 3.43 ± 1.78 1.94 ± 0.94 
 TC 4.67 ± 0.08 4.85 ± 0.06 5.53 ± 0.36 
 DC 5.51 ± 0.01 5.47 ± 0.20 5.89 ± 0.13 
Prevotella AC 4.16 ± 0.61 4.54 ± 1.20 5.18 ± 0.05 
 TC 4.62 ± 0.46 4.96 ± 0.62 5.56 ± 0.28 
 DC 4.72 ± 0.21 4.46 ± 0.09 4.56 ± 0.01 
Akkermansia AC 2.20 ± 0.79 2.80 ± 0.16 3.18 ± 0.26 
 TC 3.57 ± 0.05 3.52 ± 0.55 3.39 ± 0.41 
 DC 3.46 ± 0.04 3.89 ± 0.57 3.91 ± 0.13 
Enterobacteriaceae AC 2.84 ± 0.17 5.56 ± 0.28 7.43 ± 0.13 
 TC 6.18 ± 0.03 7.56 ± 0.08 7.75 ± 0.16 
 DC 5.95 ± 0.19 6.72 ± 0.23 7.88 ± 0.16 
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The qPCR counts were in agreement with the qualitative 
assessment of biodiversity analyzed by PCR-DGGE. The analysis was 
carried out to compare the differentiation of microbial communities within 
each colon compartment and to qualitatively detect changes to the 
biodiversity as a function of varied substrate availability. Fig. IX.1 shows 
the microbial community profiles of the AC, TC and DC compartments at 
the last day of each intervention period of the SIMGI with the HE diet 
followed by the LE diet supplemented with OsLu and finally with only the 
LE diet. The results showed that samples from the three colon 
compartments clustered together independently of the carbohydrate 
content of the diets. This feature is consequence of the characteristics of 
three-stage fermentation models that allow reproducing differences from 
proximal, characterized by acidic pH and carbohydrate-excess conditions, 
to distal colonic regions showing a carbohydrate-depleted and non-acidic 
environment (Macfarlane and Macfarlane, 2007).  
 
Figure IX.1. Clustering tree of total bacteria DGGE profiles of samples from the 
ascending (CA; green), transverse (CT; orange) and descending (CD; fucsia) 
colon compartments at the last days of feeding the SIMGI with the HE (red), LE 
(violet) and OsLu (blue) diets. 
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Results and discussion 
The results of metabolic activity, analyzed as the production of 
SCFA, lactic acid and ammonium, of the microbial community during the 
last 3 days of each fermentation period (HE, LE-OsLu and LE) in the AC, 
TC and DC compartments are shown in Table IX.2. Except for lactic and 
formic acids, the SCFA and ammonium concentrations gradually 
increased from the AC to the DC compartment because of the 
accumulation of products in the system, consistent with operation of 
three-stage culture reactors without absorption steps (Cinquin et al., 
2006; Possemiers et al., 2004). Lactic and formic acids were only 
produced in the AC compartment and the latest only in the HE and LE-
OsLu diets. Lactic acid can be further metabolised within the colon and 
turned into butyric and propionic acids through cross-feeding by gut 
bacteria (Duncan et al., 2004; Reichardt et al., 2014). Likewise, formic 
acid is a component in the mutualistic interaction between fermentative 
bacteria and syntrophic metabolizers and has an important role in 
anaerobic metabolism via interspecies cross-feeding interactions (Louis 
et al., 2014). Bifidobacterium has been described to produce formic acid 
from several carbohydrate sources, whereas some Lactobacillus species 
undergo a metabolic shift towards acetate and formate production, at the 
expense of lactate production, when growing on non-digestible 
oligosaccharides (Tabasco et al., 2014). The metabolic shift has been 
associated with more ATP production, resulting in a more efficient use of 
the available energy source (Van der Meulen et al., 2004). 
The effect of reducing the energy nutrient loading on microbial 
metabolic activity was characterized by an overall 2-fold decrease in the 
average content of total SCFA, mainly associated to acetic acid changes, 
of the three colon compartments with the LE diet compared to the HE 
intake period. Within the SCFA analyzed, propionate production was the 
least affected by nutrient load, whereas butyrate production was 
practically stopped with the LE diet (Table IX.2). These results point 
toward the microbial utilization of the butyrate via methanogenesis or 
 
Effect of lactulose-derived oligosaccharides on colonic microbiota during the shift 
between diets with different energy contents 
323 
sulfate reduction (Worm et al., 2014). The absence of net butyrate 
production could be restored by supplementating the LE diet with OsLu. 
Additionally, the shift from high to low energy medium caused a 2-fold 
increase in the ammonium content of the distal colon compartments (TC 
and DC) and a remarkable 5.5-fold increase in the proximal colon 
compartment (AC). This shift from fermentative to proteolytic metabolism 
was not observed when the LE diet was supplemented with OsLu (Table 
IX.2; Fig. S1). The SFCA and ammonium results could be compared with 
in vivo data from obese subjects, where a significant decrease of SCFA, 
particularly acetate and butyrate, and an increase of proteolytic products 
were observed when the individuals consumed diets high in protein and 
reduced in total carbohydrates (Russell et al., 2011; Levy and Borenstein, 
2014). There is evidence from both humans and animal models that 
dietary supplementation with non-digestible carbohydrates can decrease 
protein fermentation in the large intestine, which concurs with a decrease 
in the genotoxicity of faecal water (Windey et al., 2012). 
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Table IX.2. Changes in concentration (mM) of SCFA and ammonium in the 
ascending (AC), transverse (TC) and descending colon (DC) of the SIMGI at 
the end of the stabilization period with the high energy (HE) diet and at the end 
of the feeding with the low energy (LE) diet with and without oligosaccharides 
derived from lactulose (OsLu). 
 
  
Compound  HE LE OsLu LE 
Total SCFA AC 88.24 ± 2.53 59.17 ± 12.36 36.54 ± 0.74 
 TC 110.04± 14.50 94.30± 16.12 50.89± 1.36 
 DC 120.35 ± 2.50 86.88 ± 0.21 54.80 ± 0.21 
Acetic acid AC 45.46 ± 3.79 33.91 ± 2.08 22.81 ± 0.86 
 TC 57.63 ± 6.27 46.43 ± 7.55 30.84 ± 0.33 
 DC 62.84 ± 1.61 44.03 ± 0.44 30.70 ± 0.47 
Propionic acid AC 16.36 ± 0.30 17.27 ± 4.84 11.06 ± 0.14 
 TC 28.05 ± 4.64 25.60 ± 4.94 16.69 ± 1.16 
 DC 32.17 ± 1.32 26.48 ± 0.55 20.55 ± 0.34 
Butyric acid AC 21.39 ± 0.43 13.58 ± 4.29 0.05 ± 0.08 
 TC 27.53 ± 4.24 22.28 ± 3.63 3.36 ± 0.13 
 DC 25.34 ± 0.43 16.38 ± 0.77 3.34 ± 0.62 
Lactic acid AC 3.85 ± 0.00 2.53 ± 0.00 2.62 ± 0.05 
 TC nd nd nd 
 DC nd nd nd 
Formic acid AC 3.12 ± 1.32 2.90 ± 0.00 nd 
 TC nd nd nd 
 DC nd nd nd 
Ammonium AC 4.05± 1.19 7.07± 3.09 22.39± 4.97 
 TC 34.80± 15.79 50.61± 6.44 50.44± 6.99 
 DC 55.68± 19.23 67.50± 5.15 63.10± 2.47 
Nd: not detected 
 
Effect of lactulose-derived oligosaccharides on colonic microbiota during the shift 
between diets with different energy contents 
325 
In conclusion, the results obtained in this study indicate that except 
for Enterobacteriaceae, characterized by becoming great competitors in 
carbohydrate scarcity, stability of the microbial populations was the 
dominant pattern. Community structure clusters were predominately a 
function of the specific-region colonic conditions, suggesting that 
community structures are relatively robust with little substantial change 
during shifts in nutrient supply. Furthermore, metagenomic studies are 
consistently showing that inter-individual differences in gut microbiota in 
terms of microbial composition can be over 90% (Dorrestein et al., 2014), 
but that there is an assembly of functional communities that share 
similarities in their metabolic pathways (Shafquat et al., 2014). It implies 
that distinct microbial species may be responsible for specific functions 
and adapt themselves to environment and diet affecting human 
homeostasis and health status. The results obtained in this study indicate 
that substitution of easily digestible carbohydrates by OsLu allows the 
development of a fermentative functionality, maintaining the net 
production of butyric acid with potential beneficial effects on health, and 
avoiding a full transition to proteolytic metabolism profiles. 
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IX.6 SUPPLEMENTARY MATERIAL 
 
Fig. S1. Changes in concentration (mM) of butyric acid (diamonds) and 
ammonium (circles) in the ascending colon (AC; circles) of the SIMGI during the 
periods of stabilization with the HE, OsLu and LE diets. 
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CONCLUSIONS 
First 
Polyphenols of cranberry, grape seed and red wine extracts 
possess antimicrobial activity against some bacterial groups of the 
intestinal microbiota, in particular over Bacteroides, Prevotella and Blautia 
coccoides-Eubacterium rectale. Among the tested extracts, grape seed 
polyphenols showed the highest antimicrobial effect. 
Second 
Lactobacillus plantarum IFPL935 has a protective role on some 
intestinal bacteria affected by the presence of red wine polyphenols, 
Bacteroides and Bifidobacterium in batch incubations, and on the 
butyrate-producing groups Ruminococcus, B. coccoides/E. rectale and 
Clostridium leptum, particularly during dynamic simulation. Likewise, L. 
plantarum IFPL935 has a positive impact on the butyric acid production in 
distal colon regions. 
Third 
Lactobacillus plantarum IFPL935 has demonstrated that in 
presence of a complex human colonic microbiota is able to initiate the 
metabolism of flavan-3-ols, giving rise to the intermediate compounds 
diphenylpropan-2-ol, (5-(3′-hydroxyphenyl)-γ-valerolactone and 4-
hydroxy-5-(3’-hydroxyphenyl)-valeric acid, and favours the formation of 
end metabolites such as phenylpropionic acids. 
Fourth 
The moderate intake of red wine during four weeks does not 
significantly modify the composition of the human oral and intestinal 
microbiota. Overall, the large inter-individual variability in the microbial 
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profiles has a stronger influence for the grouping of samples than the 
possible influence of wine intake. 
Fifth 
The dynamic in vitro gastrointestinal simulator SIMGI is capable to 
stabilize and reproduce the composition and fermentative activity of the 
ascending, transverse and descending colon regions of the human 
microbiota. 
Sixth 
The feeding during one week with lactulose-derived 
oligosaccharides (OsLu), as a prebiotic ingredient in a low carbohydrate-
content diet, does not produce changes in the composition of the colonic 
microbiota developed in the SIMGI. The addition of OsLu allows to 
maintain the microbial fermentative functionality, represented by net 
butyric acid production in the ascending colon region, and to decrease 
proteolysis. 
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CONCLUSIONES 
Primera 
Los polifenoles de los extractos de arándano rojo, pepita de uva y 
vino tinto poseen actividad antimicrobiana frente a algunos grupos 
bacterianos de la microbiota intestinal, especialmente sobre Bacteroides, 
Prevotella y Blautia coccoides-Eubacterium rectale. Entre los extractos 
evaluados, los polifenoles de pepita de uva mostraron el mayor efecto 
antimicrobiano. 
Segunda 
Lactobacillus plantarum IFPL935 ejerce un papel protector sobre 
bacterias intestinales que se ven afectadas por la presencia de los 
polifenoles de vino tinto, como Bacteroides y Bifidobacterium en 
incubaciones estáticas, y los grupos productores de ácido butírico 
Ruminococcus, B. coccoides/E. rectale y Clostridium leptum, 
particularmente en la simulación dinámica. Asimismo, L. plantarum 
IFPL935 tiene un impacto positivo sobre la formación de ácido butírico en 
regiones colónicas distales. 
Tercera 
Lactobacillus plantarum IFPL935 ha demostrado que en presencia 
de una microbiota colónica compleja inicia el metabolismo de flavan-3-
oles, mediante la formación de compuestos intermediarios como 
dihidroxifenilpropan-2-ol, 5-(3′-hidroxifenil)-γ-valerolactona y ácido 4-
hidroxi-5-(3′-hidroxyfenil)valérico, y favorece la formación de metabolitos 
finales como ácidos fenilpropiónicos. 
Cuarta 
El consumo moderado de vino tinto durante cuatro semanas no 
causa diferencias significativas en la composición de la microbiota oral e 
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intestinal humana. En general, la alta variabilidad interindividual de los 
perfiles microbianos tiene mayor efecto en el agrupamiento de las 
muestras que el que pudiera ejercer el consumo de vino. 
Quinta 
El simulador gastrointestinal dinámico in vitro SIMGI reproduce de 
manera estable la composición y la actividad fermentativa de la 
microbiota representativa de las regiones del colon humano ascendente, 
transverso y descendente. 
Sexta 
La alimentación durante una semana con oligosacáridos derivados 
de lactulosa (OsLu) como ingrediente prebiótico en una dieta baja en 
carbohidratos no ocasiona cambios en la composición de la microbiota 
colónica desarrollada en el SIMGI. La administración de OsLu permite 
mantener la funcionalidad fermentativa representada por la producción 
neta de ácido butírico en la región ascendente del colon y reducir la 
proteólisis. 
  
